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Abstract Helminth infections are highly prevalent in de-
veloping countries, especially in rural areas. With gradual
development, there is a transition from living conditions that
are dominated by infection, poor sanitation, manual labor,
and traditional diet to a situation where burden of infections
is reduced, infrastructure is improved, sedentary lifestyle
dominates, and processed food forms a large proportion of
the calorie intake. The combinations of some of the changes
in lifestyle and environment are expected to result in alter-
ation of the landscape of diseases, which will become dom-
inated by non-communicable disorders. Here we review
how the major helminth infections affect a large proportion
of the population in the developing world and discuss their
impact on the immune system and the consequences of this
for other infections which are co-endemic in the same areas.
Furthermore, we address the issue of decreasing helminth
infections in many parts of the world within the context of
increasing inflammatory, metabolic, and cardiovascular
diseases.
Keywords Helminths . Co-infection . Allergy . Metabolic
syndrome . Cardiovascular diseases . Epidemiological
transition . Immune responses
The burden of helminth infections
A diverse range of helminth parasites, differing in terms of
their size, life cycle, and clinical impact, can lead to chronic
infections in humans. Soil-transmitted helminth (STH)
infections, together with schistosomiasis and filariasis, form
a major proportion of a group of neglected tropical diseases
and together affect about one third of the world population
[1]. Helminth infections, the ancient companions of poverty,
together with the major infectious diseases are the targets of
millennium development goals to improve global public
health outcomes.
There are more than 20 helminth species infecting
humans, of which the majority of infections are light,
asymptomatic, and rarely cause attendance to health centers
[1, 2]. However, children with heavy and chronic STH
(Ascaris lumbricoides, hookworms [Necator americanus,
Ancylostoma duodenale], and Trichuris trichiura) infections
can suffer from malnutrition, growth stunting, intellectual
retardation, as well as cognitive and educational deficits [2].
In addition, it is known that a proportion of individuals with
intestinal schistosomiasis (caused by Schistosoma mansoni,
Schistosoma japonicum, Schistosoma mekongi, and Schis-
tosoma intercalatum) can present with intestinal and hepa-
tosplenic symptoms, while those with Schistosoma
haematobium infection can suffer from urogenital symp-
toms [3]. A more serious condition has been seen when
eggs get dislodged in the spinal cord or the brain, leading
to neurological damage, such as myelopathy (acute trans-
verse myelitis and sub-acute myeloradiculopathy) in S. man-
soni- or in S. haematobium-infected subjects and acute
encephalitis of the cortex, sub-cortical white matter, or basal
ganglia in S . japonicum-infected subjects [4]. In
schistosome-naïve travelers, acute infection can result in
systemic hyper-reactive symptoms, commonly referred to
as Katayama fever [5]. The range of pathologies seen with
a third group of major helminth infections, the filarial
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nematodes, are lymphatic oedemas caused by Wuchereria
bancrofti, Brugia malayi, and Brugia timori, blindness
caused by Onchocerca volvulus, and calabar swellings
caused by Loa loa [6, 7]. In lymphatic filariasis, the lym-
phatic vessels at the site where the adult worms nest are
dilated (lymphangiectasia), most commonly seen in the
extremities and male genitalia [6]. Individuals with chronic
onchocerciasis can develop depigmentation and loss of skin
structure and elasticity that can lead to premature skin aging,
while ocular lesions resulting from the migration of micro-
filariae to the eye can lead to severe visual impairment and
blindness [6]. The calabar swelling in loaiasis is the typical
clinical sign of this infection which is presented as a region-
al fugitive/episodical angioedema around the migrating
adult worms, mostly in the arms and the legs [6, 7]. Al-
though these outcomes of helminth infections are not the
norm, their severity can form a strong basis for the urgent
calls to control helminth infections worldwide.
It remains interesting that the majority of helminth infec-
tions have no outward clinical signs. It is thought that these
infections often co-exist in harmony with their human host as
a result of long evolutionary co-adaptation. To this end, hel-
minths are able to influence their host to ensure their long-
term survival, while this same adaptation might be beneficial
to the host if it restricts damage to tissues and organs. The
current view is that, although in the majority of infected
populations these parasites can manipulate the immune sys-
tem, in a small proportion of subjects, this manipulation seems
to fail and leads to pathologies as described earlier.
The immunological consequences of helminth infections
Helminths are known to skew the immune system towards
type-2 immunity characterized by T helper (Th) 2 cells and
their cytokines (interleukin (IL)-4, IL-5, IL-9, IL-13), high
level of tissue eosinophilia, mucosal mastocytosis, and pro-
duction of immunoglobulin (Ig) E. Another hallmark of
helminth infections is their ability to induce regulatory
responses via regulatory T cells (Treg) that express mole-
cules involved in the inhibition of immune responses such
as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)
or glucocorticoid-induced TNF receptor [8] and secrete
suppressory cytokines (IL-10 and transforming growth fac-
tor (TGF) ß) [9]. Helminth infections have also been asso-
ciated with regulatory B cells (Breg), which can release IL-
10 and restrain hyper-inflammatory responses [10]. These
parasites seem to also affect the expansion of innate immune
cells with the ability to dampen immune response. Among
these are the suppressor macrophages [11] as well as the
induction of regulatory dendritic cells (DCreg) which are
characterized by the expression of IL-10, TGF-β, indole-
amine 2,3-dioxygenase, and cyclooxygenase-2 [12, 13].
Moreover, helminth infections result in the skewing of mac-
rophage development away from classically activated mac-
rophages to alternatively activated macrophages (AAM)
(which can be induced by IL-4, IL-13, and IL-10) [14]. This
army of regulatory cells can modulate immune responses in
antigen (Ag)-specific and non-specific manner and can lead
to restriction of inflammation. In terms of pro-inflammatory
responses, several studies in humans as well as in animal
models have indicated that Th1 and Th17 cells can be part
of the immune response induced by helminth infections and
might play an important role in pathological outcomes.
In schistosomiasis, immunoepidemiological studies have
indicated that Th2 responses are associated with resistance
to reinfection [15, 16]. However, in animal models, Th1
cells have been shown to also contribute to immunity
against these parasites [17, 18]. With respect to pathology,
pro-inflammatory responses, represented by high TNF and
by the type-1 associated cytokine, interferon (IFN)-γ, were
shown to be elevated in the circulation of Kenyan patients
with hepatosplenomegaly [19], yet in a study in Brazil
schistosome-related pathology was reported to be associated
with higher IL-13 production [20]. Notwithstanding the
experimental details, these apparently conflicting outcomes
might reflect the fact that pathology is a complex process
and immunological responses would be expected to be
different during the different phases of the development of
pathology. With respect to other cytokines, recent studies
that have focused on examining the role of Th17 cells have
shown these cells to be associated with schistosome-induced
pathology in animal models [21, 22] and in humans [23]. In
terms of control of the immune responses in schistosomia-
sis, several mechanisms seem to be involved, most promi-
nent being the down-modulation of effector responses by
IL-10 and TGF-ß, which prevent schistosome-induced pa-
thology [24–26]. The exact mechanisms are not fully under-
stood but could involve, in addition to Treg, IL-10
production B cells which have been shown to be present
in murine and in human chronic schistosomiasis [27]. More-
over, in a recent review, the role of AAM as key players in
controlling the development of immune pathology in schis-
tosomiasis was highlighted [28]. To what extent Treg, B
cells, or AAM play a role in the control of immune
responses and pathology in human schistosomiasis needs
to be determined in well-designed studies.
In STH infections which are mainly restricted to the
gastrointestinal tract, acute or early infections, as shown in
animal models with Trichuris muris, are often thought to be
associated with pro-inflammatory cytokines, such as TNF
[29, 30]. Th2 responses have been shown to be needed to
expel these helminths from the gut [31, 32]. One of the
mechanisms involved in the Th2-induced expulsion is the
stimulation of higher intestinal epithelial cell turnover [33]
and, as recently shown, the alteration of the composition of











the mucus layer [34]. Whereas work in experimental models
has elegantly shown how different arms of the type-2 im-
mune system are involved in intestinal worm expulsion [35]
and how gut helminths try to avoid expulsion by up-
regulation of IFN-γ to combat Th2 responses [36], relative-
ly little is known about the situation in humans. One of the
first human studies examining immune response to STH
showed that stronger Th2 cytokines were associated with
lower infection burden, suggesting that in humans type-2
responses may also be associated with protection from STH
[31]. A few studies have reported the up-regulation of
suppressory cytokines such as IL-10 and/or TGF-ß [37]. In
Cameroon, children living in areas hyperendemic for hel-
minths produce more IL-10 and TGF-ß than children living
in mesoendemic areas [38], whereas in a study in Brazil,
increased spontaneous IL-10 production was seen in a larger
proportion of children infected with STH [37]. The higher
production of these cytokines was related to hypo-
responsiveness to helminth or bystander antigens [39] and
presumably allows worm survival. A more comprehensive
analysis of the response to STH infection was undertaken in
chronically infected children whose peripheral blood gene
expression patterns were studied extensively by using
microarrays. The results indicated that chronic STH infection
was associated with altered gene expression profiles that
suggest these infections to be associated with modified Th2
responses (i.e., up-regulation of IL-5 and IL-10), with down-
regulation of neutrophil activation and function and up-
regulation of mediators associated with eosinophils [40]. In-
terestingly, microRNA (miRNA) was also studied using a
specific array [40], and the results showed that a single
miRNA, hsa-let-7d, was down-regulated during chronic
STH infection. This miRNA, already reported to affect iron
metabolism [41], is part of the let-7 miRNA family, found to
be abundant in the alveolae of normal lungs but almost absent
in the lungs of mice with idiopathic pulmonary fibrosis [42],
suggesting its possible role in preventing lung fibrosis. Al-
though these studies need to be linked to extensive target
identification and functional studies, they indicate the poten-
tial for gaining a full picture of how these parasites might
affect not only the immune system but also target organs.
In lymphatic filariasis, inflammatory responses occur
when the adult worms die, either drug-induced or spontane-
ously. Granulomas arise around the worms, characterized by
macrophages which develop into giant cells as well as
plasma cells, eosinophils, and neutrophils [43]. Peripheral
Th1 and Th17 cells as well as antibody responses are
reported to be up-regulated in patients with chronic pathol-
ogy [44]. The immune regulatory responses that are up-
regulated during microfilaremic state without any signs of
pathology are characterized by production of IL-10 and
TGF-β [45] as well as with increased Treg. Metenou et al.
[46] have shown that individuals infected with W. bancrofti
and/or Mansonella perstans have increased frequency of
natural Treg as well as IL-10 producing effector cells. A
study in a B. timori endemic area, conducted by Wammes et
al. [47], showed that the Treg of microfilaremic subjects has
stronger suppressory activity than the Treg of endemic ami-
crofilaremic controls or subjects with chronic pathology. In
onchocerciasis, hyper-reactivity has been shown to be cor-
related with pathology of the skin and lymph nodes [48]. A
possible role for IL-13 in the pathogenesis of onchocerciasis
was found in an immunogenetic study, which showed that
Th2-dominated sowda form of hyper-reactive onchocercia-
sis was associated with a mutation in the IL-13 gene, a gene
known to be linked to allergic hyper-reactivity [49]. As in
lymphatic filariasis, Treg has been described in subjects
with onchocerciasis [50, 51] and thought to keep the devel-
opment of pathology at bay.
Taken together, it seems that the pro-inflammatory
responses typified by Th1 and Th17 and also by hyper-
active Th2 responses might underlie the immunopathology
in helminth infections. However, most helminth infections
appear to be associated with regulatory mechanisms [52]
that try to keep pathological responses under control. These
regulatory responses can be helminth Ag-specific or exert
non-specific spill over suppressory effects on unrelated Ags.
Helminths and their spillover effects on health outcomes
Various helminth infections seem to have profound effects
on the immune reactions against other infections and by-
stander Ags, be it vaccines, environmental allergens, or self-
Ags. However, this is an area full of controversy and clearly
needs more research.
Co-infection
It is common that helminth infections are co-endemic with
malaria, tuberculosis (TB), and human immunodeficiency
virus (HIV) [1]. This situation raises the question of what
impact helminth infections may have on the co-endemic
infections as they are believed to be able to suppress effector
T cell responses. In filaria-infected individuals, the magnitude
of inflammatory cytokines, IFN-γ and IFN-γ inducible pro-
tein 10, in response to malaria Agwas shown to be affected by
filaria-induced IL-10 [53]. Moreover, in malaria-infected indi-
viduals, concomitant filarial infection has been shown to
decrease the frequencies of malaria-specific Th1 and Th17
cells [54]. The same seems to be the case for mycobacteria
Ag-specific responses, which appear to be down-regulated in
filaria-infected subjects via increased expression of the nega-
tive co-stimulatorymolecules CTLA-4 and inhibitory receptor
programmed death 1 [55]. Interestingly, although chronic
mycobacteria [56] and plasmodia infections [57, 58] on their











own are associated with increased Treg, a study on Flores
island, Indonesia, using in vitro Treg depletion has shown that
Treg from STH-infected subjects have stronger functional
activity than Treg from those free of STH in immune
responses to bystander mycobacteria and plasmodia Ag [59].
Although at the immunological level helminths seem to be
able to influence responses to co-infections, it is far from clear
whether this is translated into clinical and epidemiological
outcomes. Epidemiological studies on the relationship between
helminths and malaria, TB, or HIV have shown conflicting
results [60, 61] as have studies in animal models [62–67].
In some studies, a positive association has been reported
between helminths and malarial parasitemia, while in others
this has been refuted or even a negative association has been
found with clinical outcomes [68–70]. For example, there is
evidence that helminth co-infection with malaria is associ-
ated with increased risk of anemia [71], but there is also
evidence for a protective role against developing anemia
[72] or no association [73]. A recent review by Nacher
[60] suggests that there are different malaria outcomes with
different species of helminths. This is supported by a recent
case–control study in Colombia that showed an example of
how different helminth species vary in their association with
Plasmodium falciparum [74]. It showed that whereas A.
lumbricoides infection had a protective effect, hookworm
infection seemed to be a risk factor. In line with this unclear
situation on the effect that helminths have on malaria para-
sites or outcomes are the inconsistent results of the deworm-
ing trials [75–77], which might be due to the differences in
the characteristics of the populations studied, species of
helminths prevalent, and the study designs.
Regarding the relationship between helminth infections
and mycobacteria, there is still limited evidence for any
significant interaction. In helminth-infected individuals, a
higher risk to develop pulmonary TB has been reported
[78], as well as IFN-γ production in response to purified
protein derivative upon Bacillus Calmette Guerin vaccina-
tion [79]. However, in an area highly endemic for helminths
in the Amazon, where it was expected that high helminth
infection pressure would attenuate the tuberculin skin test
(TST), there was no significant suppressive effect of hel-
minth infection on the TST size [80].
The same inconclusiveness applies to the relationship be-
tween helminths and HIV. Concerning HIV acquisition and
progression, Webb and colleagues [81] have reviewed this
subject and indicate that there are inconsistent findings with
regard to whether helminth–HIV co-infection can have a more
detrimental effect on the host compared to a single HIV
infection or the beneficial effect of anthelminthic treatment
on HIV. A Cochrane review in 2009 demonstrated a beneficial
effect of deworming on both plasma HIV-1 RNA and CD4
counts [82], but a recent report on anthelminthic treatment
with albendazole and praziquantel during pregnancy in
Uganda indicated that there was no effect of treatment on
vertical HIV transmission [75]. However, in this study, the
authors acknowledge that the data were generated on a small
number of infants born to HIV-infected mothers. For the
mothers, anthelminthic treatments resulted in a modest reduc-
tion in HIV virus load in the albendazole (to treat hookworm
and T. trichiura)-treated mothers, but no difference was seen
in praziquantel (to treat S.mansoni)-treated subjects compared
to placebo at 6 weeks after administration of the drug [83].
These results might again be in line with what has been
discussed in a meta-analysis of the effect of anthelminthic
treatments on HIV that suggests that different helminth spe-
cies might have different outcomes [84].
It has to be concluded that in order to be able to draw firm
conclusions regarding the effect of helminths on malaria,
TB, or HIV, well-powered placebo-controlled anthelminthic
trials are needed with a streamlined design that will also take




Allergic diseases (allergic asthma, eczema, and rhinitis) are
dominated by type-2 responses [85]. The prevalence of
these diseases are thought to be relatively low in developing
countries especially in rural areas [86–88], which has often
been put into the context of the hygiene hypothesis and the
high prevalence of helminth infections (Fig. 1). It has been
argued that in rural areas of low-to-middle-income countries
(LMIC), the exposure to microorganisms and parasites is
high and therefore the immune system is educated in a way
that it no longer reacts to innocuous substances such as
environmental allergens. Although helminth infections skew
immune responses toward Th2, they have been reported to
be inversely associated with allergic disorders [89]. This has
been argued to be due to the ability of chronic helminth
infections to induce regulatory responses [90]. This means
that helminth infections which have been associated with
increased IL-10 or TGF-ß production by several regulatory
cells might suppress the effector mechanisms that lead to the
development of allergy. In a study in human schistosomiasis
in Gabonese children more than a decade ago, it was shown
that the anti-inflammatory cytokine, IL-10, in response to
the helminth Ags, was associated inversely with skin prick
test (SPT) reactivity to house dust mite allergen [89]. How-
ever, in a more recent study of Ecuadorian children, A.
lumbricoides infection, although inversely associated with
SPT reactivity to allergen [87], did not involve IL-10 pro-
duction in response to A. lumbricoides Ag [91]. In contrast
to the study in Ecuadorian children but in line with the
Gabon study, in another study where hookworm-infected











schoolchildren were studied in Vietnam, IL-10 production in
response to N. americanus excretory–secretory Ag was in-
versely associated with skin sensitization [92]. The discrep-
ancy between these studies might be caused by infection
intensity as shown in an animal model [93] or differences in
helminth species. Another important aspect of the relation-
ship between helminths and allergies is the issue of IgE
cross-reactivity. There is evidence for IgE cross-reactivity
between helminth Ags and allergens such as with cockroach
[94] or mite [95]. It has been suggested that this cross-
reactivity might influence allergy outcomes. Whereas in
Europe, high total and specific IgE are associated with
increased risk of SPT positivity [96] and allergic disease,
this association is less clear in areas endemic for helminth
infections [97, 98]. The reason may be that IgE cross-
reactive between helminths and allergens has low biologic
activity [90]. Thus, in areas where helminths are endemic,
early sensitization to helminth Ag might lead to weak IgE
binding to cross-reactive allergens, preventing strong aller-
gic responses, and might explain in part the mechanisms
whereby helminth infections lead to fewer allergic disorders.
With respect to deworming trials, 1 year of anthelminthic
treatment in studies in Ecuador and in Vietnam showed in-
consistent results, the former showing no effect, but the latter
led to increased SPT reactivity to allergen [92, 99]. In addition,
a study in Denmark analyzing records of children born be-
tween 1995 and 2008 showed that treatment with mebenda-
zole of children infected with Enterobius vermicularis had a
marginal effect on the incidence of asthma [100]. Interesting-
ly, in a study of anthelminthic treatment of pregnant women in
Uganda, an increased risk of infantile eczema was seen in
mothers who received anthelminthics compared to those that
received placebo [101]. This raises the issue regarding the
timing of deworming; maybe exposure to worms in early life
imprints on the immune system, affecting allergic outcomes
more profoundly than when helminths are removed later in
life [102]. Moreover, there is increasing evidence for the
difference in risk factors associated with allergic and non-
allergic asthma [103] or maybe even eczema.
The converse experiments have been attempted where
patients were infected with helminths to treat allergic disor-
ders. The outcomes of these trials did not show any beneficial
effects [104–106]. Randomized placebo-controlled trial of
treatment with hookworm in adult patients with allergic asth-
ma [106] showed improvement of bronchial responsiveness in
infected group, but this was not significantly different com-
pared to the placebo-treated group. It might indicate that
higher doses of hookworm infection are needed. It must be
pointed immediately that not all helminth infections can be
therapeutically equal; for example, in mouse models for ex-
perimental allergic inflammation, previous infections with
Strongyloides stercoralis [107] or Nippostrongylus brasilien-
sis [108] resulted in suppression of allergic response to ova (as
an allergen) challenge, while infection with Toxocara canis
resulted in exacerbation of the allergic response [109]. Alto-
gether the hypothesis that helminth infection might be benefi-
cial against allergic disease or deworming might increase risk
for the disease is still controversial and needs more convincing
evidence [110–112]. There has been one very-long-term study
where 15–17 years of ivermectin treatment to control
Infections Inflammatory diseases



















Fig. 1 A schematic representation of epidemiological transition and
disease outcomes. Epidemiological transition is associated with
changes in disease burden. With decreasing burden of infectious
diseases, populations are facing increasing inflammatory non-
communicable disorders. One hypothetical framework for these ob-
served changes is that infections such as helminths which are associ-
ated with expansion of Th2 and regulatory T and B cells are
disappearing and therefore leading to altered immune profiles. There
is evidence, as discussed in this review, that Th2 responses are
associated with lower insulin resistance while enhanced Treg and Breg
can lead to suppression of allergic diseases in animal models. There-
fore, when Th2 and regulatory cells decline, it follows that insulin
resistance and allergic diseases become rampant. The black lines
represent strong modulatory pathways in areas where infections are
highly prevalent, while gray lines represent weak modulatory path-
ways in areas where infections are largely controlled. The solid lines
represent associations based on data available, while dotted lines
represent theoretical associations that are yet to be tested











onchocerciasis in Ecuador has resulted in increased SPT reac-
tivity to allergens [113]. Understandably, such studies are
difficult to perform and the question remains whether these
can be repeated. A recent Cochrane review [104] also ac-
knowledged insufficient evidence on the efficacy, tolerability,
and likely costs of using helminth infection as therapy to
support their use in the routinemanagement of allergic rhinitis.
Autoimmune diseases and inflammatory bowel disease
There are very few epidemiological studies of autoimmune
diseases in LMIC; however, geographical differences have
been reported. The conclusion of ecological studies is that
the situation of autoimmune diseases is mirroring that seen in
the field of allergy. It is suspected that there might be an inverse
association between the prevalence of autoimmune diseases
and the prevalence of infections including helminths [114].
One of the first studies showing the association between hel-
minth and autoimmune diseases was in an animal model of
multiple sclerosis (MS), where injection of mice with S. man-
soni eggs led to reduced severity of the disease and delayed
development of clinical symptoms [115]. Recently, several
studies have demonstrated that the course of autoimmunity is
determined by a mixture of pathological Th1 and Th17
responses [116, 117], and in the light of immune regulation,
the potential role of helminths to reduce the severity of disease
in MS patients [118–120] and inflammatory bowel disease
(IBD) [121–123] has been shown in a number of trials. A
clinical trial using repeated Trichuris suis ova treatment
resulted in reduced relapses in MS patients [123]. In another
study of MS patients, B cells isolated from patients who were
infected with helminths produced higher levels of IL-10 than B
cells from uninfected patients [120]. These B cells could also
produce high levels of brain-derived neurotrophic factor and
nerve growth factor which are thought to have a neuroprotec-
tive effect. The most detailed cellular and molecular informa-
tion on changes that take place in the intestinal mucosa has
been gathered on one ulcerative colitis patient who self-treated
himself with eggs of T. trichiura [124]. Ingestion of two doses
of helminth eggs (500 and 1,000 eggs) led to nearly 3 years of
complete disease remission [124]. As the symptoms began to
deteriorate paralleling a decline in egg counts, a third dose
(2,000 eggs) was taken and resulted in both symptom and
histopathological improvement, the latter seen in biopsies fol-
lowing colonoscopy [124]. Detailed immunological studies
showed that active colitis was associated with cytokine-
producing CD4+ IL-17+ Th cells, whereas helminth coloniza-
tion and disease remission were characterized by the presence
of IL-22+ Th cells in the colonic mucosa. Moreover, the
helminth-colonized ascending colon had higher expression of
IL-4, IL-25, and RELMβ [124], while the rectum with active
symptoms had elevated IL-17 and TNF as well as reduced
expression of RELMβ [124]. With respect to IL-22, gene
delivery of this cytokine to a local inflamed colon in a colitis
model led to attenuation of colitis, which was shown to be due
to the enhancement of intestinal mucus production by goblet
cells [125]. The role of other cells such as macrophages is not
as clear. The macrophages of the gastrointestinal tract, which
are distinct from blood macrophages [14], seem to be essential
for keeping the balance of commensal microbiota such that
pathology is avoided [126]. There is however still controversy
about whether AAM are beneficial or detrimental in this
aspect. In a murine model of bacterial colitis, infection with
Heligmosomoides polygyrus, which was associated with in-
creased AAM, seemed to lead to severer colitis [127]. Yet in
another chemically induced colitis model, Hymenolepis
diminuta infection induced an increase of FIZZ1/RELMα
and argininase-1 expression as markers of AAM and attenu-
ated colitis [128]. The discrepancy on the role of macrophages
could be the result of the use of different species of helminths
in the two studies or the type of colitis model used. Neverthe-
less, Wolff and colleagues recently summarized that helmin-
thic therapy for autoimmune diseases such as IBD is relatively
safe [129] and might provide new therapeutic possibilities for
inflammatory diseases such as MS and IBD. It is again im-
portant to note that large-scale trials are essential before any
firm conclusion can be drawn.
Cardiovascular disease
Cardiovascular disease (CVD) involves the heart and the
blood vessels. Atherosclerosis is an important risk factor for
developing CVD [130] and is now believed to involve inflam-
mation. Part of the inflammatory process is thought to be
mediated by the infiltration and retention of low-density lipo-
protein (LDL) in the arterial intima. The transformation of
these lipids into oxidized lipids can initiate an inflammatory
response that can accelerate CVD progression [131]. The
oxidized lipids can stimulate innate immune responses and
lead to the recruitment of inflammatory cells, such as mono-
cytes, into the vessel wall that when activated can attract other
cells and aggravate the growing plaque (reviewed by Hansson
[132]). However, currently available therapeutics against
CVD are largely restricted to alleviating hypertension and
hyperlipidemia [133, 134], while drugs targeting inflammato-
ry mediators are not yet available. Interestingly, the lipid-
lowering drug statin, one of the most frequently used medica-
tion, has been shown to have anti-inflammatory effects [135,
136]. Moreover, studies on the role of anti-inflammatory
mechanism in atherogenesis have suggested that Treg [137]
might be involved to limit inflammation and attenuate athero-
genesis. In an experimental model of hypertensive mice,
Kassan et al. [138] showed that IL-10 released by Treg could
improve microvascular endothelial function by reducing the
nicotinamide adenine dinucleotide phosphate oxidase activity
and increasing endothelial NOS activity. These data suggest











that indeed the balance between pro- and anti-inflammatory
cytokines might be an important element in the regulation of
vascular endothelial function.
CVD prevalence is increasing in Asian countries [139]. In
this region, rapid socioeconomic development has led to a
shift in infrastructure, technology, and food supply that pro-
motes over-nutrition and sedentary lifestyles [140]. Also, in
Asia, despite large geographical differences, infectious dis-
ease control such as deworming program is underway [141].
Hypothetically, helminths might protect against CVD by re-
ducing risk factors such as nutritional status. Helminths are
known to reduce energy intake and to be associated with poor
nutritional status, which in turn is associated with beneficial
effects on traditional CVD risk factors such as reduced serum
lipid levels [142]. Using apolipoprotein deficient (apoE−/−)
mice, a transgenic mice that has impaired plasma lipoprotein
clearance and develops atherosclerosis in a short time [143],
the development of atherosclerotic lesions was reduced by
approximately 50 % in mice infected with S. mansoni [144].
The same group showed that the cholesterol-lowering effects
were mediated by soluble factors released from S. mansoni
live eggs. A similar experiment, but using frozen eggs,
showed a reduction in total cholesterol and LDL in mice
injected with schistosome egg compared to those not injected
with eggs. However, in the latter study, no difference in
atherosclerotic lesion formation was observed [145]. Taken
together, these data suggest that helminth infections or their
products might be able to act as lipid-lowering agents.
Recently, a number of studies have shown a higher risk of
death from CVD among patients with rheumatoid arthritis
(RA) [146–148], which would be in line with the notion that
increased inflammation such as higher TNF and IL17 in RA
would lead to a higher risk of CVD [149]. A meta-analysis
by Micha et al. [150] summarized that methotrexate, an anti-
RA drug which is also used for the treatment of chronic
inflammatory disorders, has a beneficial effect on CVD.
Interestingly, the reported immune-modulatory capacity of
statins is based on their ability to induce Treg recruitment
[151] and to inhibit the pro-inflammatory action of IL-17
and TNF on human endothelial cells [152]. A similar im-
mune suppression by Treg, decreasing pro-inflammatory
cytokines such TNF and IL-17, has been shown in
helminth-infected subjects [47, 54]. Moreover, a family of
antioxidant proteins, the peroxiredoxins (PRDX), essential
for the enzymatic scavenging of hydrogen peroxide [153],
has been shown to play a role as immune modulators [154].
There is evidence that PRDX-1 and -2 are able to interfere
with endothelial activation and to regulate pro-inflammatory
responses in apoE−/− mice, respectively [155, 156]. Anoth-
er PRDX family, PRDX-4 seems to protect against the
formation of unstable atherosclerotic plaques [157]. Inter-
estingly, PRDX is also one of the molecules secreted by
several helminth parasites and is thought to help the
parasites to get through the defense barriers and avoid attack
mounted by the host [158–160]. Therefore, an interesting
area of research would be to test the role of helminth-
secreted PRDX and possibly other helminth-derived prod-
ucts on CVD as potential anti-atherogenic therapy (Fig. 1).
Diabetes
Obesity, DM2, and CVD share a metabolic profile charac-
terized by insulin resistance (IR) and chronic sub-acute
inflammation [161]. It has been shown that the pro-
inflammatory cytokine TNF is able to induce IR [162,
163]. This was shown in murine models where a lack of
TNF function results in improved insulin sensitivity and
glucose homeostasis, while administration of TNF leads to
IR [164]. As already discussed in earlier sections, helminth
infections seem to affect inflammation. In this regard, cross-
sectional studies in southern India showed an inverse asso-
ciation between DM1 [165] and DM2 [166] with lymphatic
filariasis. In our study in an area endemic for STH on Flores
Island, Indonesia, individuals infected with STH showed
lower IR (Wiria et al., unpublished data). The influence of
helminth infections has been shown in animal models of
DM1 [167] and DM2 [168]. Inhibition of DM1 develop-
ment by helminth infections appeared to be due to the ability
of helminths and their products to induce IL-10 production
by DC, B cells, AAM, and Treg. Likewise in an experimen-
tal model of DM2, Ricardo-Gonzales et al. [169] demon-
strated an improvement of glucose metabolism mediated by
the IL-4/STAT6 immune axis, a key pathway in helminth
immunity and Th2 response. They showed that IL-4 admin-
istration improved insulin action, lowered levels of insulin,
total cholesterol, and triglyceride, and protected the mice
from diet-induced obesity. Another study showed that
helminth-induced eosinophilia forestalls obesity and IR
[168]. Wu et al. [168] showed that in mice kept on high-
fat diet, infection with N. brasiliensis induced sustained
eosinophilia. Eoshinophils migrated into adipose tissue, se-
creted IL-4, and then induced AAM in the tissue; these cells
are able to sustain insulin sensitivity [168]. Despite the
extensive population studies on the role of helminths in
allergy or autoimmune diseases, epidemiological or mecha-
nistic data on the relationship between helminths and DM2
are still lacking, and even less is known about the effect of
deworming programs on IR and emergence of DM2 (Fig. 1).
Helminth-derived molecules
Recent years have seen a surge in efforts to identify
helminth-derived molecules with modulatory activity
[170]. The characterization of such molecules would be
beneficial on two fronts: (1) they can serve as vaccines if











used by parasites to enhance their survival—their neutrali-
zation would be expected to enhance worm expulsion [35]
and (2) they have the potential to be used to tame hyper-
inflammatory disorders. Early studies have shown that schis-
tosomes carry lyso-phosphatidylserine that are able to mod-
ulate DC and induce Treg [171]. In addition, the ability of
schistosomes to stimulate Th2 responses [172] was shown to
be mediated via immune-modulatory molecules present in
the extracts of eggs or in products secreted by eggs (omega-
1, IPSE, PRDX). These molecules can work via modulating
DC [173] and basophils [174] and via machrophages [158].
Other human helminth parasites are also known to release
modulatory molecules, such as AvCystatine, which is de-
rived from O. volvulus worms and stimulates the preferential
production of IL-10 by macrophages [175]. Much work is
underway to characterize molecules from worms that are
used as models of human infection. For example, from
Fasciola hepatica, a molecule which is called F. hepatica
helminth defense molecule-1 [176] can prevent LPS-induced
activation of innate immune responses in macrophages, and
from H. polygyrus the excretory–secretory antigen (HES) is
able to induce Foxp3+ Treg via a TGF-ß-like activity [177].
Interestingly, vaccination by HES resulted in antibody pro-
duction and protection against infection with H. polygyrus
[178]. Thus, the study of immune modulatory molecules
may provide new candidates for treatment of inflammatory
diseases on the one hand and vaccines against parasites on
the other.
Conclusions
Studies of helminth infections which seem to be able to
modulate the immune system have provided detailed in-
formation on cellular mechanisms involved in pathology,
immunity, and tolerance. Of particular interest has been
the ability of these parasites to exert anti-inflammatory
responses. On the one hand, this could potentially have
detrimental consequences for co-infections or vaccination
programs, while on the other hand it could exert beneficial
effects on diseases that stem from strong inflammatory
reactions. The identification of helminth-specific mole-
cules with immune modulatory activities holds great po-
tential as new therapeutics. However, the clinical
implications of these parasites and their immune modula-
tory activities have yet to be determined in well-designed
population studies.
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Abstract
Background: Given that helminth infections are thought to have strong immunomodulatory activity, the question
whether helminth infections might affect responses to malaria antigens needs to be addressed. Different cross-
sectional studies using diverse methodologies have reported that helminth infections might either exacerbate or
reduce the severity of malaria attacks. The same discrepancies have been reported for parasitemia.
Methods/Design: To determine the effect of geohelminth infections and their treatment on malaria infection and
disease outcome, as well as on immunological parameters, the area of Nangapanda on Flores Island, Indonesia,
where malaria and helminth parasites are co-endemic was selected for a longitudinal study. Here a Double-blind
randomized trial will be performed, incorporating repeated treatment with albendazole (400 mg) or placebo at three
monthly intervals. Household characteristic data, anthropometry, the presence of intestinal helminth and Plasmodium
spp infections, and the incidence of malaria episodes are recorded. In vitro cultures of whole blood, stimulated with a
number of antigens, mitogens and toll like receptor ligands provide relevant immunological parameters at baseline
and following 1 and 2 years of treatment rounds. The primary outcome of the study is the prevalence of Plasmodium
falciparum and P. vivax infection. The secondary outcome will be incidence and severity of malaria episodes detected
via both passive and active follow-up. The tertiary outcome is the inflammatory cytokine profile in response to
parasite antigens. The project also facilitates the transfer of state of the art methodologies and technologies,
molecular diagnosis of parasitic diseases, immunology and epidemiology from Europe to Indonesia.
Discussion: The study will provide data on the effect of helminth infections on malaria. It will also give
information on anthelminthic treatment efficacy and effectiveness and could help develop evidence-based
policymaking.
Trial registration: This study was approved by The Ethical Committee of Faculty of Medicine, University of
Indonesia, ref:194/PT02.FK/Etik/2006 and has been filed by ethics committee of the Leiden University Medical
Center. Clinical trial number:ISRCTN83830814. The study is reported in accordance with the CONSORT guidelines for
cluster-randomized studies.
* Correspondence: M.Yazdanbakhsh@lumc.nl; Taniawati@yahoo.com
1Department of Parasitology, Faculty of Medicine, University of Indonesia,
Jakarta, Indonesia
2Department of Parasitology, Leiden University Medical Center, Leiden, The
Netherlands
Wiria et al. BMC Infectious Diseases 2010, 10:77
http://www.biomedcentral.com/1471-2334/10/77
© 2010 Wiria et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in













Worldwide, more than a billion people are infected by
geohelminths, with a majority harboring roundworms
(Ascaris lumbricoides), whipworms (Trichuris trichiura),
and/or hookworms (Necator americanus or Ancylostoma
duodenale) [1-3]. Such helminths modify the immune
system to induce predominant production of T-helper-2
(Th2) cytokines (interleukin/IL-4, IL-5, IL-9, IL-10, IL-
13), associated with increased levels of immunoglobulin
E (IgE) and eosinophilia [4,5]. Another hallmark of
chronic helminth infections is their ability to induce a
strong regulatory network characterized by T cell hypor-
esponsiveness and the increased production of suppres-
sive cytokines such as IL-10 and TGF-b [6]. Their
ability to induce regulatory responses is thought to be
advantageous for both the parasite and the host as it
allows the survival of the parasite for extended periods
of time within the host while preventing overt patholo-
gical reactions that would otherwise be damaging to the
host [7]. The latter may explain why such helminth
infections rarely result in overt clinical manifestations.
Although the immunological consequences of hel-
minth infections primarily reflect responses directed
towards helminth antigens, there may be spill-over
effects on responses to unrelated antigens [6,8].
Whereas the marked Th2 polarization may compete
with Th1 cytokines to affect the magnitude of a Th1
response to an incoming antigen, a strong regulatory
response can dampen immune reactivity of both Th1
and Th2 types to a third party antigen. Not surprisingly,
then, it is argued that helminth infections might modu-
late the human immune response to common co-infec-
tions such as malaria, TB and HIV/AIDS [9-11].
Malaria itself is one of the most serious infectious dis-
eases, infecting 5-10% of the world’s population, with
300-600 million cases and more than 2 million deaths
annually [12]. In areas of high malaria transmission, the
burden of disease is borne by infants and young children
[13,14], whilst, in areas of lower transmission, primary
infection might also occur later in life, causing severe
illness [12,15,16].
Co-infection is the norm in nature [9,17], since hel-
minth infections of different species are often endemic
in the same communities that are exposed to infection
with plasmodia [18]. The question of whether helminth
infections affect the course of malaria has been
addressed in various reports [19] in the past few years.
Only a small number of papers report on population
studies and most of them were cross-sectional in nature,
which in contrast to longitudinal studies might not be
able to demonstrate the actual dynamics of infection.
An early study by Murray and colleagues (1977) in a
malnourished population at Anjouan, Comoros Islands
suggest that A. lumbricoides might suppress malaria
symptoms [20]. Since then studies of co-infections have
shown helminths to either exacerbate [21] or reduce
[22-24] the severity of malaria. The reasons for conflict-
ing data on the effect of helminth co-infection on
malaria disease outcomes could be due to differences in
study design, study groups, and possibly, most impor-
tantly, the helminth species investigated [18,25].
Although helminth infections are considered as patho-
gens, it is clear that their course of infection is relatively
free of overt clinical manifestations and in recent years
several reports have shown their suppressive effect on
diseases such as allergy [3,26], autoimmunity [27], and
inflammatory bowel disease [28], highlighting a possible
beneficial effect on inflammation [29]. To assess the
influence of helminth infections on inflammatory dis-
eases taking into account environmental and genetic
influences in a longitudinal setting, the ImmunoSPIN
project http://www.immunospin.org has been initiated.
As part of the project ImmunoSPIN, the helminth-
malaria sub project (ImmunoSPIN-Malaria) was
designed to determine whether and how helminth infec-
tions may affect the course of a malaria infection. This
study is a double-blind randomized trial of placebo and
anthelminthic treatment to elucidate the impact of hel-
minth infections on malaria longitudinally in an area
where helminth infections and malaria coexist. It is
expected to provide new information and contribute to
our understanding of how regulatory responses that may
be induced by chronic helminth infections affect inflam-
matory conditions, especially on malaria infection.
This paper presents the rationale of the ImmunoSPIN-
Malaria study that, at the clinical and biological level,
aims to discern plausible and meaningful interactions
between these infections.
Methods/Design
Study area and population
Nangapanda is a sub-district of the Ende district, Flores
Island, Indonesia and is situated in a coastal area with a
population of about 22000 (Figure 1). Situated near the
equator (8°45’S, 121°40’E)[30], it is characterized by a
uniform high temperature, in the range of 23-33.5°C,
with humidity of 86-95%. Average yearly rain fall is
1.822 mm with about 82 rainy days, especially from
November to April, with the peak in December until
March. Malaria is reported to be highly prevalent in this
area [31]. Preliminary surveys conducted in 2005 and
2006 found this area to be endemic for geohelminths
(A. lumbricoides, hookworms and T. trichiura) and
malaria parasites (P. falciparum and P. vivax). The sub-
district is divided into villages of which those located
near the primary health centre (Puskesmas), Ndeturea,
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Ndorurea1, and Ndorurea are the focus of ImmunoS-
PIN-Malaria study.
The majority in the study area is Ende tribe and
migrants from neighbouring district of Bajawa that have
populated the island for more than 300 years. Most indivi-
duals work as farmers and grow their own food. Recently
also government employees and individuals owning small
businesses moved to the area. Individuals with Chinese
and Arabic ethnicity have come to the area about 200
years ago and most of them, run business corporations
with other tribes. There are very few other tribes from
outside of Flores and most of them were brought from
outside by marriage with Flores natives. The Nangapanda
population is dynamic and individuals shift address within
the area as well as move in and out of the area for pur-
poses of studying, marriage, or searching for jobs.
Study design, data and sample collection
Baseline mapping of houses by Global Positioning Sys-
tem (GPS) system has allowed maps to be generated
using ArcGIS 9,1 software (ESRI, USA). In order to per-
form spatial analyses based on individual data, geogra-
phical coordinates were assigned to each individual as
well as centroid coordinates to households.
Community workers were recruited and trained to do
questionnaires, follow-ups, malaria surveys (finger
prick), and distribute treatment or placebo, as well as
doing health promotion among the population. Each
community worker will be in charge of a certain num-
ber of households that they visit monthly for recording
movement and active follow-up of malaria symptoms,
and three monthly for finger pricking and distributing
the treatment.
Figure 1 The map of the study area in Nangapanda, Flores, Indonesia.
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The study is designed as a double-blind randomized
trial with two arms. One arm is treatment with albenda-
zole (single dose of 400 mg) [32], while the other arm is
treatment with matching placebo (both tablets from PT
Indofarma Pharmaceutical, Bandung, Indonesia). The
treatment is provided every three months for a period
of two years (a total of 8 treatments) to everyone, except
children below two years of age, pregnant women or
severely ill persons. Computer aided block randomiza-
tion by household, using Random Allocation Software
[33] will be assigned to the treated and placebo groups.
The treatment is coded as A or B and the codes are
concealed from investigators and patients. Labels with
the study subject ID are printed from a computer data-
base and attached to the appropriate strip of treatment
by a separate team located in Jakarta without the invol-
vement of the study investigators. An interim analysis
will be performed by the monitoring committee, 1 year
after treatment to test for any adverse effects that reten-
tion of anthelminthic treatment might have on the
growth of children and on the incidence of malaria epi-
sodes (in contrast to the hypothesis being tested). If the
trial continues, the final unblinding of the codes will
take place two years after treatment.
On approval of individuals in the area, peripheral
blood will be collected from a subset of individuals over
4 years of age that were randomly selected for whole
blood culture based on households. The assay will be
done at baseline, 1 and 2 years after treatment. For
those who are not included in whole blood assays,
malaria evaluation by finger pricking will be obtained
aiming to include the whole population in the study
area.
Every household receives a card identifying all family
members. This card is used when community workers
visit homes and when family members visit the Puskes-
mas. Data on socioeconomic status and health status is
collected at baseline and 2 years after treatment using
questionnaires in Bahasa Indonesia. Monthly data such
as birth, death and migration will be recorded. New-
borns and individuals who enter the study area will be
registered with a newly assigned ID number as well as
their geographical coordinates. Active follow-up includes
a questionnaire with questions on clinical complaints in
general and clinical malaria in particular and will be
conducted monthly by community workers. In addition
to the questionnaire, blood slides will be collected at
three monthly intervals to test for plasmodia. For exami-
nation of intestinal helminths, stool samples will be col-
lected yearly. Samples will be used for microscopy and
PCR analyses. Passive follow-up will be held in colla-
boration with the Puskesmas that keeps clinical records
of individuals that visit either for consultation or for
overnight admission, including information on diagnosis
and treatment. If malaria is suspected, two blood slides
will be collected: one to be examined by the Puskesmas
staff and another for re-examination by the research
team in Jakarta at the Department of Parasitology, Uni-
versity of Indonesia (UI).
All blood samples (serum, cell pellet, plasma, and
whole blood), blood culture supernatants, as well as
stool samples for PCR, will be kept at -20°C in a tem-
perature recorded freezer which is checked twice a day
and will be sent to Jakarta on dry ice for storage -20°C
or -80°C.
Outcomes and case definitions
The study aims to determine whether and how helminth
infections may affect the course of infection with
malaria parasites and disease outcome. Therefore we
will monitor disease in individuals treated with albenda-
zole compared to placebo. The primary outcome is the
prevalence of infection with P. falciparum and P. vivax
up to 2 years after treatment, the secondary outcome is
the incidence and severity of malaria recorded as a
result of passive and active follow-up up to 2 years after
treatment. The tertiary outcome is the inflammatory
cytokine responses to P. falciparum antigens 1 and
2 years after treatment.
Helminth and plasmodia infections will be defined by
the presence of parasites detected by microscopic exam-
ination of stool and blood samples respectively and will
be confirmed by molecular (PCR-based) methods
[34-38]. A malaria case is defined as an individual with
typical malaria symptoms and a blood slide containing
plasmodia asexual forms. Typical malaria case defini-
tions: fever (oral temperature ≥ 37.5°C) and/or history
of fever in the past 48 hours with a positive slide (P.
vivax ≥ 250/ul, P. falciparum ≥ 1000/ul). Asymptomatic
carriers have a blood slide positive for P. falciparum
and/or P. vivax asexual forms, as well as positive result
by PCR and no concomitant clinical symptoms. Sus-
pected malaria cases are defined as individuals who
report symptoms typical of malaria but for whom no
slide is available at the time of presentation with
symptoms.
Parasitological examination
Stool examination by microscopy
The Harada Mori method will be carried out on fresh
stool samples to detect hookworm larvae. A certain
amount of each stool sample is preserved in formalin
(4%) and kept at room temperature for microscopic
examination. The formol-ether acetate concentration
method [39] is performed on the formalin preserved
stool samples followed by microscopical examination for
intestinal helminth infections, as well as protozoan
infections. For hookworm detection, an amount of fresh
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stool sample is incubated using filter paper soaked by
distilled water inside sealed plastic tubes according to
the Harada Mori method [40].
Stool examination by real-time PCR
For DNA isolation from stool, approximately 100 mg
unpreserved faeces (that was kept at -20°C) are sus-
pended in 200 μl PBS containing 2% polyvinylpolypyroli-
done (PVPP; Sigma, Steinheim, Germany). DNA
isolation and setup of the PCR reactions are performed
using a custom-made Hamilton robot platform (made in
Germany). After heating for 10 min at 100°C suspen-
sions are treated with sodium dodecylsulphate-protei-
nase K for 2 h at 55°C. DNA is isolated using QIAamp
DNA-easy 96-well plates (QIAgen, Venlo, The Nether-
lands) [36]. Within the isolation lysis buffer, 103 PFU/ml
Phocine herpes virus 1 (PhHV-1) is added to serve as an
internal control [41].
A. duodenale, N. americanus (hookworm), A. lumbricoides,
S. stercoralis real-time PCR (ANAS-PCR) [or just “helminth
rt-PCR"]
Sequences of the A. duodenale-, N. americanus-, and S.
stercoralis-specific primers and probes are used as
described previously [37,38] with some modifications in
fluorophore- and quencher-chemistry. Minor groove
binding (MGB) probes are replaced by XS probes (Biole-
gio, Malden, The Netherlands) and to accommodate the
specific fluorophor combination of the CFX real-time
PCR system (Bio-Rad laboratories, USA) the A. duode-
nale specific XS-probe is labelled with Texas Red and the
S. stercoralis-specific probe is labelled with Quasar-705.
The A. lumbricoides-specific primers and probe are cho-
sen using Primer Express software (Applied Biosystems,
Foster City, CA), from the internal transcribed-spacer-1
(ITS1) sequence of A. lumbricoides (GenBank accession
ALJ000895). The A. lumbricoides-specific primers,
Alum96F 5’-GTAATAGCAGTCGGCGGTTTCTT-3’
and Alum183R 5’-GCCCAACATGCCACCTATTC-3’
amplify an 87-bp fragment of the ITS1 sequence and the
XS-probe Alum124T Yakima Yellow-5’-TTGGCGGA-
CAATTGCATGCGAT-3’-XS is used to detect the A.
lumbricoides-specific product. The real-time PCRs were
optimized first as monoplex assays with 10-fold dilution
series of A. duodenale, N. americanus, A. lumbricoides,
and S. stercoralis DNA, respectively. The monoplex real-
time PCRs were thereafter compared with the multiplex
PCR with the PhHV internal control. The cycle threshold
(Ct) values obtained from testing the dilution series of
each pathogen in both the individual assay and the multi-
plex assay were similar, and the same analytical sensitivity
was achieved. The multiplex ANAS PCR showed 100%
specificity when tested against 145 DNA controls derived
from a wide range of intestinal microorganisms [35].
Amplification reactions are performed in white PCR
plates in a volume of 25 μl with PCR buffer (HotstarTaq
master mix, QIAgen, Germany), 5 mM MgCl2, 2.5
μgram Bovine Serum Albumin (Roche Diagnostics
Nederland B.V., Almere, the Netherlands), 5 pmol of
each A. duodenale-specific primer, and of each N. amer-
icanus-specific primer, 2 pmol of each A. lumbricoides-
specific primer, 2.5 pmol of each S. stercoralis-specific
primer and 3.75 pmol of each PhHV-1-specific primer,
1.25 pmol of each N. americanus-specific XS-probe, A.
lumbricoides-specific XS-probe, S. stercoralis-specific
double-labelled probe, and PhHV-1-specific double-
labelled probe, and 2.5 pmol of the A. duodenale-speci-
fic XS-probe, and 5 μl of the DNA sample.
Amplification consists of 15 min at 95°C followed by 50
cycles of 15 s at 95°C, 30 s at 60°C, and 30 s at 72°C.
Amplification, detection, and analysis are performed with
the CFX real-time detection system (Bio-Rad laboratories).
The PCR output from this system consists of a cycle-
threshold (Ct) value, representing the amplification cycle
in which the level of fluorescent signal exceeds the back-
ground fluorescence, and reflecting the parasite-specific
DNA load in the sample tested. Negative and positive con-
trol samples are included in each amplification run.
The amplification is considered to be hampered by
faecal inhibitory factors if the expected cycle threshold
(Ct) value of 33 in the PhHV-specific PCR is increased
by more than 3.3 cycles.
Blood examination by microscopy
To detect P. falciparum, P. vivax, P. malariae, and P.
ovale, blood slides (thick and thin) are stained with
Giemsa [42] followed by microscopic examination [43].
Blood examination by real-time PCR
DNA was isolated from 200 μl blood with QIAamp
DNA-easy 96-well plates according to the manufac-
turer’s recommendations. DNA isolation and setup of
the PCR reactions are performed using a custom-made
Hamilton robot platform.
P. falciparum, P. vivax, P. ovale, and P. malariae (malaria)
real-time PCR
Sequences of the Plasmodium-specific primers and the
P. falciparum, P. vivax, P. ovale, and P. malariae-speci-
fic probes are used as described previously[34,44] with
some modifications in the fluorophore- and quencher-
chemistry. Minor groove binding (MGB) probes are
replaced by XS probes and to accommodate the specific
fluorophor combination of the CFX system the P. falci-
parum-specific XS-probe is labelled with Yakima Yellow,
the P. ovale-specific XS-probe is labelled with Texas Red
and the P. malariae-specific probe is labelled with Qua-
sar-705. An additional P. ovale-type 2 XS-probe (Texas
Red 5’-TCCAAAAGGAATTTTCTTATT-3’-XSQ) is
used for sensitive detection of the P. ovale genetic var-
iant type 2 (GenBank accession X99790/J001527).
Amplification reactions of each DNA sample are per-
formed in white PCR plates, in a volume of 25 μl with
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PCR buffer (HotstarTaq master mix), 5 mmol/l MgCl2,
12.5 pmol of each Plasmodium-specific primer and
15 pmol of each PhHV-1-specific primer, 1.5 pmol of each
P. falciparum, P. vivax-, P. malariae-specific XS-probes,
and PhHV-1-specific Cy5 double-labelled detection probe,
and 2.5 pmol of each P. ovale-specific XS-probes (Biole-
gio), and 5 μl of the DNA sample were used.
Amplification, detection, and analysis are performed as
described for the faecal PCR.
Immunological Measurements
Whole blood culture and cytokine measurements
Blood samples (6 ml) are drawn into Vacutainers (BD,
Franklin Lakes, NJ, USA) containing sodium heparin as
anticoagulant. Within 6 hours, blood cultures are set up
according to methods that were optimized and tested
under field conditions during pilot studies. The hepari-
nized blood is diluted 1:4 with RPMI 1640 medium
(Invitrogen, Breda, The Netherlands) (supplemented
with 2 mM glutamate, 1 mM pyruvate, 100 IU penicillin
and 100 μg/ml streptomycin) and cultured in 96 well
round bottomed plates in 37°C with 5% CO2. Stimula-
tions were performed with medium/control, PHA (2 μg/
ml, Wellcome Diagnostics, Darford, UK), LPS (1 ng/ml
Sigma-Aldrich, Zwijndrecht, The Netherlands), Pam3Cys
(100 ng/ml, Cayla-InvivoGen Europe, Toulouse, France),
PolyIC (50 μg/ml, Cayla-InvivoGen Europe, Toulouse,
France), Ascaris antigen (20 μg/ml, as prepared by van
Riet E et al [45]), iRBC (1 × 106, prepared by Radboud
University Nijmegen Medical Centre, Nijmegen, The
Netherlands[46]), uRBC (1 × 106, prepared by Radboud
University Nijmegen Medical Centre, Nijmegen, The
Netherlands [46]). Supernatants are collected on day 1
(unstimulated control, LPS, Pam3Cys) and day 3 (unsti-
mulated control, PHA, Ascaris, iRBC, uRBC, PolyIC).
Cytokine concentrations in supernatants are assessed by
means of immunobead-based multiplex assays. This is
an assay that permits simultaneous quantification of
multiple cytokines in a small sample volume. Panels of
capture antibody-coated beads and labeled detection
antibodies are purchased from Bio Source (Camarillo,
California, USA). The cytokines measured will represent
pro- and anti-inflammatory, Th1 and Th2 cytokines:
TNF-a and IL-10 from day 1 supernatants as well as IL-
2, IL-5, IL-10, IFN-g, and TNF-a for day 3 supernatants.
Analysis will be performed on a Liquichip 200® Work-
station (Qiagen, Venlo, The Netherlands) using Liqui-
chip analyzer software (Qiagen, Venlo, The
Netherlands).
Total IgE
Total IgE will be measured as described previously [47].
Briefly, maxisorp plates (Thermo Fisher Scientific, Ros-
kilde, Denmark) are coated overnight with 100 μl/well
rabbit anti-human IgE (Dako, Glostrup, Denmark) at 1/
1400 dilution in 0.1 M carbonate buffer. Plates are
blocked with 100 μl/well phosphate buffered saline
(PBS) containing 5% bovine serum albumin (BSA, Albu-
min Fraction V, Boehringer, Mannheim, Germany). Sera
to be tested are diluted 1:200 in PBS containing 5% fetal
calf serum (FCS, Greiner Bio-One, Alphen a/d Rijn,
Netherlands). A positive standard serum containing
human IgE (NIBSC, Potters Bar, UK) is diluted down 1/3
in a series from 90 IU/ml until a final concentration
0.12 IU/ml on each plate and incubated for 1 hour at
room temperature. After washing step, IgE biotinylated
goat anti-human IgE antibody (1/1000 (Vector Labora-
tories, Burlingame, CA, USA)) is added followed by
Streptavidin Alkaline Phosphatase conjugate (1/3000
(Boehringer, Mannheim, Germany)). The colour is devel-
oped by addition of para-nitrophenylphosphate substrate
(p-NPP (Boehringer, Mannheim, Germany)) diluted
in diethanolamine buffer (DEA, 0.5 mM Mg CL2, 0.1
M DEA, pH 9.6 (Merck, Darmstadt, Germany) and opti-
cal density is measured at 405 nm.
Statistical analyses
A database using MS Access is developed for this study.
At baseline, we will analyze whether helminth infected
subjects are at a higher risk of having P. falciparum or
P. vivax infections in terms of presence of infection and
intensity. The effect of anthelminthic treatment will be
assessed 1 and 2 years after treatment by analyzing the
prevalence ratios as well as the incidence ratios of
malaria infection (clinical cases and parasitemia). In
addition, treatment will be compared with placebo for
reduction of helminth infection and is based on an
intention to treat principle, in anticipation of individual
movement between treatment groups. Cytokine profiles
in response to parasite antigens will be analyzed for
levels of pro- and anti-inflammatory cytokines.
The characterization of immune responses to hel-
minth infections, malaria infections and co-infections
will be assessed prior to treatment using linear regres-
sion [48]. As cytokine levels are non-normally distribu-
ted, we will use log-transformed cytokine data for all
analyses regarding effect of helminth treatment on cyto-
kine profile and susceptibility to plasmodium infection.
For these analyses, multilevel modeling will be used and
the use of longitudinal data will take into account
repeated measurements [48]. Any bias related to selec-
tion of participants and outcome of treatment will be
assessed by comparing individuals that are lost to fol-
low-up and individuals that are not lost and will be
compared on the basis of their baseline characteristics,
age, gender, village, and socioeconomic status and para-
sitic infections. A similar assessment will also be under-
taken to compare the characteristics of individuals in
the treatment and placebo groups at inclusion into the
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study. Chi-square analyses will be used to test
proportions.
Multiple regression analysis will be used to determine
1) the association between helminth infections (either all
helminths or individual species) with malaria parasites
(either all or individual species); 2) the effect of decreas-
ing helminth infection on plasmodia parasitaemia and
incidence of malaria cases and 3) the effect of decreas-
ing helminth infection on immunological responses to
malaria antigen. All analyses will be adjusted for con-
founders such as socioeconomic status, body mass
index, age and sex. During the study any other confoun-
ders that are identified will be used in our analyses.
Power calculation
Unpublished microscopy data from the area showed the
combined prevalence of P. falciparum and P. vivax was
12% in the target population and the helminth infection
(A. lumbricoides, Hookworm, T. trichiura) in the popu-
lation was 60%. As study activities such as active follow-
up and prompt treatment will have an effect on the pre-
valence, we expect the malaria prevalence to decrease to
an estimated 6%. Based on these findings a power calcu-
lation (given an alpha of 0.05 and a power of 0.80) gave
a sample size of 749 study subjects needed, in order to
detect a 50% reduction or increase in the prevalence of
plasmodia after 2 years of anthelminthic treatment. The
effect of treatment will presumably be present in hel-
minth carriers only and as an estimated 60% will be car-
riers of helminths during study period, giving an
estimated 1248 subjects in each study arm will be
needed. Allowing for an estimated 20% lost to follow-up
due to movement and refusal, we would need to include
1495 participants in each arm.
Ethical consideration and trial registration, information,
recruitment and consent
This study was approved by The Ethical Committee of
Faculty of Medicine, University of Indonesia, ref: 194/
PT02.FK/Etik/2006 and registered as clinical trial ref:
ISRCTN83830814 and has been filed by ethics commit-
tee of the Leiden University Medical Center. The study
is reported in accordance with the CONSORT guide-
lines for cluster-randomized studies [49].
The regional health authorities in Ende, the regional
capital, were informed of the study and gave their agree-
ment and support. Socialization took place over a two
year period prior to the study involving staff at the pub-
lic health centre (Puskesmas) and 50 community work-
ers, including training for follow-up of study subjects
keeping the community well-informed and well-engaged.
Through many organized sessions, the village heads
were involved in passing on information about the
study, including the benefits and risks involved. The
longitudinal nature was explained and information
sheets and consent forms (in Bahasa Indonesia) were
distributed. Inhabitants of the area were invited to parti-
cipate in the study, consented either by written signa-
ture or thumb print and were informed that they may
withdraw from the study at any time, for any reason
and without consequences. For children below 15 years
old of age also parent consent was obtained. Probable
illness by burden of helminth infection will be taken
into account by three study doctors that will be present
in the area as well as by collaboration with the Puskes-
mas. Severe cases will be treated directly. The medical
doctors will also give support and treatment to the Pus-
kesmas. After completion of the study the whole popu-
lation will be adequately treated for helminth infections
[32,50].
Description of the population recruited
The study has so far provided data that are shown in a
flow chart given in Figure 2. During registration (Janu-
ary 2007 - April 2008) a total of 4650 individuals were
registered in 753 households. At baseline in (April 2008)
3854 of the registered population are residing in the vil-
lage in 734 household. For the immunological studies
250 households were randomly selected within 734
registered households, to allow for 1065 eligible indivi-
duals (Figure 2).
Table 1 shows age-stratified migration patterns. Most
migration is for seeking employment or education
opportunities and most are male. The median age of the
residents is 20 years while this is 19 for those who move
out of the area. The age pyramid is shown in Figure 3
and is typical for low to middle income countries [51].
The traditional source of income in the area is farm-
ing and fishing while some individuals engage in jobs at
government offices with a few in the private sector (Fig-
ure 4). The education level of the majority over 15 years
of age is elementary school (40.6%) followed by senior
high school (27,2%), and junior high school (18.9%)
while 5.4% has college or University degrees. Around
5.5% is illiterate, either not educated at all or dropped
out from elementary school (Figure 5).
Discussion
Since this large community-based trial provides an
important possibility to undertake a series of evaluations
on the effect of helminth infections on malaria as well
as the control of helminth and malaria at the commu-
nity level, our study could help develop evidence-based
policymaking. This study is unique in that it will provide
data on anthelminthic treatment efficacy and effective-
ness in a defined large population in a developing coun-
try. In conclusion the ImmunoSPIN helminth-malaria
study is the first and currently the only longitudinal
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Figure 2 Profile of the ImmunoSPIN-Malaria sub project http://immunospin.org







Female (n = 2087) Total (n = 3827) Male (n = 431) Female (n = 365) Total (n = 796)
0-4 175 (10%) 221 (10.6%) 396 (10.3%) 10 (2.3%) 11 (3%) 21 (2.6%)
5-14 491 (28.2%) 467 (22.4%) 958 (25%) 49 (11.4%) 47 (12.9%) 96 (12.1%)
15-24 353 (20.3%) 412 (19.7%) 765 (20%) 248 (57.5%) 224 (61.4%) 472 (59.3%)
25-34 191 (11%) 305 (14.6%) 496 (13%) 71 (16.5%) 53 (14.5%) 124 (15.6%)
35-44 207 (11.9%) 284 (13.6%) 491 (12.8%) 37 (8.6%) 15 (4.1%) 52 (6.5%)
45-54 160 (9.2%) 198 (9.5%) 358 (9.4%) 8 (1.8%) 8 (2.2%) 16 (2%)
55-64 94 (5,4%) 119 (5.7%) 213 (5.6%) 2 (0.5%) 3 (0.9%) 5 (0.6%)
> = 65 69 (4%) 81 (3.9%) 150 (3.9%) 6 (1.4%) 4 (1%) 10 (1.3%)
* Data from 4623 of 4650, because 27 individuals was not known for their age or birthday.
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Figure 4 Job distribution. At baseline, profession was assessed for everyone above 15 years of age in the study area (n = 2961).
Figure 3 Age pyramid of individuals living in Nangapanda, Flores.
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study of helminth and malaria co-infections in Indone-
sia. The study has received enthusiastic support from
the authorities in Ende. At the same time, the study
facilitates the transfer of state of the art technologies in
immunology, molecular biology, epidemiology and sta-
tistics to Indonesia.
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Abstract
Background: Helminth infections are proposed to have immunomodulatory activities affecting health outcomes either
detrimentally or beneficially. We evaluated the effects of albendazole treatment, every three months for 21 months, on STH,
malarial parasitemia and allergy.
Methods and Findings: A household-based cluster-randomized, double-blind, placebo-controlled trial was conducted in an
area in Indonesia endemic for STH. Using computer-aided block randomization, 481 households (2022 subjects) and 473
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Soil transmitted helminths (STH) (hookworms, Ascaris lumbri-
coides and Trichuris trichiura) establish chronic infections in a large
proportion of the world population.[1] Major intervention
programs using mass drug administration (MDA) to control
STH have been launched.[2] However, STH infections seem to
persist in the targeted populations raising concern over the
development of drug resistance.[3] It is therefore important to
conduct well-designed studies that allow evidence-based decisions
to be made to maximize effective STH control toward elimination.
While there is no doubt that STH are associated with
morbidities in billions of people worldwide, there is also increasing
awareness that helminth infections might, like bacterial commen-
sals, play an important role in shaping human health.[4]
Helminths may contribute to immunologic and physiologic
homeostasis. The immune system is thought to have evolved to
operate optimally in the face of helminth-induced immune
regulation, and that any disturbance of this long evolutionary
co-existence between humans and helminth parasites might be
associated with the emergence of pathological conditions[5]
possibly involving outcomes of exposure to other pathogens or
the development of inflammatory diseases.
In many parts of the world helminths and malarial parasites are
co-endemic raising the question of what impact helminth
infections may have on the plasmodial parasites that cause
malaria. The results have been conflicting in this regard. In some
studies a positive association has been reported between helminths
and malarial parasitemia while in others, this has been refuted or
in yet others a negative association has been shown between
helminths and the severity of the clinical outcomes of malaria
(reviewed by Nacher).[6]
An increase in the prevalence of allergies has been reported
worldwide, in particular in the urban areas of low- to middle-
income countries.[7] Although majority of cross-sectional studies
have reported inverse associations between helminth infections
and allergies[8,9], two randomized trials with albendazole, have
shown conflicting results. One in Ecuador, based on school
randomization, reported no change in either SPT reactivity to
allergens or allergic symptoms after one year of albendazole
treatment[10] while another in Vietnam, in which the random-
ization unit was individual schoolchildren, showed increased SPT
reactivity after one year of albendazole treatment, but consistent
Figure 1. Trial Profile. HH: Household. Lost to follow up implies that the participants have no data from this time point onward. Temporarily
absent implies that the participants have no data at this time point but have data available at other time point.
doi:10.1371/journal.pone.0057899.g001
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with the Ecuadorean study, clinical allergy did not change
significantly.[11] It has been suggested that anthelminthic
treatment of longer duration might be needed to reveal the
modulatory effect of helminths.[12,13]
In the light of global deworming initiatives, it is important to
assess the effectiveness of and to monitor the risks associated with
anthelminthic treatment regiments. There is as yet no report of a
household-based cluster-randomized double-blind placebo-con-
trolled trial of repeated anthelminthic administration in a
community that would be expected to more effectively reduce
transmission of STH by decreasing household cross-contamina-
tion.
In an area where STH and malaria are co-endemic on Flores
Island, Indonesia, we conducted a household cluster-randomized
trial of three-monthly albendazole treatment over a two year study
period in a whole community to assess benefits and risks associated
with this anthelmintic treatment. Specifically we assessed its
impact on STH, malarial parasitemia and allergy.
Methods
Study population and design
This trial was conducted in two villages in the Ende District of
Flores Island, Indonesia (Appendix S1, p2) as described in detail
elsewhere.[14,15] The treatment was based on household and
given to all household members except those less than two years
old or pregnant (the Indonesian national program guideline).
Directly observed treatment was given three monthly during the
trial period (June 2008 to July 2010, with treatment starting in
Sept 2008). The primary outcomes were prevalence of malarial
parasitemia and SPT reactivity to allergens. Additional outcomes
were treatment effect on STH and BMI as well as malaria-like and
allergy symptoms.
We measured malaria outcomes in Nangapanda only. Malaria
was not endemic in Anaranda. Artemisinin-combination therapy
(ACT) treatment and treated bed net distribution were not
implemented during our study period.[16,17]
Allergy outcomes were measured, in both villages, in school-age
children (5–15 years old) as this group is particularly at risk of
developing allergy and asthma[18] and is the target population of
global deworming programs.
The study was approved by the Ethical Committee of the
Medical Faculty, University of Indonesia (ethical clearance ref:
194/PT02.FK/Etik/2006) and filed by the Committee of Medical
Ethics of the Leiden University Medical Center. The trial was
registered as clinical trial (Ref: ISRCTN83830814). Prior to the
study, written informed consent was obtained from participants or
from parents/guardians of children. The study is reported in
accordance with the CONSORT guidelines for cluster-random-
ized studies. The protocol for this trial and supporting CON-
SORT checklist are available as supporting information; see
Checklist S1 and Protocol S1.
Randomization and masking
The population was randomized by IA using computer aided
block randomization at household level utilising Random Alloca-
tion software to receive albendazole (single dose of 400 mg) or a
matching placebo (both tablets from PT Indofarma Pharmaceu-
tical, Bandung, Indonesia). The treatment code was concealed
from trial investigators and participants. The un-blinding of
treatment codes occurred after all laboratory results had been
entered into the database (August 2011).
Procedures
Trained community workers measured fever, administered
monthly malaria-like symptoms questionnaire which was based
on WHO definitions[19] and took finger-prick blood for the three-
monthly malarial parasitemia survey. Subjects with fever
($37.5uC) or additional malaria-like symptoms (headache, fatigue
and nausea) at the time of visits were referred to the local primary
health centre (puskesmas). Thick and thin Giemsa-stained blood
smears were read at University of Indonesia. At baseline, 9 months
and 21 months after the first round of treatment blood was
collected for PCR-based detection of Plasmodium spp. (Appendix S1,
p2), a method that is more sensitive than microscopy.[20]
Regarding allergy outcomes, skin prick tests (SPT) with
allergens were performed on school-age children in Nangapanda
and Anaranda and clinical symptoms of allergy were recorded.
House dust mite (Dermatophagoides pteronyssinus and D. farinae; kindly
provided by Paul van Rijn from HAL Allergy Laboratories,
Leiden, The Netherlands) and cockroach (Blatella germanica;
Lofarma, Milan, Italy) were used for SPT which was considered
positive with 3 mm cut off.[14] The SPT was performed by one
investigator. IgE with specificity for aeroallergens (D. pteronyssinus
Table 1. Baseline characteristics.
N Placebo N Albendazole
Age (mean in years, SD) 2022 25.7 (18.7) 1982 25.8 (18.7)
Sex (female, n, %) 2022 1090 (53.9) 1982 1042 (52.6)
Area (rural, n, %) 2022 260 (12.9) 1982 253 (12.8)
BMI .19 years old (mean, SD) 575 22.3 (4.0) 582 21.8 (3.6)
Z score of BMI # 19 years old
(mean, SD)
427 21.20 (1.2) 386 21.37 (1.3)
Parasite infection (n, %)
Helminth (any spp) 655 571 (87.2) 609 533 (87.5)
Hookworm1 683 509 (74.5) 629 486 (77.3)
N. americanus1 683 503 (73.7) 629 481 (76.5)
A. duodenale1 683 44 (6.4) 629 41 (6.5)
A. lumbricoides1 683 238 (34.9) 629 209 (33.2)
S. stercoralis1 683 7 (1.0) 629 18 (2.9)
T. trichiura2 953 258 (27.1) 852 237 (27.8)
Malarial parasitemia (any spp)2 1225 60 (4.9) 1187 52 (4.4)
P. falciparum 1225 32 (2.6) 1187 28 (2.4)
P. vivax 1225 26 (2.1) 1187 18 (1.5)
P. malariae 1225 2 (0.2) 1187 7 (0.6)
Malarial parasitemia (any spp)1 772 195 (25.3) 739 200 (27.1)
P. falciparum 772 106 (13.7) 739 112 (15.2)
P. vivax 772 102 (13.2) 739 93 (12.6)
P. malariae 772 10 (1.3) 739 18 (2.4)
Skin prick reactivity (n, %)
Any allergen 711 190 (26.7) 653 163 (25.0)
House dust mite 711 88 (12.4) 653 75 (11.5)
Cockroach 711 163 (22.9) 653 140 (21.4)
Specific IgE, kU/L (median, IQR)
House dust mite 452 0.8 (0.3–2.6) 431 0.8 (0.2–2.4)
Cockroach 452 1.5 (0.4–5.7) 431 1.9 (0.5–5.0)
1diagnosed by PCR; 2diagnosed by microscopy.
The number of positives (n) of the total population examined (N).
doi:10.1371/journal.pone.0057899.t001
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and B. germanica) was measured in plasma using an ImmunoCAP
250 system (Phadia, Uppsala, Sweden) following the manufactur-
er’s instructions. All measurements were conducted in one
laboratory in the Netherlands. Symptoms of asthma and atopic
dermatitis were recorded using a modified visually-assisted version
of the International Study of Asthma and Allergy in Childhood
(ISAAC) questionnaire as reported before.[14]
Yearly stool samples were collected on a voluntary basis.
Trichuris was detected by microscopy and a multiplex real-time
PCR was used for detection of hookworms (Ancylostoma duodenale,
Necator americanus), Ascaris lumbricoides, and Strongyloides stercoralis
DNA as detailed before[15] (Appendix S1, p2). Very few subjects
were infected with S. stercoralis and therefore this infection was not
included in analyses.
Body weight and height were measured using the National
Heart Lung and Blood Institute practical guidelines (scale and
microtoise from SECA GmBH & Co, Hamburg, Germany).
Power calculation
Sample size estimation was based on the expected change in
primary outcomes taking into account a power of 90% and a
significance level of ,0.05 with a loss to follow-up of 20%. Based
on previous observations we expected to find a decrease in
malarial parasitemia prevalence and an increase in SPT reactivity
after anthelminthic treatment. Based on a prevalence of about
10% and a risk ratio (RR) of 0.60 we aimed to include 2412 people
in the malaria assessments. In a pilot study we found SPT to D.
pteronyssinus to be around 15%, and expected that due to treatment
the prevalence would increase. In order to find a RR of 1.5 we
aimed to include at least 1418 children.
Statistical analyses
For children #19 years, BMI age-standardized z-scores were
calculated according to WHO references.[21] The IgE data were
log-transformed to obtain normally distributed variable. To assess
treatment effects generalized linear mixed models were used which
provide a flexible and powerful tool to derive valid inference while
Figure 2. A) Percentage of helminth infected subjects in placebo and albendazole treatment arms. The presence of hookworms (by
PCR), Ascaris lumbricoides (by PCR) and Trichuris trichiura (by microscopy) or any of these helminth infections in subjects who provided stool samples
at baseline, 9 and 21 months post treatment (numbers are given in table S1A in Appendix S1). B) Effect of albendazole treatment on reduction
in the intensity as well as percentage of subjects positive for hookworm and Ascaris infection as determined by PCR. Negative is when
no helminth specific DNA was found. Positive Ct- values were grouped into three categories: Ct,30.0, 30.0#Ct,35.0 and $35.0 representing a high,
moderate and low DNA load, respectively.
doi:10.1371/journal.pone.0057899.g002
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capturing the data correlations induced by clustering within
households and repeated evaluations in time of the same subject.
Parameter estimates for treatment effects at 9 and 21 months and
95% confidence intervals are reported. The reported p-values are
obtained using likelihood ratio tests by comparing the model with
and without the treatment effect. Unless stated otherwise all
outcomes were adjusted for area (the two study villages in Ende
District: Nangapanda or Anaranda) as covariate in the model. For
the continuous outcomes (linear mixed-effects models[22] were
used with three random effects, namely to model clustering within
households a random household specific intercept was used and to
model correlation within subjects a random subject specific
intercept and slope were used. For the binary outcomes a logistic
model was used with random household effects and random
subject effects. All models were fitted using the lme4 package
(Appendix S1, p6-7).[23] For each fever and additional malaria-
like symptoms, total number of events and person months are
computed for each treatment arm. Hazard ratios for effect of
treatment were calculated with Cox regression with robust SE to
allow for within-household clustering (STATA 11).
Results
At baseline, 954 households with 4004 subjects were registered.
Randomization of households resulted in 1982 people assigned to
albendazole treatment and 2022 people to placebo (473 and 481
houses respectively). At baseline 87?3% of the individuals were
infected with one or more helminth species. The baseline
Figure 3. Effect of albendazole treatment on malarial parasitemia based on two age categories. Malarial parasitemia A) #15 and B) .15
years of age. The risk of malarial parasitemia after albendazole treatment compared to placebo is shown as odds ratio with 95% CI. The reference line
is set at 1, indicating that symbols at the right of this line represent an increased risk, while symbols at the left of the line would predict decreased risk
of malarial parasitemia. Note: at 9 month time point in those .15 years of age, the OR is ‘.
doi:10.1371/journal.pone.0057899.g003
Table 2. Effect of three-monthly albendazole treatment on malaria outcomes: Percentage of subjects with malarial parasitemia.
P. falciparum P. vivax P. malariae
Placebo Albendazole Placebo Albendazole Placebo Albendazole
n/N (%) n/N (%) n/N (%) n/N (%) n/N (%) n/N (%)
Malarial parasitemia by microscopy
0 month 32/1225 (2.6) 28/1187 (2.4) 26/1225 (2.1) 18/1187 (1.5) 2/1225 (0.2) 7/1187 (0.6)
3 months 41/897 (4.6) 46/910 (5.1) 17/897 (1.9) 22/910 (2.4) 1/897 (0.1) 6/910 (0.7)
6 months 8/815 (1.0) 20/794 (2.5) 4/815 (0.5) 9/794 (1.1) 0 0
9 months 14/947 (1.5) 7/950 (0.7) 4/947 (0.4) 5/950 (0.5) 1/947 (0.1) 1/950 (0.1)
12 months 9/834 (1.1) 9/813 (1.1) 4/834 (0.5) 2/813 (0.2) 0 0
15 months 14/773 (1.8) 13/772 (1.7) 3/773 (0.4) 4/772 (0.5) 1/773 (0.1) 3/772 (0.4)
18 months 3/815 (0.4) 10/803 (1.2) 1/815 (0.1) 1/803 (0.1) 1/815 (0.1) 1/803 (0.1)
21 months 6/824 (0.7) 11/824 (1.3) 6/824 (0.7) 0 3/824 (0.4) 1/824 (0.1)
Malarial parasitemia by PCR
0 month 106/772 (13.7) 112/739 (15.2) 102/772 (13.2) 93/739 (12.6) 10/772 (1.3) 18/739 (2.4)
9 months 35/656 (5.3) 56/627 (8.9) 56/656 (8.5) 50/627 (8.0) 7/656 (1.1) 9/627 (1.4)
21 months 21/584 (3.6) 31/553 (5.6) 24/584 (4.1) 27/553 (4.9) 10/584 (1.7) 5/553 (0.9)
The number of positives (n) of the total population examined (N).
doi:10.1371/journal.pone.0057899.t002
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characteristics were similar between the treatment arms (table 1).
The overall trial profile is shown in figure 1, and figure S1A, S1B,
S1C (p13–15) in Appendix S1 separately for malaria, allergy and
helminth outcomes. The analysis was intention-to-treat and
involved all participants as assigned randomly at the start of the
trial. During the study, in the albendazole arm 61 people moved to
a house that was assigned to placebo while in the placebo arm 62
people moved to a house that was assigned to albendazole. The 44
subjects who died during the trial, included 4 people below the age
of 20, 3 between 20 and 40 and the rest above 40 years of age, and
were equally distributed between the treatment arms. At 9 months
post-treatment full compliance was 77.8% for albendazole
treatment and 78.0% for placebo. This was 63.1% and 62.5%
respectively at 21 months.
This intensive treatment with albendazole resulted in a
reduction but not elimination of STH. There was a decrease
both after 9 (OR (95% CI) = 0.07 (0.04–0.11) and 21 months (0.05
(0.03–0.08)) of treatment (p,0.0001). Albendazole had the largest
effect on hookworm followed by Ascaris while the effect on Trichuris
was less pronounced (figure 2A and table S1 in Appendix S1 p8).
Treatment also led to statistically significant reduction in the
intensity of hookworm and Ascaris infection as determined by PCR
(figure 2B). The fact that the stool sampling was on a voluntary
basis could have created a selection bias. Analyzing baseline
characteristics of subjects providing stool samples and those who
did not at 9 months follow up, showed no differences in helminth
prevalence, age and sex. Although at 21 months post treatment,
sex and helminth prevalence were not different, age was slightly
but significantly higher in subjects who provided stool samples
mean age in years (SD) = 29.9 (20.4) vs 24.3 (17.5), p = 0.006)
The overall percentage of subjects with malarial parasitemia,
irrespective of treatment arm, decreased over the trial period
(table 2). However, when the data were modelled to assess the
effect of albendazole treatment over time, there was a significant
(P = 0.0064) increase, which might result from the transient four-
fold increased risk of malarial parasitemia (OR 4.16 (1.35–12.80))
(table 3) at 6 months after initiation of treatment (after 2 doses of
albendazole). The effect of anthelminthic treatment was assessed
in those younger than 15 years of age who would be the prime
target of the global deworming programs. The transient increase
in parasitemia was only seen in the older (.15 years) age group
(figure 3). Malarial parasites were also assessed by PCR, at 9 and
21 months after initiation of treatment and revealed that
albendazole had no effect when all Plasmodium species were
considered together, but when analyzed separately there was a
significant increase in the percentage of subjects positive for P.
falciparum at 9 months post-treatment (table 4). There was no
difference in the incidence of fever and additional malaria-like
symptoms between the two treatment arms (table S2 in Appendix
S1 p10).
The proportion of subjects with SPT reactivity was 353/1364
(25.9%) at baseline. Albendazole treatment had no statistically
significant effect on SPT to any allergen (table 5), but it was noted
that there was an incremental increase in the risk of being SPT
positive to any allergen at 9 months and 21 months post initiation
of treatment. Moreover, additional analysis on allergens separate-
ly, showed a significantly higher SPT to cockroach at 21 months
after treatment (1.63 (1.07–2.50)) (table 6). The levels of IgE to
allergens showed that albendazole treatment had no effect (table 6).
No effect of treatment was seen on symptoms of asthma or atopic
dermatitis (table S3 in Appendix S1 p11).
No significant change in BMI was observed in children or in
adults (table S4 in Appendix S1 p12). Moreover, there was no
adverse effect of treatment reported.
Discussion
This household-based clustered-randomized, double-blind, pla-
cebo-controlled trial shows that administering a total of seven
single doses of albendazole, at three-monthly intervals, to a
population living in an area of Indonesia where STH are highly
prevalent, leads to decreased prevalence of helminth infections
which although statistically significant, can be taken as an
incomplete reduction. The results show a transient increase in
Table 3. Effect of three-monthly albendazole treatment on
malaria outcomes: Malarial parasitemia by microscopy
Placebo Albendazole OR (95%CI) *
n/N (%) n/N (%)
Malarial parasitemia (any
spp)
3 months 59/897 (6.6) 72/910 (7.9) 1.54 (0.75–3.16)
6 months 12/815 (1.5) 29/794 (3.7) 4.16 (1.35–12.80)
9 months 19/947 (2.0) 13/950 (1.4) 0.57 (0.16–2.04)
12 months 13/834 (1.6) 10/813 (1.2) 0.62 (0.12–3.15)
15 months 18/773 (2.3) 20/772 (2.6) 1.17 (0.18–7.65)
18 months 5/815 (0.6) 12/803 (1.5) 1.84 (0.12–29.03)
21 months 15/824 (1.8) 12/824 (1.5) 0.26 (0.01–6.59)
The number of positives (n) of the total population examined (N). *Odds ratio
and 95% confidence interval are based on mixed effects logistic regression
models. OR’s and 95% CI are shown for the separate time points on malarial
parasitemia. The p-value is generated from the modeled data for the combined
effect of albendazole treatment over time, which is significant (P = 0.0064) and
might result from the effect of 6 months post treatment time point.
doi:10.1371/journal.pone.0057899.t003
Table 4. Effect of three-monthly albendazole treatment on
malaria outcomes: Malarial parasitemia by PCR.
Placebo Albendazole OR (95% CI)
n/N (%) n/N (%)
Malaria (any spp)
9 months 95/656 (14.5) 103/627 (16.4) 1.13 (0.77–1.64)
21 months 53/584 (9.1) 59/553 (10.7) 1.09 (0.68–1.76)
P. falciparum
9 months 35/656 (5.3) 56/627 (8.9) 2.82 (1.29–6.15)
21 months 21/584 (3.6) 31/553 (5.6) 1.63 (0.63–4.22)
P. vivax
9 months 56/656 (8.5) 50/627 (8.0) 0.84 (0.41–1.71)
21 months 24/584 (4.1) 27/553 (4.9) 1.40 (0.56–3.52)
P. malariae
9 months 7/656 (1.1) 9/627 (1.4) 0.34 (0.04–2.79)
21 months 10/584 (1.7) 5/553 (0.9) 0.04 (0.00–0.39)
The number of positives (n) of the total population examined (N). Odds ratio
and 95% confidence interval based on logistic mixed models. The statistically
significant results are given in bold. The p-values are generated from the
modeled data for the combined effect of albendazole treatment over time for
each of the species separately, which were significant for P. falciparum
(P = 0.029) and P. malariae (P = 0.016).
doi:10.1371/journal.pone.0057899.t004
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malarial parasitemia in the albendazole- compared with the
placebo-treated arm in the first six months after initiation of
treatment. Albendazole treatment had no statistically significant
effect on the designated co-primary outcome, skin prick test
reactivity to allergens.
The clinical data collected of fever and additional malaria-like
symptoms, were not affected by the deworming. Clinical signs of
asthma and atopic dermatitis were also not affected by albendazole
treatment.
The prevalence of infection was high (.60%), which reflects the
situation in many areas that are being targeted by the global
deworming programs. Using a three-monthly treatment regimen
which represents an extreme scenario for helminth control
strategy, percentage of subjects positive for STH was reduced by
39% compared to placebo. It should be noted that in our study the
sensitive PCR method has been used. The reduction in the
proportion of subjects infected with hookworm and Ascaris was
more pronounced than for Trichuris infections, confirming the
findings using a single dose of albendazole.[24] Subjects who
provided stool samples at 21 months were slightly but significantly
older than those who did not. Given that hookworm infection is
more prevalent in older subjects, this may have contributed to the
poor deworming achieved by albendazole. The reduction achieved
in worm loads, did not have any beneficial effect on BMI.
Observational studies have reported that helminth infections affect
growth; however randomized trials have not been consis-
tent.[25,26] In this regard, our study would support the outcome
of a recent Cochrane review of no beneficial effect of deworming
programs on nutritional indicators [27] even though it can be
argued that in our study the suboptimal reduction in the STH
would not allow any beneficial effect of anthelmintic in terms of
BMI to be seen in the community. Importantly, the fact that the
effect of such an intensive deworming strategy in a community is
incomplete, needs to be considered in the agenda for the control
and elimination of helminth diseases of humans.[28]
Most studies on the effect of helminth infections on malarial
parasitemia and clinical malaria episodes have used cross-sectional
designs and have been inconclusive.[6] Longitudinal studies of
anthelminthic treatment have also reported conflicting re-
sults.[29,30] A small study conducted in Madagascar[29] has
reported an increase in malarial parasitemia in levimasole treated
subjects, older than 5 years of age, while in Nigeria [30],
albendazole treatment of pre school children was associated with
lower P. falciparum infection and anemia, however, the lost to
follow up in this study was very high. The question whether
albendazole treatment during pregnancy could affect health
outcomes in the offspring, was addressed in a recent report from
Uganda.[31] It was found that the incidence of malaria up to one
years of age was not different in the offspring of mothers born to
those treated with albendazole or placebo. Our study, reports the
results of a community wide randomized-controlled trial that used
three-monthly malarial parasitemia data obtained by microscopy.
A significantly higher percentage of subjects positive for malarial
parasites in the albendazole compared to the placebo arm was
seen but this seemed to be a transient effect and restricted to
individuals older than 15 years of age, an age group that is not the
main target of the current deworming programs. The question
Table 5. Effect of three-monthly albendazole treatment on
allergy outcomes: Skin prick test to any allergens.
Placebo Albendazole OR (95%CI) *
n/N (%) n/N (%)
SPT to any allergen
9 months 80/462 (17.3) 82/454 (18.1) 1.18 (0.74–1.86)
21 months 145/455 (31.9) 161/439 (36.7) 1.37 (0.93–2.01)
The number of positives (n) of the total population examined (N). *Odds ratio
and 95% confidence interval are based on mixed effects logistic regression
models. OR’s and 95% CI are shown for the separate time points on SPT to any
allergen. The p-value is generated from the modeled data for the effect of
albendazole treatment overtime and no significant effects were found (P.0.05).
doi:10.1371/journal.pone.0057899.t005
Table 6. Effect of three-monthly albendazole treatment on allergy outcomes: Skin prick test and specific IgE to aeroallergens.
Placebo Albendazole
Skin prick test reactivity* n/N (%) n/N (%) OR (95% CI)
House dust mite
9 months 36/462 (7.8) 35/454 (7.7) 1.31 (0.52–3.27)
21 months 77/455 (16.9) 76/439 (17.3) 1.37 (0.62–3.02)
Cockroach
9 months 60/462 (13.0) 65/454 (14.3) 1.27 (0.75–2.15)
21 months 112/455 (24.6) 139/439 (31.7) 1.63 (1.07–2.50)
Specific IgE** N (Median, IQR) N (Median, IQR) b (95% CI)
House dust mite
9 months 391 (0.46, 0.16–2.35) 381 (0.46, 0.14–1.98) 1.01 (0.91–1.12)
21 months 339 (0.82, 0.27–3.29) 334 (0.65, 0.20–2.69) 0.93 (0.81–1.06)
Cockroach
9 months 391 (1.47, 0.30–5.01) 381 (1.55, 0.44–4.40) 1.04 (0.93–1.16)
21 months 339 (1.83, 0.47–5.44) 334 (1.64, 0.42–4.82) 0.98 (0.85–1.14)
The number of positives (n) of the total population examined (N). *Odds ratio and 95% confidence interval based on logistic mixed models; **b (beta) and 95%
confidence interval based on generalized linear mixed models from the log-transformed IgE. The values shown are back-transformed. The p-values are generated from
the modeled data for the effect of albendazole treatment overtime and no significant effects were found (P.0.05).
doi:10.1371/journal.pone.0057899.t006
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arises as to why this effect was only seen in those .15 years of age.
This could be due to the fact that Ascaris infection is lower in older
age and therefore more easily cleared. It has been suggested that
Ascaris is the spesies of helminth that has the most effect on
malarial parasitemia and diseases.[6] Therefore by removing
Ascaris in older age, we might be seeing a more profound effect on
malarial parasitemia.
Using PCR, which enables detection of sub-microscopic
infections at species level, it was also concluded that albendazole
did not affect overall malarial parasitemia. When malaria species
were analyzed separately, the percentage of subjects infected with
P. falciparum but not with P. vivax increased significantly in the first
9 months post-treatment in the albendazole-treated arm, which is
contrary to our hypothesis that anthelminthic treatment would
reduce prevalence of malarial parasitemia.[32] It was expected
that by decreasing STH, the immune hyporesponsiveness would
be reversed and this would be associated with stronger immune
effector responses to malaria parasites. One of the possible
explanations for the enhanced malarial parasitemia would be that
with a reduction in STH, there is increased nutrient availability for
other co infections and their growth.
It has been suggested that there are different malaria outcomes
with different species of helminths; Ascaris being associated with
protection regarding parasitemia and severity of malaria while
hookworm with higher incidence of malaria.[6] Our study was not
powered to conduct a stratified analysis, and with the overall
gradual decrease in malaria in the study area during our study, the
numbers of subjects positive for malaria parasites are too few for
an ad hoc analysis.
The findings concerning allergy outcomes, although not
significant, are in line with our hypothesis that anthelminthic
treatment would increase SPT reactivity. The risk of SPT
reactivity increased incrementally with longer treatment and raises
the question whether even longer deworming periods are needed
for more pronounced effects on allergic outcomes. In support of
this, a recent study reported that 15–17 years of ivermectin
treatment for onchocerciasis control in Ecuador led to a significant
increase in SPT reactivity to allergens.[12] In the same country,
one year of anthelmintic treatment in schoolchildren did not lead
to any change in SPT.[10] The question whether different species
of helminths might affect allergic outcomes to a different degree,
remains unanswered. It is interesting that a one year anthelmintic
treatment in Vietnam where hookworm infection was the
prominent species, as in our study, resulted in a significant
increase in SPT positivity in schoolchildren. This is in contrast to
what was seen in Ecuador where Ascaris lumbricoides was the most
prevalent species. One common feature of the anthelmintic trials
seems to be that clinical symptoms of allergy do not change with
deworming. However, an important trial in pregnant women in
Uganda has shown an increased risk of infantile eczema in infants
of mothers treated with anthelminthics compared to those that
received placebo.[33] This could indicate that exposure to worms
in early life, might affect allergic outcomes more profoundly than
when helminths are removed later in life.[34]
One of the limitations of this trial is the overall decrease in
malarial parasitemia during the two year study period, most
probably caused by actively referring subjects with malaria-like
symptoms to puskesmas. Therefore further studies in areas highly
endemic for malaria are needed. Treatment in the trial did result
in a significant reduction in percentage of subjects infected with
STH, but this reduction was incomplete. It is therefore possible
that the community was insufficiently dewormed. However, our
primary aim was to measure the possible effect of deworming
programmes on malaria or allergy. We conclude that despite
transient increase in malarial parasitemia as a result of albendazole
treatment, there were no clinically relevant changes to outcome
measures 21 months after treatment was initiated.
In conclusion, an extremely intensive anthelminthic treatment
in a community where STH are highly endemic, does not lead to
elimination but reduces both prevalence and intensity of
helminths. Such MDA regiment appears safe and does not lead
to any significant change with respect to malaria infections or
allergies. However, it is worrying that such vigorous community
treatment does not have a more pronounced effect on STH
burden. Better integrated control strategies would be needed to
deworm and subsequently assess whether the risk for malaria
infections or allergies change.
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Additional information on the study area and procedures
Ende district, an area highly endemic for STH, is situated near the equator (8o45’S, 121o40’E) and 
it is characterized by a uniform high temperature, in the range of 23-33.5 °C, with humidity of 
86-95%. Average yearly rain fall is 1.822 mm with about 82 rainy days, especially from November 
to April, with the peak in December until March. The semi-urban village of Nangapanda, endemic 
for malaria, had a population of 3583 and is located in the coastal area with most villagers being 
farmers and fishermen with some government officers or private sector employees. The rural 
village Anaranda had 1631 inhabitants and is located 80 km further inland of Nangapanda. There 
was poor infrastructure and inhabitants generated income mainly from farming.  
Regarding the availability of the anthelminthics in the community, there was no deworming 
campaign in this area during the study period. Pyrantel pamoat (Combantrin®) and dehydropiperazine 
(Bintang 7 puyer 17®) were the only available anthelminthics in the market. The local primary health 
centre (Puskesmas) did not provide the current trial study participants by any anthelminthic 
treatment but referred them to the trial team. 
Malaria control, such as by artemisinin-combination therapy (ACT) treatment and 
insecticide-treated nets (ITN) or long-lasting insecticide-treated nets (LLIN) although planned, 
were not implemented yet during our study period. This was due to several difficulties faced in 
some parts of Indonesia, such as instable drug supply, lack of training on definitive diagnosis 
of malaria by the laboratory staff, as well as insufficient bednet supply and poor compliance 
(17). Malaria drugs such as chloroquine and quinine were available in the shops, however, little 
information is available on proper self medication. Therefore, before and during the study period, 
regular training of field workers was undertaken on how to prevent malaria (use of repellent and 
bednet, irrigation of breeding places) and how to treat malaria (not to self medicate but to visit 
puskesmas for diagnosis and treatment). Indoor residual spraying was done by the local health 
authority for dengue control against an outbreak at the beginning of 2008.
The treatment of suspected malaria cases at the puskesmas was chloroquine and primaquine 
for P. vivax, while for P. falciparum sulfadoxine/pyrimethamine was commonly used. Subjects 
in our study with fever and/or any one of the malaria-like symptoms (see below for detailed 
description) were referred to the puskesmas for assessment and treatment according to local 
health center policy. 
The anthelmintic treatment and placebo were coded and the code was concealed from trial 
investigators and participants. The tablets were distributed by trained health workers and the 
intake was directly observed. Labels with the study subject ID were printed from a computer 
database and attached to the appropriate strip of treatment by a separate team located 
in Jakarta without the involvement of the study investigators. In order to assess whether 
anthelminthic treatment had any adverse effect on the growth of children or on the incidence 
of allergy, interim analyses were done at one year post-treatment by a monitoring committee. 
After completion of the study the whole population was treated with albendazole (a single dose 
of 400mg for three consecutive days).
The malaria slides were read by microscopy at the Department of Parasitology in Jakarta. The 











with NAMRU-2 (US Naval Medical Research Unit-2) two microscopists from our team were trained, 
inter-observer differences were assessed and following satisfactory training they were certified. 
At the pilot phase, and throughout the study, PCR was used to monitor the microscopy data with 
a high degree of agreement between microscopy and PCR. In a random sub-sample at 9 months 
and 21 months post-treatment we measured malarial parasitemia by PCR.
Primers and the P. falciparum, P. vivax, P. ovale, and P. malariae-specific probes were used 
with some modifications in the fluorophore- and quencher-chemistry. Amplification reactions 
of each DNA sample are performed in white PCR plates, in a volume of 25 μl with PCR buffer 
(HotstarTaq master mix), 5 mmol/l MgCl2, 12.5 pmol of each Plasmodium-specific primer and 15 
pmol of each PhHV-1-specific primer, 1.5 pmol of each P. falciparum, P. vivax, P. malariae-specific 
XS- probes, and PhHV-1-specific Cy5 double-labelled detection probe, and 2.5 pmol of each 
P. ovale-specific XS-probes (Biolegio), and 5 μl of the DNA sample were used. Amplification 
consists of 15 min at 95ºC followed by 50 cycles of 15 s at 95ºC, 30 s at 60ºC, and 30 s at 72ºC. 
Amplification, detection, and analysis are performed with the CFX96 real-time detection 
system (Bio-Rad laboratories). The PCR output from this system consists of a cycle-threshold 
(Ct) value, representing the amplification cycle in which the level of fluorescent signal exceeds 
the background fluorescence, and reflecting the parasite-specific DNA load in the sample 
tested. Negative and positive control samples are included in each amplification run.
Stool samples were collected and preserved in 4% formaldehyde for microscopy examination 
or frozen (-20°C) unpreserved for PCR detection. The formol-ether acetate concentration 
method was performed on the formalin preserved stool samples followed by microscopic 
examination for Trichuris trichiura infections. As described in detail before(15), DNA was isolated 
from approximately 100 mg unpreserved feces and examined for the presence of Ancylostoma 
duodenale,  Necator americanus, Ascaris lumbricoides and  Strongyloides stercoralis DNA by 
the multiplex qPCR. The qPCR output from this system consisted of a Ct value; negative and 
positive control samples were included in each run of the amplification. Positive Ct- values were 
grouped into three categories: Ct<30.0, 30.0≤Ct<35.0 and ≥35.0 representing a high, moderate 
and low DNA load, respectively. 
Data collection on clinical symptoms
A year before the study enrolment, community workers were recruited and trained in taking 
finger-prick blood for the three-monthly malarial parasitemia survey in Nangapanda, observing 
drug intake, recording adverse treatment effects, as well as measuring fever and administering 
monthly malaria-like symptoms questionnaire. These questionnaires were based on WHO 
definitions (19) and were assessed in all individuals that were present at the time of the survey. 
Subjects with fever (≥37.5oC) or additional malaria-like symptoms (headache, fatigue and nausea) 
at the time of visits were referred to the puskesmas for treatment according to local standard 
protocols. The monthly data on fever (≥37.5, using digital thermometer) and additional malaria-
like symptoms were collected at baseline September 2008 and in the months Oct 08, Nov 08, 
Dec 08, Jan 09, Feb 90, March 09, Apr 09, May 09, June 09, Aug 09, Sept 09, Oct 09, Nov 09, Dec 
09, Jan 10, Feb 10, March 10 and Apr 10. At baseline, 1396 individuals were assessed in placebo and 
1381 in the albendazole arm and at the last timepoint, 1165 and 1181 subjects were followed up in 











47.2% of placebo and albendazole group whereas data for 80% of the timepoints were available 
from 83.8% and 87.6% of the two groups, respectively. The number of events was recorded in 
total of 15259 and 15307 person months at risk for placebo and albendazole groups, respectively.
The modified video-assisted (for asthma symptoms) and illustration-assisted (for atopic 
dermatitis) ISAAC questionnaire, translated to Bahasa Indonesia and back translated for use 
in our studies within the EU funded project GLOFAL (www.glofal.org), were administered 
at baseline and at 21 month timepoints. Data were available from 629 in placebo and 635 in 
albendazole arm at baseline, while these numbers were 460 and 445, respectively, at the 21 
month timepoint. These questionnaires were administered to the parents/guardians of 
subjects who were skin prick tested with allergens: the trial profile is given in supplementary 
figure 1B. The prevalence of asthma symptoms were obtained from the following questions: (i) 
has your child ever had asthma? (ii) has your child ever been diagnosed for asthma by a doctor? 
and (iii) has your child in the past 12 months had wheezing or whistling in the chest?; while the 
prevalence of atopic dermatitis was obtained from the questions: (i) has your child ever had 
doctor/paramedic diagnosed allergic eczema and (ii) has your child ever had one or more skin 
problems accompanied by an itchy rash?  
If the answer to one or more of these questions was positive, the subjects were considered 
to have either asthma or atopic dermatitis symptoms.
Detailed description of the statistical models used 
Descriptives were computed for each variable (mean and standard deviation or median and 
interquartile range for continuous outcomes, numbers and percentages for categorical 
variables). For children ≤ 19 years, BMI age-standardized z-scores were calculated according to 
WHO references (21).
Two sources of correlation among observations should be accounted for when modeling 
these data, namely observations at various timepoints for a subject are correlated due to subject 
specific effects and observations within households are correlated due to environmental 
effects shared within households. To model these correlations we used random effects. For 
subject effects a random intercept and a random slope were used, i.e. each subject has its own 
intercept and slope, where the latter models the change of the outcome variable over time. 
Observations within a household also have a shared random intercept. Thus the intercept 
for an observation of a specific subject from a specific household is the overall mean plus the 
subject specific effect plus the household effect. By doing so correlation among observations 
of the same household was modeled since these observations share the same household effect. 
To assess treatment effects generalized linear mixed models (22) were used where the term 
“mixed” corresponds to the used random effects. Unless stated otherwise all models included 
area as covariate in the model to take into account the differences between the two villages. 
Generalized linear mixed models provide a flexible and powerful tool to derive valid inference 
while capturing the data correlations induced by clustering within households and repeated 
evaluations in time of the same subject.
For continuous outcome variables which were measured at 0, 9 and 21 months, treatment 
effects were modeled at timepoint 9 and 21 months, because treatment started at 0 months and 











for different treatment effects at 9 and 21 months. Beta’s and 95% confidence intervals are 
provided for 9 and 21 months. The betas represent the mean difference between the placebo 
and treatment group. An overall test for treatment effect over time was performed by using a 
likelihood ratio test which compares the model with and without the treatment effect (2 df test).
For binary outcome variables measured at 9 and 21 months, the logit link was used (mixed 
effect logistic regression). In these models only the two random intercepts were included and the 
random subject specific slope was omitted. Odds ratios and 95% confidence intervals are reported. 
Analogously to continuous outcome variables two degrees of freedom likelihood ratio tests were 
performed to assess treatment effects over time. Note that the model based odds ratios are 
different from crude odds ratios directly computed from the sample due to missing observations 
and due to the presence of random effects and the covariate area in the model. Malarial parasitemia 
by microscopy was measured at a three monthly basis. To model these data, similar models were 
used. Specifically at each of the seven timepoints (excluding time zero) a treatment effect was 
included. The likelihood ratio test for treatment effect over time has therefore 7 degrees of 
freedom. All generalized linear mixed models were fitted using the lme4 package (Douglas Bates, 
Martin Maechler and Ben (2011). lme4: Linear mixed-effects models using S4 classes. R package 
version 0.999375-42. http://CRAN.R-project.org/package=lme4)  in R (23).
For each malaria-like symptom (fever, headache, fatigue, and nausea), total number of 
events and person months were computed for each treatment group. We calculated incidence 
rates for all events. Symptom episodes within three months of an initial presentation with 
the same symptom were regarded as part of the same episode. Hazard ratios for effect of 
treatment were calculated with Cox regression with robust SE to allow for within-subject and 
















n/N (%) OR (95% CI)
Helminth infection (any spp)
     9 months 395/477 (82.8) 247/480 (51.4) 0·07 (0·04-0·11)
     21 months 353/448 (78.8) 172/411 (41.9) 0·05 (0·03-0·08)
Hookworm1
     9 months 359/524 (68.5) 161/508 (31.7) 0·02 (0·01-0·04)
     21 months 305/466 (65.5) 99/423 (23.4) 0·01 (0·01-0·03)
A. lumbricoides1
     9 months 174/524 (33.2) 65/508 (12.8) 0·24 (0·16-0·36)
     21 months 140/466 (30.0) 41/423 (9.7) 0·18 (0·11-0·29)
T. trichiura2
     9 months 219/726 (30.2) 160/673 (23.8) 0·58 (0·42-0·80)
     21 months 177/633 (28.0) 101/571 (17.7) 0·40 (0·28-0·58)
The number of positives (n) of the total population examined (N).1diagnosed by PCR. 2diagnosed by microscopy. Odds 
ratio and 95% confidence interval based on logistic mixed models. The p-values are generated from the modeled data 
for the combined effect of albendazole treatment over time, which were significant (P < 0.001) for any helminth and for 
each of the species separately.















Fever 414 (18494) 0.02 429 (18636) 0.02 1.03 1.03
Headache 333 (19067) 0.02 340  (19563) 0.02 1.00 1.00
Fatigue 49 (22362) 0.002 69  (22535) 0.003 1.39 1.41
Nausea 76 (21749) 0.003 55 (22211) 0.002 0.71 0.71
Any symptom 661 (15259) 0.04 690 (15307) 0.05 1.04 1.04
IRR: incidence rate ratio
PM: Person months
Adjusted with age and sex
The p-values are generated from Cox regression of albendazole treatment over time with robust SEs to allow for within-
















n/N (%) OR (95% CI)
Asthma    
     21 months 8/461 (1.7) 11/445 (2.5) 1.11 (0.07-17.26)
Atopic dermatitis  
     21 months 13/461 (2.8) 9/445 (2.0) 0.57 (0.16-2.02)
The number of positives (n) of the total population examined (N).The p-values are generated from the modeled data 
for the effect of albendazole treatment after 21 months and no significant effects were found (P>0.05).
At baseline 8/692 (1.2%) and 18/692 (2.6%) in the placebo group reported symptoms of asthma and atopic dermatitis, 
respectively, while in Albendazole this was 10/635 (1.6%) and 11/635 (1.7%). 




N (Median, IQR) β (95% CI)
BMI
        9 months 498 (22.42, 19.91 - 25.54) 499 (22.07, 19.96 - 24.56) -0·10 (-0·29-0·09)
      21 months 430 (22.42, 19.68 - 25.56) 425 (21.56, 19.44 - 24.12) -0·15 (-0·39-0·10)
z-BMI
        9 months 346 (-0.81, -1.44 - -0.13) 334 (-0.96, -1.56 - -0.30) -0·04 (-0·17-0·09)
      21 months 272 (-1.29, -2.21 - -0.56) 269  (-1.57, -2.32 - -0.74) -0·07 (-0·23-0·10)
The total population examined (N). IQR = Interquartile range. β (beta) and 95% confidence interval based on 
generalized linear mixed models. The p-values are generated from the modeled data for the combined effect of 
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Figure S1A. Profile of trial with malarial parasitemia as outcome in the village of 
Nangapanda where malaria is endemic
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Figure S1B. Profile of trial with skin prick test (SPT) reactivity as outcome in children 5-15 years of age in 
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Figure S1B. Profile of trial with skin prick test (SPT) reactivity as outcome in children 5-
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Figure S1C. Profile of trial with helminth infection as outcome in villages of Nangapanda 
and Anaranda












Three-monthly albendazole treatment 
alleviates geohelminth-induced 
immune hyporesponsiveness; results 





Background Chronic helminth infections are proposed to induce cellular immune 
hyporesponsiveness, which secures their long-term survival in their host, but which also 
may affect immune responses to unrelated antigens. As there are several other causes of 
immunosuppression, we conducted a household-clustered RCT to evaluate the specific effect 
of deworming on cellular immune responses in an helminth-endemic area in Indonesia. 
Methods Cytokine (IL-2, IL-5, IL-10, IFN-γ and TNF) responses to antigens and mitogens were 
assessed in 1059 subjects at baseline, 9 and 21 months after three-monthly treatment with 
either albendazole or placebo. 
Results This intensive treatment resulted in significant increase in malaria-specific and 
mitogen-induced TNF and IFN-γ responses. This effect was not associated with changes in cell 
counts or BMI. 
Conclusions These findings establish unequivocally that helminth infections suppress pro-
inflammatory responses, which may help to understand the possible protective effect of 
helminths on inflammatory diseases in rural areas of the world.
Trial registration: http://www.controlled-trials.com/ISRCTN83830814
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Infection with soil-transmitted helminths (STH) is the most common infectious disease 
worldwide and affects mostly inhabitants of rural areas in low- and middle-income countries (1). 
In addition to causing direct worm-associated morbidities, chronic STH infections may magnify 
poor health conditions common in communities remote from health care facilities, such as 
anemia, poor nutritional status, stunting and possibly poor cognitive development (1,2). 
An important hallmark of chronic helminth infections is cellular hyporesponsiveness, which 
is thought to allow the long-term survival of these parasites within their host (3,4). Although 
unresponsiveness in lymphocyte proliferation was already described in the 1970s for individuals 
with Schistosoma mansoni infection or bancroftian filariasis (5,6), the evidence for this has not 
moved beyond animal models and cross-sectional studies in humans (reviewed by Danilowicz-
Luebert et al. (7)). An important drawback to the cross-sectional nature of these studies is 
that other factors, which are also associated with immune suppression, could bias the results. 
Individuals infected with helminths may be in a poor nutritional state and shortage of proteins 
or amino acids can interfere with expression of immune effector molecules. Malnutrition has 
been specifically associated with decreased cell-mediated immunity, exemplified by atrophy 
of the thymus and other lymphoid tissues leading to lower T-cell numbers and reactivity (8). 
It is also known that other microorganisms and parasites can be associated with immune 
suppression or T-cell exhaustion (9) and therefore coinfections could act as confounders (10).
The consequences of immunosuppression are manifold and could be of major public health 
importance. Immune hyporesponsiveness, in the presence of helminth infections, can affect 
responses to unrelated antigens, it could curtail the development of effective immune responses 
to incoming protozoan, bacterial or viral infections, thereby increasing susceptibility to these 
pathogens. Similarly, vaccination studies have shown suboptimal responses to childhood 
vaccinations in subjects infected with STH (11,12). On the other hand, the dampened immune 
responses associated with helminths might help to prevent immune-induced pathology during 
coinfections and, possibly, overt reactivity to self- or environmental antigens (13). 
A few longitudinal studies have been undertaken to assess the effect of anthelminthic 
treatment on cellular immune responsiveness, however these were in small number 
of subjects or specifically targeted children (14-16). Conversely, clinical trials that have 
experimentally infected humans have mostly not evaluated cellular immune responses and 
have all been conducted in adults (17,18). Moreover, therapeutic infections are often not long 
enough to establish a chronic infection, which could be important for the gradual onset of 
hyporesponsiveness. So far there are no large-scale community-based intervention studies 
that show helminth infections lead to immune hyporesponsiveness in man. 
To disentangle the impact of helminths on the immune system from other influences, we 
conducted a randomized double blind placebo-controlled trial of three-monthly single dose 
albendazole treatment in an area where STH are highly endemic. Here we present the results of 
our trial; the effect of anthelminthic treatment on the peripheral blood cytokine responses of a 
















This report describes a nested study within the ImmunoSPIN trial (19,20). The trial was conducted 
in two villages in Ende district, Flores island, Indonesia. The coastal village Nangapanda is located 
around the main road of Flores and can be characterized as semi-urban, based on the location 
and the presence of a primary healthcare centre. Anaranda village is located 80 km north of 
Nangapanda and is more remote from roads, health centres and other facilities. In 2008 the double 
blind placebo-controlled trial of two year duration was initiated by randomizing all households 
in the two villages to receive either a single dose of 400 mg albendazole or a matching placebo 
every three-months over a two year study period (tablets from PT Indofarma Pharmaceutical, 
Bandung, Indonesia). Treatment allocation was based on household to minimise the risk cross-
contamination and therefore reinfection of treated individuals. Treatment was provided to 
all household members older than two years of age, except for pregnant women (according 
to Indonesian national guidelines), and intake was observed by field workers. The study was 
approved by the Ethical Committee of the Medical Faculty, University of Indonesia, Jakarta (ref: 
194/PT02.FK/Etik/2006) and has been filed by the ethics committee of the Leiden University 
Medical Center, the Netherlands. The trial was registered as clinical trial (ISRCTN83830814). 
Informed consent or parental consent was obtained from all participants.
Study population
The randomisation for the total study was based on 954 households in the two villages, 
comprising of 4004 individuals, resulting in 2022 (481 houses) and 1982 (473 houses) subjects 
in placebo and albendazole group, respectively. For the immunological component of this 
study in Nangapanda, aiming at 1000 participants, 250 households were randomly selected 
and individuals older than 4 years of age were invited for morning venous blood sampling and 
assessment of anthropometric parameters. This resulted in the inclusion of 882 individuals from 
the semi-urban area, of which 858 provided sufficient blood samples for whole blood cultures. 
In the rural area Anaranda, only children were included since this area was included for our 
allergy studies (19). 250 children were randomly selected from the total population and children 
from the same households were also included, leading to a total number of 295 children with 
whole blood cultures. After exclusion of cytokine data from wells that were suspected of being 
infected (see below), the number of subjects included at baseline was 839 and 220 for the two 
respective areas, corresponding to 572 placebo- and 487 albendazole-treated individuals. 
Whole blood culture and cytokine measurements
Heparinized blood was diluted 1:4 with RPMI 1640 medium (Invitrogen, Breda, the Netherlands) 
and cultured in 96-well round-bottomed plates. Cultures were stimulated for 24h to assess innate 
responses (to lipopolysaccharide (LPS) from E. coli, Sigma-Aldrich, Zwijndrecht, the Netherlands), 
and for 72h to detect adaptive responses (to Ascaris lumbricoides antigen, Plasmodium 
falciparum-parasitized red blood cells (PfRBC), uninfected RBC (uRBC) and phytohaemagglutinin 
(PHA, Wellcome Diagnostics, Darford, UK)) and at each time point unstimulated control wells 
were included. PfRBC and uRBC were kindly provided by professor Sauerwein from Radboud 














area, since the rural area was not endemic for malaria. The cultures were carried out in the field 
laboratory in Nangapanda and the supernatants were kept at -20°C and transported to Jakarta. 
There cytokine responses were quantified using Luminex cytokine kits (Biosource, Camarillo, 
CA, USA) and run on a Liquichip 200® Workstation (Qiagen, Venlo, The Netherlands) equipped 
with Liquichip analyzer software (Qiagen, Venlo, The Netherlands). TNF and IL-10 were assessed 
in 24h supernatants and TNF, IFN-γ, IL-2, IL-5 and IL-10 in 72h supernatants. Samples with TNF 
levels ≥250 pg/mL in unstimulated blood were excluded from the analyses as they are considered 
unreliable with respect to possible infection in the culture. This value was derived from the data 
distribution, which indicated outliers to be identified with this cut-off. Cytokine levels that fell 
below the assay’s detectable range were replaced by half of the detection limit.
Stool examination by microscopy and PCR
In order to examine the effect of treatment on helminth prevalence, yearly stool samples 
were collected. T. trichiura was detected by microscopy after formol-ether concentration and 
18S-based multiplex real-time PCR was used for the specific amplification and detection of 
hookworm (Ancylostoma duodenale, Necator americanus), A. lumbricoides, and Strongyloides 
stercoralis DNA, as described previously (20). 
Complete blood counts
Complete blood counts (CBC) and differential counts before and one year after treatment were 
determined using heparinized blood on a routine cell counter (Coulter® Ac-T™ diff Analyzer, 
Beckman Coulter Inc., Fullerton, CA, USA), while CBC 2 years after treatment were determined 
using heparinized and EDTA blood on Sysmex KX-21N hematology analyzer (PT Sysmex Indonesia, 
Jakarta, Indonesia). Since both heparinized and EDTA blood samples were used at the last time 
point, 325 samples were tested in parallel analysis. All outcomes were highly comparable except 
for thrombocyte counts, thus the data of all parameters but thrombocyte counts were pooled.
Statistical analysis
The cytokine data were log transformed (log10(concentration+1)) to obtain normally distributed 
variables. For children ≤19 years, BMI age-standardized z-scores were calculated according to WHO 
references (21). To assess treatment effects, generalized linear mixed models were used with addition 
of three random effects, namely a random household-specific intercept to model clustering within 
households and a random subject-specific intercept and slope to model correlation within subjects. 
Linear or logistic mixed-effects models (22) were applied for continuous and binary outcomes, 
respectively. Parameter estimates for treatment effects at 9 and 21 months and 95% confidence 
intervals are reported. The reported p-values are obtained using likelihood ratio tests by comparing 
the model with and without the treatment effect. Unless stated otherwise, all outcomes were adjusted 
for area by using area as covariate in the model. All models were fitted using the lme4 package (23).
Results
Study population
The baseline characteristics of the study participants are shown in table 1. At baseline 














Table 1. Baseline characteristics
N Placebo N Albendazole
Age (mean in years, SD) 572 25.7 (18.5) 487 24.9 (18.4)
Sex (female, n, %)* 572 328 (57.3) 487 279 (57.3)
Area (rural, n, %)* 572 114 (19.9) 487 106  (21.8)
BMI  > 19 years old (mean, SD) 264 22.1 (4.1) 220 22.1 (3.8)
Z score of BMI ≤ 19 years old (mean, SD) 194 -1.15 (1.11) 386 -1.14(1.15)
Parasite infection (n, %)*
Helminth (any spp) 322 286 (88.8) 237 210 (88.6)
Hookworm1 335 255 (76.1) 245 192 (78.4)
  N. americanus1 335 252 (75.2) 245 188 (76.7)
  A. duodenale1 335 25 (7.5) 245 17 (6.9)
A. lumbricoides1 335 105 (31.3) 245 80 (32.7)
S. stercoralis1 335 3 (0.9) 245 14 (5.7)
T. trichiura2 415 106 (25.5) 310 62 (20.0)
Malarial parasitaemia (any spp)2 567 24 (4.2) 483 24 (5.0)
  P. falciparum 567 16 (2.8) 483 11 (2.3)
  P. vivax 567 8 (1.4) 483 10 (2.1)
  P. malariae 567 0 (0.0) 483 4 (0.8)
Cytokine production, pg/mL [median, IQR]
LPS
TNF-α 554 743 [368-1293] 468 769 [339-1318]
IL-10 554 271 [163-441] 468 256 [158-406]
PHA
TNF-α 516 100 [50-222] 435 103 [50-214]
IL-10 515 76 [41-129] 435 70 [37-116]
IFN-γ 516 1625 [584-3983] 435 1270 [538-4340]
IL-2 516 23 [0-101] 432 23 [0-92]
IL-5 516 563 [309-840] 435 520 [317-829]
iRBC
TNF-α 299 18 [4-42] 237 14 [3-38]
IL-10 300 10 [5-19] 238 10 [5-20]
IFN-γ 300 163 [75-388] 239 176 [70-376]
IL-2 300 50 [5-125] 239 40 [5-112]
IL-5 300 14 [5-26] 239 12 [4-23]
Ascaris
TNF-α (pg/mL) 517 5 [0-15] 438 6 [0-14]
IL-10 (pg/mL) 516 7 [2-15] 438 7 [1-14]
IFN-γ (pg/mL) 516 19 [6-47] 441 21 [7-47]
IL-2 (pg/mL) 497 38 [4-114] 426 36 [0-107]
IL-5 (pg/mL) 515 24 [9-68] 440 24 [9-63]
1diagnosed by PCR; 2diagnosed by microscopy. 














infection being the most prevalent (77.1% of total). The consort diagram of the trial is shown 
in figure 1; follow-up after 9 months was 88% for both groups and 76% for placebo- and 75% 
for albendazole-treated groups after 21 months, corresponding to a total loss of 138 and 123 
individuals respectively. Six subjects died during the study period, which were all above the 
age of 35, suggesting non-infectious causes of death. The analysis was intention-to-treat, and 
involved all participants as assigned randomly at the start of the trial. No significant change 
in BMI was observed over the 2-year study period in children (analysed by zBMI, p=0.70) or in 
adults (BMI, p=0.45; data not shown). 
Effect of albendazole treatment on helminth prevalence
Treatment with albendazole resulted in a reduction in the prevalence of geohelminths both 
after 9 (51.9% vs. 84.1% for placebo) and after 21 months (39.2% vs. 80% for placebo) (Table S1). 
Albendazole had the most effect on hookworm (from 78.4% at baseline to 32.6% at 9 months 
and 21.6% at 21 months post-treatment) compared to placebo (from 76.1% to 70.5% and 67.0% 
respectively), followed by on Ascaris (albendazole from 32.7%, to 13.3% and 12.2%; placebo from 
31.3% to 33.5% and 24.2%), while the effect on Trichuris was less pronounced (from 20.0% at 
baseline to 21.0% at 9 months and 16.2% at 21 months post-treatment, compared to placebo 
from 25.5% to 31.7% and 28.8%). When assessing the intensity of infection in categories based 
on cycle threshold values of PCR, it was in particular the high-load infections that were greatly 
diminished in the treatment group (24).
Effect of albendazole treatment on whole blood cytokine responses
In figure 2, we present the effect of treatment on cytokine responses to Ascaris antigens, 
PfRBC and PHA. The model-estimated treatment effects on cytokines at 9 months (figure 2A) 
and 21 months (figure 2B) are shown. Regarding helminth (Ascaris) antigen-specific cytokine 
responses, IL-2 responses were significantly enhanced by treatment over the study period 
(p
time
=0.018), with significantly higher IL2 in the treated group at 9 months (estimate [95% 
CI]: 0.17 [0.05–0.28], figure 2A). Neither Th1, nor Th2 responses changed with treatment. In 
response to P. falciparum antigens, there was an increase over time in pro inflammatory cytokine 
TNF, which was highly significant (p
time
<0.0001), and IFN-γ (p
time
=0.036), in the albendazole-
treated group. As shown in figure 2A, both TNF and IFN-γ were significantly higher than in 
the placebo treated group at the 9 months time point (0.37 [0.21-0.53] for TNF and 0.14 [0.03-
0.24] for IFN-γ). Moreover, the general adaptive response (cytokine production stimulated by 





=0.003 respectively) over the trial period. Interestingly, for TNF, albendazole treatment 
resulted in elevated response at 9 months whereas for IL-10 the response was significantly 
higher at the later 21 months time point (for TNF 0.14 [0.05–0.24], figure 2A; for IL-10 0.12 [0.05–
0.19], figure 2B). At 9 months post-treatment, IFN-γ (0.10 [0.01-0.19]) and IL-2 (0.12 [0.01-0.23]) 
responses were transiently increased (figure 2A) and at 21 months a significant enhancement of 
IL-5 production (0.10 [0.01-0.19]) was observed (figure 2B), however these alterations were not 







Albendazole had no effect on immune responses to LPS (overall p-value for TNF p=0.77, for IL-10 
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Figure 1. Consort diagram. The current study is nested within the ImmunoSPIN trial, with a total of 4004 
individuals in two participating villages. Allocation of placebo and albendazole treatment resulted in 
480 and 471 households including 1944 and 1891 in the two groups, respectively. For the immunological 
studies, a random selection was made and 1723 individuals were invited to participate (n=944 and 
n=779 respectively). Cytokines were assessed for 1059 subjects, of which 572 in the placebo and 487 
in the albendazole arm. After 9 months 504 and 428 and after 21 months 434 and 364 individuals were 
analyzed, in placebo and albendazole group, respectively. Availability of complete blood counts (CBC) and 














treatment-related differences (data not shown). When assessing responses to uRBC as control 
for PfRBC, we found that IFN-γ levels were not different between the treatment arms (p=0.91), 
however TNF production was increased post-treatment in the albendazole arm, although to a 
lesser extent than what was seen in response to PfRBC (p=0.018; figure S1).
Increase in proinflammatory responses after treatment in helminth-infected individuals
To determine whether the enhanced cytokine responses could be due to a direct effect 
of albendazole, we stratified the analysis based on STH infection status at baseline. The 
enhancement of mitogen- as well as malaria-induced TNF by albendazole treatment was 





=0.0004 respectively, figure 3A and 3B), but not in uninfected ones (data not shown). 
Importantly, uRBC-induced TNF responses were not increased in either helminth-infected or 
uninfected subjects (data not shown). Also in the response to Ascaris antigen, enhancement 
of TNF was observed in the stratified analysis of helminth-positives at baseline (p
time
=0.044, 
figure 3C) but not in helminth negatives (data not shown). Moreover, elevated IFN-γ and IL-2 





=0.006 respectively; not shown). 
Increased cytokine responses are not associated with changes in cell counts
The total leukocyte count increased in the albendazole group at 9 months post-treatment and was 
similar in both groups at 21 months (p=0.035 and p=0.14 respectively; data not shown). However, 
we observed a negative association of leukocyte counts and both TNF and IFN-γ responses to 
PfRBC, indicating that increased leukocyte numbers could not be responsible for the enhanced 
cytokine responses after treatment. When analyzing differential cell counts and proportions, the 
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Figure 2. Effect of deworming on cytokine responses to Ascaris, PfRBC and PHA TNF, IFN-γ, IL-2, IL-5 
and IL-10 concentrations were assessed in supernatants of 72h-stimulated whole blood cultures. The 
effect of albendazole treatment on cytokine responses to PHA (black circles), PfRBC (dark grey squares) 
and Ascaris (light grey triangles) is shown. The estimates of the treatment effect in the whole study 
population after 9 (A) and 21 (B) months of albendazole treatment were obtained by general linear mixed 
models; asterisks with corresponding colors (black for PHA, dark grey for PfRBC, light grey for Ascaris) 














lymphocytes and granulocytes did not change after treatment, whereas monocyte proportions 
and numbers were higher in the albendazole group. No association was found between monocyte 
numbers and cytokine production in response to any of the stimuli (data not shown). No treatment 
effect was noted on thrombocyte or erythrocyte counts, hemoglobin levels or hematocrit.
Discussion
This is the first time that helminth-specific and -unrelated cytokine responses have been 
analyzed in a whole community before and after repeated long-term placebo-controlled 
anthelminthic treatment. We show that treatment of STH infections increases cytokine 







































































    







































































    
Figure 3. Effect of deworming on TNF 
responses stratified by helminth infection. 
TNF secretion was measured in supernatants 
from whole blood stimulated with (A) PHA, 
(B) PfRBC and (C) Ascaris antigen for 72 
hours. The estimated effect of albendazole 
treatment on TNF responses in helminth-
infected subjects is displayed for the 9 and 
21 months time points, with corresponding 
95% confidence intervals. The estimates 
of the treatment effect were obtained by 
general linear mixed model and overall 
p-values over time are indicated.





















































































responses, with profound effects on helminth-specific and other adaptive immune responses, 
providing conclusive evidence for helminth-induced immune hyporesponsiveness in humans.
Most pronounced were elevated pro-inflammatory, TNF and IFN-γ, cytokine responses 
after stimulation with mitogen and malarial antigens. Albendazole is a drug, which might induce 
production of inflammatory cytokines in a human monocytic cell line (25). Stratifying the analysis 
for helminth infection status at baseline revealed stronger effects in the helminth-infected group, 
indicating that the suppression of pro-inflammatory cytokine responses is unlikely to be due to 
direct effects of albendazole, but can be regarded as a true helminth-induced phenomenon. 
Subsequent to the rise in pro-inflammatory responses at 9 months, an interesting finding 
was the enhancement of IL-5 and IL-10 responses at 21 months post-treatment. Although 
helminth infections skew the immune system towards type 2 responses, suppression of these 
responses during helminth infections has been reported before in studies comparing helminth 
infected and uninfected subjects (26,27). IL-10 upregulation appears particularly surprising; 
as it has been postulated that helminth-associated inhibition of pro-inflammatory responses 
is mediated by this suppressory cytokine (28). Increased IL-10 responses after anthelminthic 
treatment have previously been observed in schistosomiasis (29) and STH infection (16). 
Whether the increased pro-inflammatory responses in the first year leads to higher IL-10 in 
the second year to prevent overt inflammation, is not clear from these data. Moreover, it is 
known that IL-10 can be part of the Th2 response and therefore the increased IL-10 might 
be a component of the enhanced Th2 response following deworming, leaving the question 
whether IL-10 originating from other cells is involved in cellular hyporesponsiveness caused 
by helminth infections. However, the fact that different cytokines appear to all increase in 
response to antigens and mitogens after anthelminthic treatment seems to indicate that all 
adaptive immune responses are enhanced after deworming. This would predict that there is a 
general helminth-mediated hyporesponsiveness which is neither restricted to a particular pro- 
or anti-inflammatory nor to a Th1 or Th2 response, but might stem from a common general 
effect such as alternation in cell counts, changes in nutrients essential to functioning of the 
immune system or suppressory cells and factors which do not involve IL-10.
Importantly, cell counts were affected by reduction in helminths, but did not show any 
correlation with cytokine responses, excluding the possibility that the general increase in 
responsiveness is due to higher numbers of cytokine-secreting cells. As immune responses can 
be enhanced by improved energy resources, we assessed BMI, and fasting glucose level (not 
shown), as proxies for nutritional status but these parameters were not affected by deworming. 
The three-monthly albendazole treatment over a two-year period was not effective in 
eliminating all helminth infections. Treatment efficacy was particularly low for Trichuris, shown 
in earlier studies that used single or double doses of albendazole and / or mebendazole (30,31). 
Here we show that even 7 doses of albendazole over a 21 month period is not sufficiently 
effective against Trichuris infection. By using a household-clustered design for randomization, 
repeated treatments and observed intake, we had expected a more effective reduction in 
transmission of STH. For better deworming results, more intensive treatment or inclusion of 
environmental control would be needed. However, it is clear that even a reduction in helminth 
infections in the community can lead to alleviation of immune hyporesponsiveness and that 














There is an increasing awareness that helminths might play an essential role in the 
development and homeostasis of the human immune system (32,33). In areas where chronic 
helminth infections are persistent, the immune system may have evolved to operate optimally 
in the face of helminth-induced downmodulation; any disturbance of the long evolutionary 
coexistence between humans and helminths might be associated with the emergence of 
pathological conditions (34). The question of what the clinical consequences of the enhanced 
adaptive immune responses are following deworming will need to be addressed next. So far, 
our trial of three-monthly albendazole treatment over a 21-month period did not show clear 
clinical changes (24). Although we found a transient increase in malarial parasitemia at 6 months 
post treatment, the time point after the rainy season, this could not be confirmed during the 
further follow-up period, as the prevalence of malaria decreased drastically in the study area. 
With respect to allergy, skin prick test (SPT) reactivity was assessed in school children in our 
study cohort. This revealed a specific increase in SPT reactivity to cockroach allergens after 
two years of anthelminthic treatment, but no effect on allergy symptoms (24). The effects 
of anthelminthic treatment on other infectious or inflammatory diseases should probably be 
investigated over a longer period, since the immunomodulatory effects of helminths are likely 
to have developed over several years of chronic infection. In the case of allergic diseases this is 
illustrated by a recent publication, showing an increase in allergen SPT reactivity and possibly 
eczema symptoms after more than 15 years of ivermectin treatment (35), whereas studies with a 
shorter treatment course failed to show increased SPT reactivity or symptoms (14,15).
Several clinical trials are underway to evaluate the possible beneficial effect of helminth 
infection or their excretory products on the symptoms and prevalence of inflammatory 
diseases (36,37), while at the same time efforts are made to control STH by implementing 
regular treatment programs in developing countries (38). These studies, if conducted within 
appropriate time frames, should be able to answer the question what clinical consequences 
of human helminth infections are. Given our results that there are major effects on immune 
responses following deworming, it will be important to include immunological measurements 
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9 months Placebo 227 191 (84.1%) 160 (70.5%) 76 (33.5%) 72 (31.7%)
Albendazole 181 94 (51.9%) 59 (32.6%) 24 (13.3%) 38 (21.0%)
21 months Placebo 215 171 (80.0%) 144 (67.0%) 52 (24.2%) 62 (28.8%)
Albendazole 148 58 (39.2%) 32 (21.6%) 18 (12.2%) 24 (16.2%)














Figure S1. Effect of deworming on TNF and IFN-γ responses to PfRBC and uRBC. TNF (A, B) and 
IFN-γ (C, D) responses were measured after 72h of stimulation with Plasmodium falciparum-infected 
and -uninfected RBC (PfRBC (A, C) and uRBC (B, D), respectively). The estimated effect of albendazole 
treatment on TNF responses in helminth-infected subjects is displayed for the 9 and 21 months time 
points, with corresponding 95% confidence intervals. The estimates of the treatment effect were obtained 
by general linear mixed model and overall p-values over time are indicated.






























































































































Relationship between Carotid Intima 
Media Thickness and Helminth 
Infections on Flores Island, Indonesia
5
Relationship between Carotid Intima Media Thickness
and Helminth Infections on Flores Island, Indonesia
Aprilianto Eddy Wiria1,2*, Linda J. Wammes2, Firdaus Hamid2,3, Olaf M. Dekkers4,6,
Margaretta A. Prasetyani1,2, Linda May2, Maria M. M. Kaisar1,2, Jaco J. Verweij2¤, Jouke T. Tamsma5,
Felix Partono1, Erliyani Sartono2, Taniawati Supali1., Maria Yazdanbakhsh2., Johannes W. A. Smit6,7.
1Department of Parasitology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia, 2Department of Parasitology, Leiden University Medical Center, Leiden, The
Netherlands, 3Department of Microbiology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia, 4Department of Clinical Epidemiology, Leiden University
Medical Center, Leiden, The Netherlands, 5 Vascular Medicine, Department of Endocrinology and General Internal Medicine, Leiden University Medical Center, Leiden, The
Netherlands, 6Department of Endocrinology and General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands, 7Department of General Internal
Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Abstract
Objective: To examine the association between helminth infections and atherosclerosis.
Background: Chronic helminth infection, which can lead to poor nutritional status and anti-inflammatory response, might
protect against the development of atherosclerosis.
Methods: A cross-sectional study was performed in Flores, Indonesia, an area highly endemic for soil-transmitted helminths
(STH). Stool samples from 675 participants aged 18–80 years were collected and screened for Trichuris trichiura by
microscopy and for Ascaris lumbricoides, Necator americanus, Ancylostoma duodenale, and Strongyloides stercoralis by qPCR.
We collected data on body mass index (BMI), waist to hip ratio (WHR), blood pressure, fasting blood glucose (FBG), lipid,
high sensitive C-reactive protein (hs-CRP), total immunoglobulin-E (TIgE) and Escherichia coli lipopolysaccharide stimulated
cytokines (tumor necrosis factor and interleukin-10). In a subset of 301 elderly adults ($40 years of age) carotid intima
media thickness (cIMT) was measured.
Results: Participants with any STH infection had lower BMI (kg/m2) (mean difference 20.66, 95%CI [21.26, 20.06]), WHR
(20.01, [20.02, 20.00]), total cholesterol (mmol/L) (20.22, [20.43, 20.01]) and LDL-cholesterol (mmol/L) (20.20, [20.39,
20.00]) than uninfected participants. After additional adjustment for BMI the association between helminth infection and
total cholesterol (mean difference 20.17, 95%CI [20.37, 0.03]) as well as LDL-cholesterol (20.15, [20.33, 0.04]) was less
pronounced. BMI, WHR, and total cholesterol were negatively associated with number species of helminth co-infections.
Participants with high TIgE, an indicator of exposure to helminths, had lower FBG, TC, and HDL. The association between
TIgE and TC and HDL remained significant after adjustment with BMI. No clear association was found between STH infection
or TIgE and mean cIMT.
Conclusions: This cross-sectional study presents evidence that helminth infections were negatively associated with risk
factors for cardiovascular disease, an association at least partially mediated by an effect on BMI. The significance of this
finding needs to be determined.
Citation: Wiria AE, Wammes LJ, Hamid F, Dekkers OM, Prasetyani MA, et al. (2013) Relationship between Carotid Intima Media Thickness and Helminth Infections
on Flores Island, Indonesia. PLoS ONE 8(1): e54855. doi:10.1371/journal.pone.0054855
Editor: David Joseph Diemert, The George Washington University Medical Center, United States of America
Received July 23, 2012; Accepted December 17, 2012; Published January 24, 2013
Copyright:  2013 Wiria et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded by The Royal Netherlands Academy of Arts and Science (KNAW), Ref.KNAW-05-PP-35, European Commission contracts INCO-CT-
2006-031714 and INCO-CT-2006-032436, and the Prof. Dr. P.C. Flu Foundation. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: a.e.wiria@lumc.nl
¤ Current address: Laboratory for Medical Microbiology and Immunology, St. Elisabeth Hospital, Tilburg, The Netherlands
. These authors contributed equally to this work.
Introduction
Mortality from cardiovascular diseases (CVD) accounts for
30% of total global deaths [1]. CVD is no longer a disease of
Western countries exclusively since 80% of all CVD deaths
worldwide take place in developing countries. In many Asian
countries, rapid socioeconomic development has led to a shift in
infrastructure, technology and food supply that promotes over
nutrition and sedentary lifestyle [2,3]. The relationship between a
disturbed energy balance resulting from decreased physical
activity or excess consumption of high-energy foods and CVD
has long been acknowledged, but there is now abundant
evidence that inflammation plays a role in chronic non-
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communicable diseases, including CVD. Indeed, in CVD
elevated levels of several inflammation-related markers such as
interleukin 6 (IL-6), IL-8, tumor necrosis factor (TNF), and C-
reactive protein (CRP) [4] have been reported. One particular
modifier of the pathogenesis of CVD in non-western societies
may be related to differences in infectious pressure between rural
and urban societies.
Although helminth infections, vary in their lifecycle and clinical
impact in humans, they appear to share the ability to decrease
inflammation and subsequently the development of inflammatory
diseases which may include CVD [5]. We and others have shown
that various helminth infections, which are endemic in many non-
western societies, induce regulatory T cells (Treg) in order to
ensure their survival within an immune competent host [6–9].
Helminths, such as schistosomes, that establish a systemic infection
or soil-transmitted helminths (STH), which are restricted to the
intestine, are also known to reduce energy intake and to be
associated with poor nutritional status [10,11]. Interestingly, in a
study with apoE2/2 mice, the development of atherosclerotic
lesions was reduced by approximately 50% in animals with S.
mansoni infections [12] whereas lipid-lowering effects were medi-
ated by factors released from S. mansoni eggs [13]. Moreover, in an
animal model of helminth infection with Nippostrongylus brasiliensis, a
gastrointestinal nematode, with a lifecycle similar to hookworm in
humans, it has been shown that infection is associated with
beneficial effects of reducing traditional CVD risk factors such as
obesity and serum lipid levels [14]. So far, to our knowledge, no
studies have been published on the association between STH
infections and atherosclerosis in humans.
Carotid intima media thickness (cIMT), is a marker for
subclinical atherosclerosis [15] and is strongly associated with risk
of CVD [16]. Assessment of cIMT is widely used in large-scale
observational and experimental research. We set out to study the
relationship between helminth infections CVD risk factors and
cIMT as marker for atherosclerosis in an area endemic for STH
on Flores Island, Indonesia.
Materials and Methods
Study Objectives
The primary objective of the study was to investigate the
association between helminth infections and cIMT as marker for
subclinical atherosclerosis. Our hypothesis was that, since
helminths might protect against CVD, cIMT is lower in subjects
with helminth infections than in subjects without helminth
infections. The secondary objective was to study the association
between helminth infections as well as total immunoglobulin E
(TIgE), an indicator of exposure to helminths [17], and
conventional CVD risk factors, including body mass index
(BMI), waist hip ratio (WHR), blood pressure (BP), fasting blood
glucose (FBG), serum lipid profile and serum markers of
inflammation.
Study Population
The study area is the semi urban area of Nangapanda on Flores
Island in Indonesia [18,19]. The area of Nangapanda is endemic
for STH infections but not for filarial nematodes [9]. In this area, a
large project is being conducted on the relationship between
helminth infections and the immune system (ImmunoSPIN study
[18,19]). For the current study, a cross sectional representative
sample was included from all inhabitants aged 18 years and above.
Data were collected between May and August 2009.
Study Design
From 2799 inhabitants from the Nangapanda area who
participated in the ImmunoSPIN project, 691 were randomly
selected to participate in the present cross-sectional study and
invited to provide data on BMI, WHR, BP, and blood sampling
for fasting glucose measurements, lipid profiles, TIgE, hs-CRP and
whole blood culture to stimulate cytokine production. Data on
helminth infections, BP, BMI and WHR ratio were available from
675 subjects included in the present analysis. In 595 of these
subjects, laboratory measurements were performed. Carotid artery
IMT was measured in a subset of 301 adult participants above 40
years of age.
The study was approved by The Ethical Committee of Faculty
of Medicine, University of Indonesia, ref: 194/PT02.FK/Etik/
2006 with addendum ref: 96/PT02.FK/Etik/2010 and registered
as clinical trial ref: ISRCTN83830814 and was filed by the Leiden
University Medical Center Committee of Medical Ethics (CME).
Because of the high rate of illiteracy amongst elderly participants,
either written or verbal informed consent was obtained from each
participant.
Clinical and Laboratory Assessment
Anthropometric measurement of body weight (SECA 761,
SECA GMBH & Co. Kg., Hamburg, Germany), height (SECA
206, SECA GMBH & Co. Kg., Hamburg, Germany), waist and
hip circumference (WC and HC) (SECA 203, SECA GMBH &
Co. Kg., Hamburg, Germany) were obtained using the NHLBI
practical guidelines (NHLBI web). Three blood pressure (BP)
measurements (left arm, sitting upright position, after resting 5
minutes) were taken from each subject, using a digital Omron
sphygmomanometer (705IT HEM-759P-E2, OMRON Health-
care Europe BV, The Netherlands), and calibrated using a Riester
nova-presameterH-Desk model mercury sphygmomanometer
(Gerhard Glufke Rudolf Riester GmbH & Co, Jungingen,
Germany) and a 3MTM LittmannH Classic II S.E. Stethoscope
(3M, St. Paul, Minnesota, USA). The average of three systolic/
diastolic BP measurements was used. Abnormal BMI is $25 kg/
m2 and the Asian modified abnormal waist hip ratio (WHR) is
.0.9 (men) and.0.8 (women) [20]. Abnormal blood pressure was
considered as hypertension when BP$140/90 mmHg.
All participants were instructed to be fasting before venous
sampling. FBG was analyzed using BreezeH2 glucose meter (Bayer
Health Care LLC, Basel, Switzerland). Lipid profile was measured
using commercial enzymatic kits for total cholesterol (TC), high
density lipoprotein-cholesterol (HDL-c) and triglycerides (TG)
(Roche Molecular Biochemicals, Indianapolis, USA) and deter-
mined using ELISA reader (LabSystem Multiscan, MHC347,
Helsinski, Finland). Low density lipoprotein-cholesterol (LDL-c)
was calculated by using the Friedwald calculation [21]. High
sensitive C-reactive protein (hs-CRP) level was measured using
MSDH 96-Well MULTI-ARRAYH CRP Assay (Meso Scale
Discovery, Gaithersburg, USA). TIgE level was measured by an
ELISA as described in detail previously [18,19].
Helminth Status
Stool samples were collected and preserved in 4% formaldehyde
for microscopy examination or frozen (220uC) unpreserved for
PCR detection. The formol-ether acetate concentration method
was performed on the formalin preserved stool samples followed
by microscopy examination for Trichuris trichiura infections [19]. As
described in detail before [19] the DNA of Ancylostoma duodenale,
Necator americanus, Ascaris lumbricoides and Strongyloides stercoralis were
isolated from approximately 100 mg unpreserved faeces and were
examined by the multiplex qPCR. The qPCR output from this
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system consisted of a cycle-threshold (CT) value, representing the
amplification cycle in which the level of fluorescent signal exceeds
the background fluorescence, and reflecting the parasite-specific
DNA load in the sample tested. Negative and positive control
samples were included in each run of the amplification. We
defined a positive case for T. trichiura by the egg findings and for A.
duodenale, N. americanus, A. lumbricoides and S. stercoralis by parasite-
specific DNA findings. Participants were also grouped by number
of helminth co-infections.
Carotid Intima Media Thickness
We used ultrasound for measuring cIMT [22]. Quality control
and details of the IMT measurement have been described before
[23]. cIMT was measured while the participant was lying in a
supine position. Measurements were made at 3 different angles of
both the right and left common carotid artery at 10 mm proximal
of the carotid artery bulb using a mobile device: MylabH25
ultrasound system with a LA523 13-4 MHz transducer (ESAOTE,
S.p.A, Maastricht, The Netherlands). The mean of these 6
measurements was used in the analysis. In order to keep variation
minimal, one of the physicians (AEW) performed all intima-media
thicknesses measurements on the participants in this study.
Whole Blood Stimulation and Cytokine Measurement
The procedure of whole blood stimulation and cytokines
measurement has been described previously [19]. Briefly, hepa-
rinized blood within 6 hours of blood draws was diluted 46 and
stimulated. Stimulations were performed with control medium or
Escherichia coli lipopolysaccharide (LPS, 1 ng/ml Sigma-Aldrich,
Zwijndrecht, The Netherlands), incubated for 24 hours at 37uC
and 5% CO2. The supernatants were frozen at 220uC and
transported to Jakarta where TNF and IL-10 were assessed by
means of immunobead-based multiplex assays (Biosource, Camar-
illo, CA, USA) on a Liquichip 200H Workstation (Qiagen, Venlo,
The Netherlands) using Liquichip analyzer software (Qiagen,
Venlo, The Netherlands). Samples with TNF levels higher than
250 pg/ml in medium stimulation were excluded from further
analyses (2 samples).
Statistical Analysis
Participant characteristics were stratified for helminth infection
(uninfected and infected). Linear regression was used to study the
associations between helminth infections and also number of
helminth species co-infection and risk factors for CVD adjusted for
age and sex. Differences between infected and uninfected
participants were reported as mean differences with 95%
confidence intervals (95% CI). TIgE, cytokines and CRP
concentrations were normalized by log-transformation, analyses
were performed with these log transformed values but results were
presented as geometric means after exponentiation of the values
on a logarithmic scale. To assess whether a potential association
between helminth infection and CVD risk factors is mediated
through an effect on BMI, we performed a second analysis
additionally adjusted for BMI. Similar analyses were performed on
the cIMT subset participants. Furthermore, in the helminth
infected group we tested the association of helminth load per
species with CVD risk factors. In addition, as high TIgE is
associated with exposure to helminth infections, we tested the
association between TIgE and risk factors for CVD as well as
cIMT. Subjects were considered to have high or low TIgE based
on the value above or below and equal the geometric mean. P
values ,0.05 were considered to be statistically significant.
Statistical analysis was done using SPSS statistics 17.0.2 (SPSS
Inc., Chicago, Illinois, USA).
Results
Characteristics of Study Participants
A total of 446 participants infected with at least one helminth
were compared to 229 uninfected participants. There were more
males in the infected group (37.7%) than in the uninfected group
(34.1%), whereas the mean age was similar (45.0 vs. 44.8 years).
The most prevalent STH infections were N. americanus 348/675
(51.6%), A. lumbricoides 149/675 (22.1%) and T. trichiura 139/675
(20.6%). The proportion of participants infected with A. duodenale
24/675 (3.6%) and with S. stercoralis 5/675 (0.7%) was clearly
lower. 273 participants were infected with one helminth only, 131
with two helminths and 42 with 3 or more helminths species. As
expected, TIgE was higher in individuals infected with STH
infection. (Table 1).
Association between Helminth Infection and CVD Risk
Factors
Participants with any helminth infection had lower BMI (mean
difference 20.66, 95%CI 21.26, 20.06), WHR (20.01, 95%CI
20.02, 20.00), total cholesterol (20.22, 95%CI 20.43, 20.01)
and LDL-cholesterol (20.20, 95% CI 20.39, 20.00) than
uninfected participants (Table 1). After additional adjustment for
BMI the association between helminth infection and total
cholesterol (mean difference 20.17, 95%CI 20.37, 0.03) as well
as LDL-cholesterol (20.15, 95%CI 20.33, 0.04) was less
pronounced. No clear associations were found between helminth
infection and blood pressure, fasting blood glucose and triglycer-
ides. No difference in hs-CRP between helminth-infected and –
uninfected groups was found.
Next, we analyzed whether the number of helminth species
infecting a participant was related to CVD risk factors (data not
shown). BMI, WHR, and total cholesterol were negatively
associated with the number of helminth infections. Adjustment
for BMI attenuated the association between number of infections
and total cholesterol. No marked associations were found between
number of infections and blood pressure, LDL, HDL, triglycerides
or fasting glucose levels. In addition, TNF production in response
to LPS stimulation was positively associated with the number of
helminth infections with the highest LPS-TNF levels in partici-
pants with 3 or more infections. This association remained after
adjustment for BMI (p = 0.03).
Looking at intensity of infection; in infected participants no
associations were found between N. americanus load (as measured
by qPCR) and BMI, WHR, fasting blood glucose, blood pressure
or cholesterol levels. A negative association was found between A.
lumbricoides load and triglyceride independent of BMI (P,0.001).
The Association between Helminth Infections and IMT
IMT was measured in 70% of participants $40 years (table 2).
In accordance with the whole study population, BMI, WHR, TC
and LDL were lower in helminth infected patients. IMT was only
marginally lower in infected participants than in uninfected
participants (mean difference 24.7, 95% CI 227.7, 18.3). In
addition, no relationships between the number and load of helminth
infections and IMT were found. No differences in IMT were
found between N. americanus infected participants and non-infected
participants either.
The Association between TIgE Level, CVD risk Factors and
cIMT
A negative association was found between TIgE and FBG
(mean difference 20.31, 95%CI 20.61, 20.02), TC (20.23,
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95%CI 20.42, 20.03), and HDL (20.08, 95%CI 20.14, 20.01).
The association remained significant after adjustment for BMI for
TNF (1.22, 95%CI 0.96, 1.57) and IL-10 (1.27, 95%CI 1.03,
1.57). No difference was found between TIgE and cIMT. In
analyses using continuous levels of TIgE, we found a significant
association between TIgE and TNF.
Discussion
The objective of this study was to examine the association
between helminth infections and atherosclerosis in a population
residing in an area highly endemic for STH. The hypothesis being
tested is that helminth infections may have a beneficial effect on
the development of atherosclerosis, both by influencing conven-
tional CVD risk factors and systemic inflammation. Although this
beneficial effect has been illustrated in animal studies [12,13], no
human studies on the relationship between STH infections and
atherosclerosis have been published before.
We found a negative association between helminth infections
and conventional CVD risk factors, including BMI, WHR and
serum cholesterol levels, which was independent of age and
gender. In addition, with increasing number of helminth species,
the negative association with CVD risk factors increased. The
association was similar when we analyzed TIgE as a marker of
exposure to helminth infections and reflects not only current but
also prior exposure to helminth infection [17].
The finding of lower lipid levels in individuals with infections in
our study area is similar to what was found in Tsimane [24] or
Shipibo [25] population. The lipids measured included HDL,
which might seem surprising as decreased HDL level is considered
to be a CVD risk factor. Interestingly, the anti-atherogenic
properties of HDL might be dependent on the composition of
HDL and the context in terms of type of inflammation [26]. It
would be important to investigate whether helminth infections
affect the type of HDL or its role in cholesterol transport.
With regards to cytokine production, we found a positive
association of TNF production in response to LPS stimulation with
helminth infections as well as with TIgE. These data suggest that
helminths are associated with pro-inflammatory responses.
Although higher TNF and pro-inflammatory cytokines have been
found in the circulation of helminth infected patients with
pathology [27–29], most studies of subjects infected with helminths
with no overt pathology, report an anti-inflammatory effect of
these parasites on the immune system. However, the before







for age and sex
(95% confidence interval)
Mean difference adjusted for
age, sex and BMI
(95% confidence interval)
Age (year) (mean, Range) 44.8 (18.2–80.2) 45.0 (18.0–79.5) – –
Male (%) 34.1 37.7 – –
Trichuris trichiura1 (%) 0 31.2 – –
Ascaris lumbricoides2 (%) 0 33.4 – –
Necator americanus2 (%) 0 78.0 – –
Ancylostoma duodenale2 (%) 0 5.4 – –
Strongyloides stercoralis2 (%) 0 1.1 – –
BMI (Kg/m2) (mean, SD) 23.1 (3.7) 22.5 (3.8) 20.66 (21.26, 20.06), p = 0.031 –
WHR (mean, SD) 0.89 (0.07) 0.88 (0.06) 20.01 (20.02, 20.00), p = 0.011 –
Systole (mmHg) (mean, SD) 130.9 (22.5) 129.8 (24.4) 21.18 (24.56, 2.19), p = 0.49 20.38 (23.71, 2.95), p = 0.82
Diastole (mmHg) (mean, SD) 78.5 (12.2) 76.7 (12.6) 21.76 (23.71, 0.20), p = 0.078 21.28 (23.17, 0.61), p = 0.19
FBG (mmol/L) (mean, SD) 5.9 (1.5) 5.9 (1.6) 20.05 (20.31, 0.21), p = 0.71 0.02 (20.24, 0.27), p = 0.89
TC (mmol/L) (mean, SD) 5.1 (1.2) 4.9 (1.1) 20.22 (20.43, 20.01), p = 0.037 20.17 (20.37, 0.03), p = 0.098
HDL-c (mmol/L) (mean, SD) 1.6 (0.4) 1.5 (0.4) 20.02 (20.09, 0.05), p = 0.49 20.03 (20.10, 0.04), p = 0.34
TG (mmol/L) (mean, SD) 1.2 (0.7) 1.3 (0.7) 0.00 (20.13, 0.13), p = 1.00 0.05 (20.07, 0.17), p = 0.45
LDL-c (mmol/L) (mean, SD) 3.3 (1.1) 3.1 (1.0) 20.20 (20.39, 20.00), p = 0.048 20.15 (20.33, 0.04), p = 0.13
TC to HDL-c ratio (mean, SD) 3.5 (1.1) 3.3 (1.0) 20.09 (20.27, 0.10), p = 0.38 20.03 (20.21, 0.15), p = 0.74
TIgE (IU/ml) (geometric mean
[95%CI])*
834.3 (716.5–971.5) 1182.1 (1044.5–1337.8) 1.42 (1.15, 1.75), p = 0.0010 1.40 (1.14, 1.73), p = 0.0016
hs-CRP (mg/l) (geometric mean
[95%CI])*
0.5 (0.4–0.6) 0.5 (0.4–0.6) 1.15 (0.74, 1.30), p = 0.90 1.16 (0.77, 1.37), p = 0.85
TNF (pg/ml) (geometric mean
[95%CI])*
217.8 (175.3–270.5) 278.6 (243.7–318.4) 1.28 (1.00, 1.64), p = 0.050 1.27 (0.99, 1.64), p = 0.062
IL-10 (pg/ml) (geometric mean
[95%CI])*
128.0 (105.4–155.6) 125.5 (111.7–140.0) 0.98 (0.79, 1.22), p = 0.87 0.98 (0.99, 1.22), p = 0.85
1. positive by microscopy.
2. positive by PCR.
Abbreviations: BMI = body mass index, WHR=waist to hips ratio, FBG= fasting blood glucose, TC = total cholesterol, TG = triglyceride, HDL-c = high density lipoprotein
cholesterol, LDL-c = low density lipoprotein cholesterol, TIgE = total immunoglobulin E, hs-CRP = high sensitive C reactive protein, TNF = tumor necrosis factor, IL-
10 = interleukin 10 cytokines were stimulated for 24 h with E. coli lipopolysaccharide (LPS). *Adjusted mean difference for TIgE, hs-CRP and cytokines were anti-log
transformed and represent ratio.
doi:10.1371/journal.pone.0054855.t001
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mentioned have focused on the adaptive responses and include
Tregs [6–9]. It should be noted that, in line with the current data,
a recent study in Gabon found that S. haematobium infected children
develop a more pro-inflammatory TLR-mediated response [30].
We did not observe substantial differences in STH species and
their effects on CVD risk factors.
Although we showed a relationship between helminth infections
and traditional CVD risk factors, we did not find an association
between helminth infections and cIMT. The following explana-
tions may account for the absence of a relationship between
helminth infection status and cIMT. In our study, helminth
infection was assessed at one time-point. Theoretically, it may be
possible that helminth-negative subjects in our study have only
recently become helminth negative. In this situation, the beneficial
effects of helminths can be seen on some of the traditional CVD
risk factors, but not atherosclerosis development, as the dewormed
state may have been too short to affect cIMT. As the development
of atherosclerosis is a chronic process, ideally, lifetime exposure to
helminth infections should be assessed in relation to atherosclerosis
development. Although this is not feasible, the association was also
not significant when TIgE, reflecting current and prior helminth
infection, was considered. Another explanation is that the
population studied has a low cardiovascular risk profile. Although
the association of CVD risk factors and IMT in the Flores
population was similar to other studies [4,31–34], mean IMT in
the study population was lower than comparable age groups in
Europe [35], the USA [36], and Japan [37]. Indeed most other
CVD risk parameters were well within the normal reference range.
In this situation, the absolute levels of CVD risk factors may be
below the threshold for accelerated atherosclerosis development.
In conclusion, in a large cross-sectional study in an area
endemic for helminth infections, we found an association between
STH infection and conventional risk factors for CVD. The effect
of helminth infections on CVD was at least partially mediated by
an effect on BMI. However, no direct association between
helminth infections and IMT was found. Nevertheless we believe
that this study shows that in the explanation of increase in CVD in
non-western societies, changes in infectious pressure should be
taken into account. Further studies are necessary to assess the
causal relationships between helminth infections and atheroscle-
rosis.







Mean difference adjusted for
age and sex
(95% confidence interval)
Mean difference adjusted for
age, sex and BMI
(95% confidence interval)
Age (year) (mean, Range) 53.4 (40.0–80.2) 53.6 (40.5–79.5) – –
Male (%) 40.7 45.7 – –
Trichuris trichiura1 (%) 0 31.6 – –
Ascaris lumbricoides2 (%) 0 28.9 – –
Necator americanus2 (%) 0 79.4 – –
Ancylostoma duodenale2 (%) 0 5.5 – –
Strongyloides stercoralis2 (%) 0 1.4 – –
IMT ($40 years old) (mm) (mean, SD) 654 (122) 650 (112) 24.68 (227.65, 18.29), p = 0.69 20.95 (224.17, 22.27), p = 0.94
BMI (Kg/m2) (mean, SD) 23.2 (3.7) 22.2 (3.8) 20.91 (21.65, 20.17), p = 0.017 –
WHR (mean, SD) 0.89 (0.07) 0.88 (0.06) 20.02 (20.03, 20.00), p = 0.015 –
Systole (mmHg) (mean, SD) 139.8 (23.4) 136.8 (26.1) 23.08 (28.06, 1.91), p = 0.23 21.52 (26.43, 3.39), p = 0.54
Diastole (mmHg) (mean, SD) 81.3 (13.7) 78.2 (13.4) 22.99 (25.75, 20.24), p = 0.033 22.12 (24.77, 0.53), p = 0.12
FBG (mmol/L) (mean, SD) 6.1 (1.8) 6.1 (1.9) 20.01 (20.41, 0.39), p = 0.96 0.10 (20.29, 0.49), p = 0.62
TC (mmol/L) (mean, SD) 5.2 (1.3) 5.0 (1.1) 20.24 (20.50, 20.01), p = 0.063 20.18 (20.43, 0.08), p = 0.17
HDL-c (mmol/L) (mean, SD) 1.5 (0.4) 1.5 (0.4) 20.03 (20.12, 0.06), p = 0.49 20.05 (20.13, 0.04), p = 0.31
TG (mmol/L) (mean, SD) 1.4 (0.6) 1.4 (0.8) 20.01 (20.18, 0.16), p = 0.89 0.07 (20.10, 0.23), p = 0.43
LDL-c (mmol/L) (mean, SD) 3.4 (1.1) 3.2 (1.0) 20.21 (20.45, 0.03), p = 0.085 20.15 (20.38, 0.09), p = 0.23
TC to HDL-c ratio (mean, SD) 3.5 (1.1) 3.3 (1.0) 20.10 (20.34, 0.14), p = 0.40 20.03 (20.26, 0.21), p = 0.82
TIgE (IU/ml) (geometric mean
[95%CI])*
743.3 (613.5–900.5) 1080.3 (927.5–1258.3) 1.41 (1.09, 1.84), p = 0.010 1.39 (1.07, 1.82), p = 0.015
hs-CRP (mg/l) (geometric mean
[95%CI])*
0.6 [0.4–0.7] 0.6 [0.5–0.7] 1.20 (0.77, 1.37), p = 0.88 1.21 (0.74, 1.55), p = 0.72
TNF (pg/ml) (geometric mean
[95%CI])*
223.5 [168.2–297.0] 265.4 [226.5–310.6] 1.21 (0.89, 1.65), p = 0.22 1.18 (0.85, 1.62), p = 0.32
IL-10 (pg/ml) (geometric mean
[95%CI])*
123.9 [95.3–161.1] 119.2 [104.3–136.2] 0.97 (0.74, 1.27), p = 0.81 0.96 (0.73, 1.27), p = 0.77
1. positive by microscopy.
2. positive by PCR.
Abbreviations: BMI = body mass index, WHR=waist to hips ratio, FBG= fasting blood glucose, TC = total cholesterol, TG = triglyceride, HDL-c = high density lipoprotein
cholesterol, LDL-c = low density lipoprotein cholesterol, TIgE = total immunoglobulin E, hs-CRP = high sensitive C reactive protein, TNF = tumor necrosis factor, IL-
10 = interleukin 10. *Adjusted mean difference for TIgE, hs-CRP and cytokines were anti-log transformed and represent ratio.
doi:10.1371/journal.pone.0054855.t002
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Infection with soil-transmitted 
helminths is associated with increased 
insulin sensitivity. Experiments  





Systemic inflammation has been propagated an important phenomenon in the pathogenesis 
of type-2 diabetes. Remarkably helminth infections shift the immune system to an anti-
inflammatory profile. We therefore hypothesized that helminth infections, as an experiment of 
nature, lead to decreased insulin resistance, which has not been studied before in humans. We 
performed a cross-sectional study in Flores, Indonesia, an area endemic for soil-transmitted 
helminths to explore whether helminth infections are associated with increased insulin 
sensitivity. Stool samples from 646 participants aged 18-80 years were collected and screened 
for Trichuris trichiura by microscopy and for Ascaris lumbricoides, Necator americanus, 
Ancylostoma duodenale, and Strongyloides stercoralis by qPCR. We documented data on body 
mass index (BMI), waist-to-hip ratio, fasting blood glucose, insulin, high sensitive C-reactive 
protein level and E. coli lipopolysaccharide stimulated cytokines (TNF and IL-10). The HOMA-IR 
was calculated and the association between helminth infection status and insulin resistance 
was tested by linear regression adjusted for age, sex and BMI. Participants with any helminth 
infection had lower BMI (kg/m2) (mean difference -0.63, 95%CI [-1.22, 0.02], p=0.044), WHR 
(-0.01, [-0.02, -0.00], p=0.020) as well as insulin (pmol/L) (0.85, [0.74, 0.98], p=0.023) and 
HOMA-IR (0.83, [0.73, 0.95], p=0.0075) than uninfected subjects. After adjustment for BMI the 
association between helminth infection and insulin (pmol/L) (mean difference 0.89, 95%CI 
[0.78, 1.01], p=0.081) as well as HOMA-IR (0.88, [0.77, 0.99], p=0.036) remained. We conclude 
that helminth infections are associated with improved insulin sensitivity, which may support a 
direct association between systemic inflammation and type-2 diabetes. 
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The prevalence of type-2 diabetes is rising in urban areas in low-to-middle income countries 
(LMIC) (1). In many Asian countries, rapid socioeconomic development has led to a shift in 
infrastructure, technology and food supply that promotes over nutrition and sedentary lifestyles 
(2, 3). Indeed, the increased prevalence of type-2 diabetes has traditionally been explained by 
decreased physical activity or excess consumption of high-energy foods, which lead to a disturbed 
energy balance. However, there is now compelling evidence that inflammation plays a role in 
chronic non-communicable diseases, including type-2 diabetes (4). Indeed, in type-2 diabetes, 
elevated levels of inflammation-related markers such as interleukin 6 (IL-6), IL-8, tumor necrosis 
factor (TNF), and C-reactive protein (CRP) (4) have been reported. In this respect, it is interesting 
that some chronic infections, such as helminth infections, which are highly prevalent in rural areas 
of LMIC, have been shown to induce anti-inflammatory and immune regulatory effects (5). One 
particular modifier are the production of T helper (Th) 2 cells and regulatory cytokines (IL-4, IL-5, 
IL-10, and IL-13), that are capable of keeping Th1 and TNF responses in balance. Therefore it has 
been hypothesized that chronic helminth infections by inducing anti-inflammatory responses 
decrease systemic inflammation and might be beneficial to the prevention of inflammatory 
diseases, such as allergy (6), inflammatory bowel disease (7), and metabolic diseases (8).
In addition, in animal models, the response associated with helminth infections can forestall 
obesity and enhance glucose tolerance (9). Currently, there are no published human studies on 
the relationship between helminth infections and glucose metabolism.
In the present study, we aim to investigate the relationship between helminth infections 
and insulin resistance, as assessed by HOMA-IR (10) in an area endemic for soil-transmitted 
helminths on Flores Island, Indonesia.
Material and Methods
Study objectives
The primary objective of the study was to investigate the association between helminth 
infections and HOMA-IR. Chronic inflammation is a central feature in the pathophysiology 
of IR and type-2 diabetes. Therefore our hypothesis was that, since helminths might induce 
an immune evasion strategy by inducing anti-inflammatory responses, HOMA-IR is lower in 
subjects with helminth infections than in subjects without helminth infections.
Study population
The study area is Nangapanda on Flores Island in Indonesia, highly endemic for soil-transmitted 
helminths (6, 11). In this area, a large investigational project is being conducted on the 
relationship between helminth infections and the immune system (ImmunoSPIN study (6, 11)). 
For the current study, a cross sectional representative sample was included from all inhabitants 
aged 18 years and above. Data were collected between May-August 2009.
Study design
From 1841 inhabitants age 18 years and above in Nangapanda who participated in the 
ImmunoSPIN project, 683 were randomly selected to participate in the present cross-sectional 




study and invited to provide data on BMI, WHR, and blood sampling for fasting glucose (FBG), 
insulin, High sensitive C-reactive protein (hs-CRP) and whole blood culture. 646 subjects 
of whom data on helminth infections, BMI and WHR ratio are available were included in the 
present analysis. In 584 of these subjects, laboratory measurements were performed.
The study was approved by the ethical committee of the Faculty of Medicine, University 
of Indonesia, ref: 194/PT02.FK/Etik/2006 with addendum ref: 96/PT02.FK/Etik/2010 and 
registered as clinical trial ref: ISRCTN83830814 and was filed by the Leiden University Medical 
Center Committee of Medical Ethics (CME). Because of the high rate of illiteracy amongst elderly 
participants, either written or verbal informed consent was obtained from each participant.
Clinical and laboratory assessment
Anthropometric measurements of body weight (SECA 761, SECA GMBH & Co. Kg., Hamburg, 
Germany), height (SECA 206, SECA GMBH & Co. Kg., Hamburg, Germany), waist and hip 
circumference (SECA 203, SECA GMBH & Co. Kg., Hamburg, Germany) were performed using 
the NHLBI practical guidelines (NHLBI web). Abnormal BMI is defined as ≥ 25 kg/m2 and the 
Asian modified abnormal waist hip ratio (WHR) is >0.9 (men) and >0.8 (women) (12). Impaired 
fasting glucose (FBG) was defined as ≥5.6 mmol/L (13). A FBG ≥7.1 mmol/L of is indicative of 
diabetes mellitus (13). All participants were instructed to be fasting before venous sampling. 
FBG was analyzed using Breeze®2 glucose meter (Bayer Health Care LLC, Basel, Switzerland). 
Insulin was measured using MSD® 96-Well MULTI-ARRAY® Human insulin assay (Meso Scale 
Discovery, Gaithersburg, USA). HOMA-IR, a well-validated measure of IR was calculated to 
estimate insulin resistance (10). High sensitive C-reactive protein (Hs-CRP) level was measured 
using MSD® 96-Well MULTI-ARRAY® CRP Assay (Meso Scale Discovery, Gaithersburg, USA). 
Health questionnaires on smoking habits, medical history, and family history were collected.
Helminth status
Stool samples were collected and preserved in 4% formaldehyde for microscopy examination 
or frozen (-20°C) unpreserved for PCR detection. The formol-ether acetate concentration 
method was performed on the formalin preserved stool samples followed by microscopy 
examination for Trichuris trichiura infections (11). As described in detail before (11), DNA was 
isolated from approximately 100 mg unpreserved feces and a multiplex real-time PCR for 
the detection of Ancylostoma duodenale, Necator americanus, Ascaris lumbricoides and 
Strongyloides stercoralis was performed. The real-time PCR output from this system consisted 
of a cycle-threshold (CT) value, representing the amplification cycle in which the level of 
fluorescent signal exceeds the background fluorescence, and reflecting the parasite-specific 
DNA load in the sample tested. Negative and positive control samples were included in each 
run of the amplification. We defined a positive case for T. trichiura by the egg findings and 
for A. duodenale, N. americanus, A. lumbricoides and S. stercoralis by parasite-specific DNA 
amplification. Participants were also grouped by number of helminth species infections.
Whole blood stimulation and cytokine measurement, and haemoglobin count
The procedure of whole blood stimulation and cytokines measurement has been described 
previously (11). Briefly, heparinized blood was diluted 4x and stimulated within 6 hours after drawing. 




Stimulations were performed with control medium or E. coli lipopolysaccharide (LPS, 1 ng/ml Sigma-
Aldrich, Zwijndrecht, The Netherlands), incubated for 24 hours at 370C and 5% CO
2
. The supernatants 
were frozen at -200C and transported to Jakarta where TNF and IL-10 supernatants were assessed by 
means of immunobead-based multiplex assays on a Liquichip 200® Workstation (Qiagen, Venlo, The 
Netherlands) using Liquichip analyzer software (Qiagen, Venlo, The Netherlands). Samples with TNF 
levels higher than 250 pg/ml in medium stimulation were excluded from further analyses (2 samples). 
Haemoglobin was determined using heparinized blood on a routine cell counter (Coulter® Ac-T™ 
diff Analyzer, Beckman Coulter Inc., Fullerton, CA, USA)
Statistical analysis
Participant characteristics were stratified for helminth uninfected and infected. Insulin, 
HOMA-IR, cytokines and CRP concentrations were normalized by log-transformation. Analyses 
were performed with these log transformed values but results were presented as geometric 
means after exponentiation of the values on a logarithmic scale. Linear regression was used 
to study the associations between infection with any helminth species as well as the number 
of helminth species and HOMA-IR and adjusted for age and sex. To assess whether a potential 
association between helminth infection and HOMA-IR is mediated through an effect on BMI 
or WHR, we adjusted for BMI or WHR. Furthermore, in the helminth infected group we tested 
the association of helminth intensity per species with HOMA-IR. Differences between infected 
and uninfected participants were reported as mean differences with 95% confidence intervals 
(95% CI). P values <0.05 were considered to be statistically significant. Statistical analysis was 
performed with SPSS statistics 17.0.2 (SPSS Inc., Chicago, Illinois, The USA).
Results
Characteristics of study participants 
A total of 424 participants infected with at least one species of soil-transmitted helminths 
were compared to 222 uninfected participants (Table 1). There were slightly more males in the 
infected group (38%) than in the uninfected group (34%), whereas the mean age was similar 
(45.1 vs 44.7 years). The most prevalent soil-transmitted helminth species were N. americanus 
334/646 (51.7%), A. lumbricoides 141/646 (21.8%) and T. trichiura 127/646 (19.7%). The proportion 
of participants infected with A. duodenale 24/646 (3.7%) and with S. stercoralis 4/646 (0.6%) 
was clearly lower. 261 participants were infected with one helminth species only, 124 with two 
helminth species and 39 with 3 or more helminth species. 322 of 584 (55.1%) participants had 
elevated FBG (≥5.6 mmol/L) of whom 27 (4.6%) with FBG ≥7-11 mmol/L and 10 (1.7%) ≥11 mmol/L. 
We found no significant differences in hemoglobin levels between participants infected with 
helminths and uninfected participants.
Association between helminth infection and glucose metabolism
Participants with any helminth infection had lower BMI (kg/m2) (mean difference -0.63, 95%CI 
[-1.22, -0.02]), WHR (-0.01, [-0.02, -0.00]), insulin (pmol/L) (0.85, [0.74, 0.98]) and HOMA-IR 
(0.83, [0.73, 0.95]) than uninfected participants (Table 1). After adjustment for BMI, the 
association between helminth infection and insulin (0.89, [0.78, 1.01]) as well as HOMA-IR (0.88, 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































[0.77, 0.99]) remained (Figure 1). No clear associations were found between helminth infection 
and FBG, hs-CRP or TNF-LPS. Using WHR as a marker of central obesity gave similar results that 
there is negative association between helminth and insulin as well HOMA-IR (data not shown). 
Additional correction for smoking, medical history, and familial history did not change the 
association between helminth infection and HOMA-IR (data not shown).
When considering the relationship between the number of helminth species, we found that 
BMI, WHR, insulin and HOMA-IR were negatively associated with the number of helminth species 
(p=0.036, p=0.010, p<0.001, p<0.001, respectively). Adjustment for BMI attenuated the association 
between number of infections and insulin as well as HOMA-IR but both associations remained 
significant (p=0.0015 and p<0.001, respectively). The results were also similar after adjustment for 
WHR (p=0.0024 and p=0.0013, respectively). TNF-LPS was positively associated with increasing 
number of helminth species with the highest LPS-levels in participants with 3 or more infections. This 
association was not attenuated after adjustment for BMI or WHR (p=0.035 and p=0.032, respectively).
17

















































































































Figure 1. The association of soil-transmitted helminths infection and metabolic parameters. Relation 
of helminth infection with (A) fasting blood glucose (FBG), (B) insulin* and (C) HOMA-IR* with correction 
for age, sex, and BMI. 208 participants had no helminth infection and 376 were infected with at least one 
helminth species. Mean FBG was 5.9 mmol/L 95%CI (5.7, 6.1) and 5.90 (5.8, 6.1), insulin was 36.6 pmol/L 
(33.0, 40.8) and 32.7 (30.3, 35.2), and HOMA-IR was 0.7 (0.6, 0.8) and 0.6 (0.6, 0.7) for helminth-uninfected 
and infected group, respectively. *Adjusted mean for insulin and HOMA-IR were anti-log transformed and 
represents geometric means.




We also investigated whether there were differences in the association between different 
species of helminths with HOMA-IR. We found no association between N. americanus, A. 
lumbricoides, or T. trichiura, individually with HOMA-IR (prevalence of S. stercoralis and A. 
duodenale were too low to be considered). 
Discussion
The objective of this study was to examine the association between helminth infections and 
insulin resistance in a population residing in an area highly endemic for soil-transmitted 
helminths. The hypothesis being tested is that helminth infections may have a direct beneficial 
effect on glucose metabolism, by influencing systemic inflammation.
The influence of helminth infections has been shown in animal models of type-1 diabetes (T1D) 
(14, 15) or type-2 diabetes (9) but has not been studied in humans. In our study, we found a negative 
association between HOMA-IR with helminth infections, which was independent of BMI or WHR. 
While both helminth infected and uninfected participants in our study had relatively low HOMA-IR, 
we found that helminth infection was associated with even lower HOMA-IR. No clear association was 
found for each single helminth species in the absence of infection with other helminths.
Studies in experimental models have shown that injecting helminth antigens to young 
non-obese-diabetic mice prevented the onset of T1D. This inhibition of T1D development 
appeared to be due to the ability of helminth and its products to induce IL-10 production by 
dendritic cells, B cells, alternatively activated macrophages, as well as regulatory T cells (16). 
In the model of type-2 diabetes, mice with high fat diet that were infected with helminths, had 
eosinophilia, became less obese and less insulin resistant which seemed to be in conjunction 
with maintenance of alternative activated macrophages in adipose tissues (9). Ricardo-Gonzales 
et al, have also shown that the IL-4/STAT6 immune axis, which is a key pathway affected by 
helminths, promotes control on peripheral nutrient metabolism and insulin sensitivity (17).
Inflammation is known to be an important factor in the pathogenesis of type-2 diabetes (4) 
and increased CRP has been shown to be either a causal or a prediction marker of metabolic 
syndrome and IR (18-22). Individuals with Asian descent may exhibit the characteristics of 
inflammation while relatively lean (2, 23, 24), however, our participants who were lean, had also 
very low hs-CRP level (0.4-0.6 mg/L) and even lower than what has been reported in China 
(0.6-0.8 mg/L) (21, 22), South Asia (0.9-2.8 mg/L in rural and in urban 2.2-2.6 mg/L) (19, 20) or 
US population of various ethnicities (1.1-4.5 mg/L) (18, 24, 25). 
We acknowledge the limitation of this cross-sectional study in nature. As the development 
of type-2 diabetes is a chronic process, ideally, lifetime exposure to helminth infections should 
be related to the disease development, which is however not feasible. The causal relationship 
between helminth infection and glucose metabolism could be studied in a placebo-controlled 
trial with anti-helminth treatment.
Conclusion
In a large cross-sectional study in an area endemic for helminth infections, we found an 
association between soil-transmitted helminths infection and decreased insulin resistance. We 




believe that this experiment of nature supports the notion of a direct relationship between 
systemic inflammation and the pathogenesis of type-2 diabetes, although further studies are 
needed to assess the causal relationships.
Acknowledgments
The authors thank the team from University of Indonesia, the staff from Puskesmas Nangapanda, 
Ende health authorities, the community field workers and most of all the study participants 
from Nangapanda, Flores, Indonesia. 
Transparency declaration 
All authors declare that they have no conflict of interest.
This work was supported by the following grants: The Royal Netherlands Academy of Arts 
and Science (KNAW), Ref.KNAW-05-PP-35, European Commission contracts INCO-CT-2006-
031714 and INCO-CT-2006-032436, and the Prof. Dr. P.C. Flu Foundation.
Authorship/Contribution
Conceived and designed the experiments: AEW, FP, ES, TS, MY and JWAS.  Patient enrolment 
and performed the experiment: AEW, FH, LJW, and MAP. PCR detection on helminths: MMMK 
and JJV. Analyzed and interpreted the data: AEW LM OMD MY JWAS. Wrote the paper: AEW. 
Review of paper: ES, OMD, BG, MY and JWAS. All authors revised the report for important 
intellectual content and have seen and approved the final version. MY and TS had full access to 
all the data in the study and takes responsibility for the integrity of the data and the accuracy 
of the data analysis.





1. World Health Organization. Diabetes Programme. Available at: http://www.who.int/diabetes/en/. 
Accessed 30 November 2012.
2. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 
2009; 301:2129-2140.
3. Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet 2010; 375: 408-418.
4. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801.
5. Wiria AE, Djuardi Y, Supali T, Sartono E, Yazdanbakhsh M. Helminth infection in populations undergoing 
epidemiological transition: a friend or foe? Semin Immunopathol 2012; 34: 889-901.
6. Hamid F, Wiria AE, Wammes LJ, et al. A longitudinal study of allergy and intestinal helminth infections in 
semi urban and rural areas of Flores, Indonesia (ImmunoSPIN Study). BMC Infect Dis 2011; 11: 83.
7. Summers RW, Elliott DE, Urban JF, Jr., Thompson RA, Weinstock JV. Trichuris suis therapy for active 
ulcerative colitis: a randomized controlled trial. Gastroenterology 2005; 128: 825-832.
8. Chawla A, Nguyen KD, Goh YP. Macrophage-mediated inflammation in metabolic disease. Nat Rev 
Immunol 2011; 11: 738-749.
9. Wu D, Molofsky AB, Liang HE, et al. Eosinophils sustain adipose alternatively activated macrophages 
associated with glucose homeostasis. Science 2011; 332: 243-247.
10. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-1495.
11. Wiria AE, Prasetyani MA, Hamid F, et al. Does treatment of intestinal helminth infections influence malaria? 
Background and methodology of a longitudinal study of clinical, parasitological and immunological 
parameters in Nangapanda, Flores, Indonesia (ImmunoSPIN Study). BMC Infect Dis 2010; 10: 77.
12. Barzi F, Woodward M, Czernichow S, et al. The discrimination of dyslipidaemia using anthropometric 
measures in ethnically diverse populations of the Asia-Pacific Region: the Obesity in Asia Collaboration. 
Obes Rev 2010; 11: 127-136.
13. IDF Clinical Guidelines Task Force. Global guideline for Type 2 diabetes. Brussels: International Diabetes 
Federation, 2005. Available at: http://www.idf.org/webdata/docs/IDF%20GGT2D.pdf. Accessed 30 
November 2012.
14. Liu Q, Sundar K, Mishra PK, et al. Helminth infection can reduce insulitis and type 1 diabetes through. 
Infect Immun 2009; 77: 5347-5358.
15. Saunders KA, Raine T, Cooke A, Lawrence CE. Inhibition of autoimmune type 1 diabetes by 
gastrointestinal helminth infection. Infect Immun 2007; 75: 397-407.
16. Cooke A. Review series on helminths, immune modulation and the hygiene hypothesis: how might 
infection modulate the onset of type 1 diabetes? Immunology 2009; 126: 12-17.
17. Ricardo-Gonzalez RR, Red EA, Odegaard JI, et al. IL-4/STAT6 immune axis regulates peripheral nutrient 
metabolism and insulin sensitivity. Proc Natl Acad Sci U S A 2010; 107: 22617-22622.
18. Coe CL, Love GD, Karasawa M, et al. Population differences in proinflammatory biology: Japanese have 
healthier profiles than Americans. Brain Behav Immun 2011; 25: 494-502.
19. Mahajan A, Jaiswal A, Tabassum R, et al. Elevated levels of C-reactive protein as a risk factor for 
metabolic syndrome in Indians. Atherosclerosis 2012; 220: 275-281.
20. Indulekha K, Surendar J, Mohan V. High sensitivity C-reactive protein, tumor necrosis factor-alpha, 
interleukin-6, and vascular cell adhesion molecule-1 levels in Asian Indians with metabolic syndrome 
and insulin resistance (CURES-105). J Diabetes Sci Technol 2011; 5: 982-988.
21. Ye X, Yu Z, Li H, Franco OH, Liu Y, Lin X. Distributions of C-reactive protein and its association with 
metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol 2007; 49: 1798-1805.
22. Yang T, Chu CH, Hsieh PC, et al. C-reactive protein concentration as a significant correlate for metabolic 
syndrome: a Chinese population-based study. Endocrine 2012; 10.1007/s12020-012-9743-7 [doi]
23. Pandit K, Goswami S, Ghosh S, Mukhopadhyay P, Chowdhury S. Metabolic syndrome in South Asians. 
Indian J Endocrinol Metab 2012; 16: 44-55.
24. Shah T, Newcombe P, Smeeth L, et al. Ancestry as a determinant of mean population C-reactive protein 
values: implications for cardiovascular risk prediction. Circ Cardiovasc Genet 2010; 3: 436-444.
25. Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 1999; 22: 
1971-1977.







To de-worm or to re-worm:  
the impact of helminth infections  
on co-infections and on health 
outcomes on Flores island, Indonesia
7
Abstract
Many countries are currently at various stages of an “epidemiological transition” in which 
infectious disease is replaced by cardiovascular disease (CVD) as the major cause of death. 
Evidence suggests that a sedentary lifestyle, with low physical activity and excessive caloric 
intake, are risk factors for metabolic syndrome and CVD. In addition to life style, low grade 
chronic inflammation seems to also be associated with CVD. In fact, the so called inflammatory 
diseases such as allergies, autoimmunities, inflammatory bowel diseases are all on the rise 
in affluent countries and in urban centers of low-to-middle income countries (LMIC).  It is 
interesting, that certain infections, such as bacterial or protozoan, lead to inflammation, which 
when uncontrolled can lead to death, while others, such as helminth infections are generally 
believed to lead to anti-inflammatory responses. As helminth infections can induce host 
immune hyporesponsiveness, we hypothesized that this would affect co-infections, such as 
malaria, and inflammatory diseases, such as allergies, and that deworming would modulate 
these effects. The variability of the geographical and disease landscapes in Indonesia provided 
an opportunity to investigate whether helminth infections and a deworming program could 
have an impact on co-infections and other health outcomes. This thesis describes the results 
of a longitudinal study on a household-based cluster-randomized double-blinded placebo-
controlled anthelminthic trial on malarial parasitemia, allergy and immune responsiveness, with 
particular focus on malarial parasitemia. In addition and as a starting point for future studies, a 
cross-sectional study in a subset population on the association between helminth infection and 








The previous chapters of this thesis described the findings of our study on the Island of Flores, 
Indonesia, where we explored the hypothesis that helminth infections, by inducing immune 
hyporesponsiveness, have an impact on co-infections (lead to higher malarial parasitemia and 
lower malaria disease) and on  inflammatory diseases (suppress allergic reactions and allergic 
inflammation). We investigated whether periodic anthelminthic treatment, using single dose 
albendazole, can alleviate helminth-induced immune hyporesponsiveness. In Chapter 1, we 
reviewed and discussed current knowledge of major helminth infections in the shaping of host 
immune responses, consequences for other infections, and the outlook related to the increasing 
prevalence of allergy, autoimmune disease, type-2 diabetes (T2D) and CVD. In the context of 
malaria, while a host requires adequate pro-inflammatory responses as protection against 
malarial parasites (1), the inability to control inflammatory responses can be associated with 
pathology (2;3). The question can be posed as to whether deworming in areas where malaria is 
co-endemic can improve the clearance of malarial parasites but increase risk of unwanted clinical 
outcomes (Chapter 2). Using a household-clustered randomized double-blinded placebo-
controlled anthelminthic trial, we investigated the effects of reducing helminth infections on 
the prevalence of malarial parasitemia in albendazole-treated group compared to a placebo-
treated group (Chapter 3). We also asked whether we can alleviate helminth-induced immune 
hyporesponsiveness in the albendazole treatment group (Chapter 4). The household-clustered 
treatment randomization was aimed at reducing possible infection through other household 
members. As inflammation is a known risk factor for T2D and CVD (4;5), we explored the possibility 
that helminth-induced hyporesponsiveness might have a beneficial effect on preventing the 
development of T2D and CVD (6). We therefore investigated the association between helminth 
infection and risk factors for CVD and carotid intima media thickness (cIMT) (Chapter 5), as well as 
between the parasite and metabolic parameters and insulin resistance (IR) (Chapter 6).
Introduction
The term “epidemiological transition” is used to classify a population undergoing a transition 
from a state where infectious diseases (communicable diseases) as the major cause of death to a 
state in which CVD (non-communicable diseases) is the main cause of death (7). This transition 
is at different stages in different regions of the world. In industrial/developed countries (also 
known as high income countries [HIC]), infectious diseases are relatively well controlled 
compared to developing or low-to-middle income countries (LMIC), especially when compared 
to rural areas of LMIC. Causes of death in HIC are mainly due to degenerative diseases or to 
metabolic syndrome (MetS) related non-communicable diseases such as T2D and CVD (8). 
The results of a global disease burden assessment were reported recently and in some HIC 
regions, although still showing a high incidence, CVD is now better controlled (9). However, 
while the LMIC, which include the majority of the world’s population, are still struggling with 
infectious diseases, in their urban areas, they are also facing the emergence of health problems 
similar to those of HIC. Indonesia is one of the emerging world economies and covers a large 







continental plates, forming a crossroad between the Pacific and Indian Oceans. In terms of 
lifestyle and disease landscape, the urban areas in Indonesia are reasonably comparable to 
developed countries and deworming programs in these areas have been reported (10). The 
recent improvements in infrastructure and control of infectious diseases in rural and semi-
urban areas may represent a paradigm for the transition to a sedentary lifestyle coupled to 
a decline in infections (also including reduced helminth infections). A better understanding 
of the dynamic changes between communicable and non-communicable diseases could help 
guide a healthier transition.
Helminth parasites generally cause chronic infections in their host, which results from their 
ability to influence the immune system of the host leading to immune hyporesponsiveness. This 
ensures the long term survival of the parasites in the human host while possibly benefiting the 
host by preventing immune pathological reactions (11). As it can be assumed that both the host 
and the helminth evolve within this relationship, a sudden deworming process might disrupt 
this relationship. It is important to note that helminth induced immune hyporesponsiveness 
may also affect host responses to bystander antigens (12). In rural LMIC, helminth infections 
are commonly co-endemic with malaria, tuberculosis (TB) or HIV/AIDS (13) and therefore the 
question what the consequence of deworming will be on co-endemic infections needs to be 
answered. Helminths are also thought to be associated with a lower incidence of allergy (14) 
and autoimmune disease (15) again raising the question whether these diseases patterns would 
change in the absence of helminth infections. The prevalence of T2D and CVD in rural LMIC, 
while increasing, are lower than urban areas of LMIC or in HIC (9). The evidence of the possible 
association between helminth infections and T2D and CVD in experimental models is gradually 
becoming available but in humans this has remained largely unexplored (6).
The large geographic area of Indonesia and the widespread population, with a declining 
helminth burden in some places, provides an opportunity to investigate whether helminth 
infections and deworming have an impact on co-infections such as malaria and on other health 
outcomes such as allergy, T2D and CVD. Specifically, here, we discuss our investigation of the 
relationship between soil-transmitted helminths (STH) and malaria, allergy, IR (a marker for 
T2D) and atherosclerosis (a marker for CVD).
Albendazole treatment reduced but did not eliminate helminth infections
In Chapters 3 and 4, we showed that a two-year course of intensive albendazole treatment 
reduced but did not entirely eliminate helminth infections. Other longitudinal, three to four 
monthly interval deworming trials, using various drugs against STH have also reported difficulties 
in eliminating helminths (16-18). These poor results could be related to highly contaminated 
environment and reinfection but also to the limited efficacy of available anthelminthic drugs 
or the possible emergence of drug resistance (19). Altogether, in terms of egg load, these 
earlier studies (16-18) reported significant decreases that were similar to our own findings. 
Using a sensitive PCR diagnostic method, we have also shown that evaluation of deworming 
by microscopy can fail to identify submicroscopic infections. This represents a possible source 
of continuing transmission when treatment is discontinued. Given that global campaigns are 
underway to control and eliminate STH, our findings and those of others suggest an urgent 







The impact of deworming on malarial outcomes
Despite a significantly reduced load of helminth infections following deworming, these 
parasites remained, in part due to persisting Trichuris worms, which appear not to be affected 
by albendazole used as a single dose at three monthly intervals. In addition, compared to 
our preliminary findings during the piloting phase of the program, the prevalence of malarial 
parasitemia in our study population dropped at the beginning of the study and gradually 
declined during the study period, which led to the low level of malarial prevalence in our co-
infection study. This situation affected the study power and the statistical analyses, especially 
at the end of the study. Nevertheless, we found that compared to placebo, the prevalence 
of malarial parasitemia was transiently increased in the albendazole group, when there was 
sufficient transmission. Findings regarding clinical symptoms were not significant (Chapter 3). 
Malaria-related clinical symptoms were also not paralleled by the malarial parasitemia findings 
during the study, suggesting that most malaria in the population is asymptomatic. This might 
be related to the previously high rates of malaria transmission in the area, which may have led 
to a certain degree of immunity to malaria in this population.
Regarding the recent fall in the prevalence of malarial parasitemia, a model has shown 
that the loss of protective immunity is gradual (22). Our malaria-infected subjects were found 
to be relatively asymptomatic, but malarial parasitemia prevalence was higher in the younger 
age group. Therefore, while both immunity to disease severity and parasitemia might be well 
established in the older age group, in younger children an earlier malaria exposure may have only 
resulted in immunity to clinical disease. The low malaria transmission may have played a role in 
our study, resulting in new infections that were insufficient to provoke clinical symptoms. This was 
indeed shown in a study in five communities in Kenya and Gambia with differing levels of malaria 
transmission, in which higher malaria transmission was related to greater severity of malaria (23). 
The increased risk of malarial parasitemia was not expected. However, a recent review by 
Nacher suggested that Ascaris infection is associated with protection against malaria disease 
or parasitemia (20), perhaps indicating that the increased risk for malarial parasitemia in our 
study participants may have been caused by a reduced level of Ascaris infection. However, 
as our study was not designed to stratify the analyses based on helminth species at baseline, 
the power of the study was insufficient to address this specific question. The same problem 
precluded the investigation of the effects of deworming on different malaria species.
Another question is why the effect of albendazole treatment was primarily confined 
to individuals >15 years of age. A possible explanation is that the lower Ascaris infections in 
the older age group compared with the younger, may mean better reduction of infection 
and therefore more profound effect on malarial parasitemia in those older than 15 years of 
age. Similar findings were reported from a small study in Madagascar where higher malarial 
parasitemia was seen in older age group, the group in which Ascaris egg loads were strongly 
decreased following anthelminthic treatment (16;21).
Deworming to improve immune responsiveness
Through investigations in children infected with STH, we showed that depletion of regulatory 
T cells (Treg) improved responses to in vitro malaria antigen stimulation (18). Indeed, we found 







increase in malaria-specific and mitogen-induced tumor necrosis factor (TNF) and interferon 
(IFN)-γ cytokine production was seen (Chapter 4). However, our hypothesis that alleviation 
of immune suppression by helminth infections would stimulate a better clearance of malarial 
parasites (and therefore result in lower prevalence of this parasite in our study population), in 
parallel with an increase in clinical outcomes, was not clearly resolved. As mentioned previously, 
albendazole treatment had neither a beneficial nor a detrimental impact in terms of clinical 
outcomes (Chapter 3). Despite the possibly already established immunity to clinical malaria, 
one can speculate that the increased pro-inflammatory responses to the malarial parasite 
observed during the trial may not be sufficient to cause clinical symptoms. This could be due 
to the maintenance of a certain level of anti-inflammatory responses, because of incomplete 
deworming that resulted in a sufficient immune suppression to prevent the development of 
clinical symptoms.
Two years of deworming has a minimal impact on allergy outcomes
In brief, we also found no significant impact of albendazole treatment on allergy outcomes. 
Although not statistically significant, the trend for increased skin prick test (SPT) reactivity 
was in line with our hypothesis. The risk of SPT reactivity increased incrementally with longer 
treatment and raises the question of whether even longer deworming periods are needed to 
produce more pronounced effects on allergic outcomes, as seen in a study where 15-17 years 
of ivermectin treatment for onchocerciasis in Ecuador resulted in increased prevalence of SPT 
reactivity (24). The question of whether this is related to differences in the prevalence and 
type of helminth infections remains unanswered. As with investigations of helminth-malaria 
co-infection outcomes, further research is needed before sufficient information is available on 
whether helminths may provide protection or actually increase the risk for the development of 
allergies as suggested by some investigations (25;26).
Helminth infection is negatively associated with risk factors for T2D and CVD
We have shown in cross sectional manner, in Chapter 5, that STH infection was associated with 
lower risk factors for CVD. Individuals with helminth infections had a significantly lower body 
mass index (BMI) or waist-to-hip ratio, and lower lipid levels, compared to uninfected individuals. 
However, a direct association between helminth infection and CVD markers, such as cIMT as a 
marker of atherosclerosis (Chapter 5), was not clear cut. In addition, no significant difference 
in fasting blood glucose (FBG) was found between infected and uninfected individuals. Indeed, 
the cIMT of our study participants was relatively low compared to individuals of the same age 
living in HIC (27;28). It is possible that cIMT level and FBG are still within the normal range, and 
therefore could not be affected by helminth infections.
In Chapter 6 we have shown that helminth infection was associated with improved insulin 
sensitivity, despite this, there was no significant difference in FBG level as already alluded to. 
The improvement in insulin sensitivity seemed to be related, in part, to lower levels of insulin. 
This lower insulin level might be due to less insulin being needed to maintain normal blood 
glucose in individuals with helminth infections.
In line with our study, where we showed helminth infections were associated with lower 







lipid-lowering effects (29). Indeed, it was recently shown in an experimental hookworm model 
that infection with Nippostrongylus brasiliensis could prevent obesity, as well as reduce lipid 
levels and improve insulin sensitivity (30). The authors showed that the protective effect was 
associated with eosinophilia induced by helminth infection and was related to interleukin (IL)-4 
mediated alternatively activated macrophages in adipose tissue. Moreover, Bhargava et al. also 
demonstrated that lacto-N-fucopentose III, an immunomodulatory glycan that can be found 
in human milk and in parasitic helminths (in S. mansoni soluble egg antigen), could improve 
insulin sensitivity by enhancing white adipose tissue insulin signalling through induction of 
IL-10 production (31). Whether helminth infections lead to similar changes in humans still 
requires further investigation (Fig. 1).
C-reactive protein (CRP) is commonly measured as a marker of inflammation (32). Measuring 
high sensitivity (hs)-CRP in our study participants, we found a very low level of hs-CRP despite 
the probable high infection pressure in the community. As blood samples were analyzed in 
a laboratory facility in the Netherlands that carries out routine measurements using a gold 
standard assay, differences in laboratory protocols cannot account for the low hs-CRP level. 
Although studies in Philippines (33) and Ghana (34) show also low level of CRP in rural areas 
where high infection rates are expected, in the Tsimane Indians in Bolivia, high levels of CRP 
were measured (35). These variable findings need to be further investigated. Interestingly, total 
IgE (TIgE) levels have been reported to be inversely correlated with growth and the hs-CRP level 
in LMIC (36). The level of TIgE is thought to reflect the length of helminth exposure during the 
host lifetime (37). The inverse association is suggested to be related to a concept of trade off in 
the use of limited energy available to the host defence (36;37). Blackwell and colleagues have 
put forward the following explanation: when facing high burden of different infections, there 
would be a trade-off between defence against helminths (with production of TIgE) and defence 
against other infections, such as bacterial or protozoan, that are associated with elevated CRP 
(36). This argument is not entirely satisfactory, as helminth infections are altogether considered 
less life threatening than bacterial or protozoan infections. Alternative explanations such as the 
ability of helminth infections (high IgE) to suppress inflammation (low CRP) needs to be tested.
Is there a similarity in the association of helminths and CVD to that of helminths and 
allergy?
It might be interesting to test whether helminths or their products can be used as a treatment 
for CVD, as extensively highlighted in the allergy field. Around two decades ago, an elevated 
TIgE was shown to be associated with risk for CVD (myocardial infarction, stroke or peripheral 
arterial disease) in studies conducted in affluent countries (38-40). A recent study by Wang 
et al. (41) showed that IgE was most elevated in patients with myocardial infarction, followed 
by unstable angina pectoris, and least elevated in stable angina pectoris. This suggests that 
different types of CVD are associated with specific differences in the level of TIgE. A number of 
these authors have also reported increased levels of IgE and FcεR1 in the atherosclerotic lesions 
of patients. To demonstrate the role of IgE and FcεR1 in atherosclerotic lesions, an apoE-/- mice 
model deficient for the FcεR1α receptor (apoE–/–, Fcer1a –/– ) has been used and it has been 
demonstrated that these mice have lower occurrence of atherosclerotic lesions. Interestingly, 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































mice did not affect total cholesterol (TC) or LDL levels, although they were associated with 
increased serum triglyceride (TG) and HDL levels (41). Altogether, these results seem to be in 
contrast to our findings: while in western countries IgE levels were positively associated with 
FBG, in our study in Indonesia, a high level of TIgE was associated with lower FBG. Moreover, 
in contrast to studies of atherosclerosis mentioned above, we noted a negative association 
between TIgE, which in our studies is related to helminth exposure, and risk factors for CVD 
that included TC, LDL and HDL. 
The question arises whether findings in CVD may have some analogy with studies of allergic 
disorders. In areas where helminths are not endemic, allergy is associated with high levels of 
TIgE, while in helminth endemic populations, high levels of TIgE are associated with helminths, 
but inversely correlate with allergy (14). It is tempting to speculate that the possible protective 
effect of living in areas where helminths are highly endemic against development of CVD is 
based on similar mechanisms to the protection against the development of allergy, namely, the 
presence of strong anti-inflammatory and modified responses (Fig. 1).
Conclusions and future perspectives
We have shown in this thesis that helminth infections were associated with hyporesponsiveness. 
Yet we observed no consistent beneficial or detrimental effect regarding malaria or allergy after 
two years of community based anthelminthic therapy, which reduced but did not eliminate 
helminths. We also showed that helminth infections were negatively associated with risk factors 
for CVD, as well as being possibly beneficial for insulin sensitivity. The role of helminths in T2D 
and CVD needs to be followed up.
Altogether long-term, well-powered, placebo controlled anthelminthic trial are needed 
with better anthelminthics to investigate the causal relationship between helminth infections 
and malaria and allergy. A number of issues need to be considered for such future studies:
1. more adequate anthelminthic drugs and/or schedules
2. longer deworming period
3. areas where the endemicity of malaria is high
4. use of molecular methods to determine Trichuris worm burden
Only then will it be possible to bridge the gap between the findings in animal models that show 
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In this thesis we reported our investigations of the relationship between soil-transmitted 
helminths (STH) and a number of outcomes, in particular malaria, insulin resistance (a marker 
for type-2 diabetes (T2D)) and atherosclerosis (a marker for cardiovascular diseases (CVD)) on 
Flores island, Indonesia.
Chapter 1
Here we discussed how the major helminth infections that affect a large proportion of the 
population in the developing world can have impact on the immune system and the consequences 
of this for other infections which are co-endemic in the same areas. Furthermore, we addressed 
the issue of decreasing helminth infections in many parts of the world within the context of 
increasing inflammatory, metabolic, and cardiovascular diseases. We assembled from the available 
literature the evidence from experimental models and epidemiologic studies that helminth 
parasites appear to be able to induce immune hyporesponsiveness, which results in the host’s 
inability to eliminate the parasites and affects the host responses to bystander antigens. In the 
context of malaria, while a host requires adequate pro-inflammatory responses to protect itself 
against malaria parasites, the inability to control overt inflammatory responses can be associated 
with pathology. Therefore, helminth infections might be associated with more susceptibility to 
malaria infection but less severe pathology. Moreover, as inflammation is a known risk factor for 
T2D and CVD, we addressed the possibility that helminth-induced hyporesponsiveness might 
have a beneficial effect on preventing the development of T2D and CVD.
Chapter 2
Here we described in detail our study protocol and our study population in the context of 
helminth and malaria co-infection. In order to investigate the effect of helminths on malaria 
infection and disease outcome, as well as on immunological parameters, the area of Nangapanda 
on Flores Island, Indonesia, where malaria and helminth parasites are co-endemic, was selected 
for a longitudinal study. A household-clustered, double-blind randomized trial, incorporating 
repeated treatment with albendazole (400 mg) or placebo at three monthly intervals was 
performed to elucidate the impact of helminth infections on malaria longitudinally. We 
collected information on household characteristics, anthropometry, the presence of intestinal 
helminths and Plasmodium spp infections, and the incidence of malaria episodes. Detailed 
methods of PCR detection of studied parasites, which were used in our trial were described, in 
addition to the whole blood procedures for immunological analysis of the trial.
Chapters 3 and 4
These chapters reported the outcome of the 2 years duration randomized trial. Chapter 3 
reported results of malarial parasitemia and allergy outcome, while Chapter 4 reported the 
immunological outcomes. Helminth infections in our albendazole treated group decreased 
significantly (Chapter 3 and 4). However, this intensive deworming could not eliminate helminth 
infections. This was perhaps due to persisting helminths such as Trichuris, which appear not to be 
affected by albendazole used as a single dose at three monthly intervals as well as to the strong 






We found a transient increased risk of malarial parasitemia (mainly in >15 years of age) in 
albendazole treatment group (Chapter 3). However, it is still unclear what the mechanism 
behind the high malarial parasitemia in the treatment group is. We also showed that there 
did not seem to be any effect on clinical symptoms. The consistently decreasing malarial 
parasitemia prevalence in our study population during the study period, led to very low extent 
of malaria helminth co-infection than expected based on our findings during the piloting phase 
prior to the start of our deworming trial. This might have had an effect not only on the power 
of the study but also on the immunological status regarding anti malaria responses. Studies 
in areas with high prevalence of clinical malaria are needed to establish whether helminth 
infections affect this outcome.
As shown in Chapter 4, we found that in vitro immune responses were improved after 
albendazole treatment and significant increases in malaria-specific and mitogen-induced 
tumor necrosis factor and interferon γ cytokine production were observed. However, these 
increased pro-inflammatory responses to the malaria parasite observed during the trial may 
not have been sufficient to cause clinical symptoms; no changes in clinical symptoms observed 
in Chapter 3. This could also be due to the maintenance of a certain level of anti-inflammatory 
responses, because of incomplete deworming, which would still be able to prevent the 
development of clinical symptoms.
Chapter 5
There is now compelling evidence that inflammation plays a role in chronic non-communicable 
diseases, including CVD and T2D. In this respect, it is interesting that some chronic infections, 
such as helminth infections, which are highly prevalent in rural areas of low-to middle income 
countries, have been shown to induce anti-inflammatory and immune regulatory effects as 
discussed in Chapter 1. Here we showed in a cross-sectional manner that STH infection was 
associated with lower risk factors for CVD that include lower body mass index (BMI) or waist-to-hip 
ratio (WHR), and lower lipid levels, compared to uninfected individuals. We also noted a negative 
association between total IgE (TIgE), which related to helminth exposure, and risk factors for CVD 
that included total cholesterol, low density lipoprotein and high density lipoprotein. In this study, 
the effect of helminth infections on CVD risk factors was at least partially mediated by an effect on 
BMI/WHR. However, a direct association between helminth infection and CVD markers, such as 
to carotid intima media thickness (cIMT) as a marker of atherosclerosis, was not seen. Indeed, the 
cIMT of the study participants was relatively low compared to individuals of the same age living in 
high income countries (HIC) and still below what is considered pathological. Further studies are 
necessary to assess the causal relationship between helminth infections and CVD.
Chapter 6
With respect to T2D, it has been hypothesized that chronic helminth infections by inducing anti-
inflammatory responses decrease systemic inflammation and may help to prevent metabolic 
diseases. Here, we have shown that helminth infection was associated with improved insulin 
sensitivity even though there was no significant effect on fasting blood glucose (FBG) level. The 
improved insulin sensitivity seemed to be related, in part, to lower levels of insulin meaning that 







In this chapter I discussed questions that remained or emerged from our findings. The first one 
is why with our intensive deworming treatment, helminth infections remained. Secondly, why 
we found increased risk of malarial parasitemia (mainly in >15 years of age) in the albendazole 
treatment group. Moreover, I questioned whether the association between helminths and CVD 
or T2D is similar to that seen between helminths and allergy.
First, I propose that the poor result of our intensive deworming trial could be related to highly 
contaminated environment and reinfection as well as to the limited efficacy of albendazole or 
possible emergence of drug resistance. Given that global campaigns are underway to control 
and eliminate STH; our finding suggests an urgent need for new approaches to helminth 
elimination programs. Furthermore, well-designed population studies that include adequate 
anthelminthic treatment regiment are needed to confirm our propositions. Diagnostic 
methods that are able to reveal submicroscopic infection such as Trichuris infection or other 
intestinal infections are also needed.
For the second question, I thought that the increased risk for malarial parasitemia in our 
study participants may have been caused by a reduced level of Ascaris infection. It is possible 
that Ascaris infection in the older age groups which was lower than in the younger age group 
prior to treatment was more effectively cleared. Therefore, the level of Ascaris infection might 
have been sufficiently high to keep malarial parasitemia at a low level in the younger age group, 
while the low infection after treatment in older age group was not able to do so. Whether this 
association between helminth and malaria is immune mediated or competition for resources 
is currently unknown.
In non-helminth endemic populations, allergy is associated with high levels of TIgE, while 
in helminth endemic populations, high levels of TIgE are associated with helminths, which are 
inversely correlated with allergy. Interestingly, in HIC, elevated TIgE has been shown to be 
associated with risk for CVD (myocardial infarction, stroke or peripheral arterial disease). In 
contrast, we found that TIgE levels were related to helminth exposure and we noted a negative 
association between TIgE and risk factors for CVD as well as association between TIgE and lower 
FBG. One can hypothesize that during helminth infections, the immune system may be somehow 
modified, that it no longer predisposes to the development of CVD. Also, chronic exposure to 
infections, in addition to the reduction in energy intake and association with poor nutritional 
status, could play an important role in the establishment of effective regulatory networks 
that, to a certain degree, are beneficial in preventing CVD and T2D. A possible approach will 
be a long-term, well-powered, placebo controlled anthelminthic trials to investigate whether 
alleviation of helminthic pressure is inversely correlated with anti-inflammation, lipid levels and 








In dit proefschrift beschrijven we ons onderzoek naar de relaties tussen worminfecties en een 
aantal andere kenmerken, in het bijzonder malaria infectie, insulineresistentie (een marker 
voor type-2 diabetes (T2D)), en atherosclerose (een marker voor hart- en vaatziekten (HVZ)) 
op het eiland Flores in Indonesië.
Hoofdstuk 1
In hoofdstuk 1 wordt beschreven dat parasitaire wormen, waarmee een groot deel van de 
bevolking van ontwikkelingslanden is geïnfecteerd, het afweersysteem kunnen beïnvloeden 
en wat gevolgen kan hebben voor andere infecties die in dezelfde gebieden ook voorkomen. 
Daarnaast beschrijven we dat in ontwikkelde gebieden in verschillende delen van de wereld er 
een toename van ontstekingsziekten, metabole ziekten en hart- en vaatziekten is vastgesteld, 
wat mogelijk een gevolg is van het verdwijnen van worminfecties. Er is een aantal bewijzen uit 
muismodellen en uit humaan epidemiologisch onderzoek dat aantoont dat wormparasieten het 
afweersysteem van de gastheer kunnen onderdrukken. Deze onderdrukking resulteert in het 
onvermogen van de gastheer om de parasieten te elimineren en beïnvloedt tevens reacties van 
de gastheer tegen andere infecties en ziekteprocessen. Bij een malaria infectie heeft de gastheer 
voldoende afweerreacties nodig om zichzelf te beschermen tegen malariaparasieten, maar als 
deze reacties niet gecontroleerd worden kan dit leiden tot ongewenste bijverschijnselen, zoals 
te veel ontsteking en schade aan de weefsels. Daarom zouden worminfecties geassocieerd 
kunnen zijn met de vatbaarheid voor malaria infectie, maar tegelijkertijd ook met de beperking 
van de pathologie.  Aangezien ontstekingsreacties een bekende risicofactor zijn voor T2D 
en HVZ, bespreken we ook de mogelijkheid dat de onderdrukking van afweerreacties door 
wormen een remmend effect kan hebben op de ontwikkeling van T2D en HVZ. 
Hoofdstuk 2
Hier zijn de details van ons onderzoeksprotocol en de studiepopulatie op Flores beschreven. 
Voor ons onderzoek naar het effect van wormen op malaria infectie, de ziekteverschijnselen, 
en de daarmee samenhangende immunologische parameters is het dorp Nangapanda 
geselecteerd, waar malaria en worminfecties beide voorkomen. Er is een grote, longitudinale 
studie uitgevoerd, waarbij per huishouden de inwoners elke drie maanden behandeld werden 
met albendazol (een medicijn tegen wormen) of placebo. Hiermee wilden we bekijken wat 
voor effect worminfecties hebben op malaria over een periode van twee jaar. We hebben veel 
informatie verzameld over de huizen, het huishouden, de lichaamsbouw, de aanwezigheid van 
worm- en malaria infecties, en het voorkomen van klachten door malaria. Verder worden ook 
de in ons onderzoek gebruikte methoden voor immunologische analyses beschreven, naast 
details van de PCR methode om parasieten te detecteren. 
Hoofdstukken 3 and 4
In deze hoofdstukken hebben we de uitkomsten van dit twee jaar durende onderzoek beschreven. 
Hoofdstuk 3 behandelt de resultaten op het gebied van malaria en allergie, terwijl Hoofdstuk 4 
over de immunologische analyse gaat. Worminfecties zijn aanzienlijk gedaald in de groep die door 





geëlimineerd; vooral de zweepworm (Trichuris) bleef volhardend aanwezig bij veel mensen. Dit 
zou kunnen komen door de hoge graad van besmetting in de omgeving en door de beperkte 
gevoeligheid van Trichuris voor behandeling met een enkele dosis albendazol per 3 maanden. We 
hebben gevonden dat de aanwezigheid van malaria infectie in het bloed kortstondig toenam in 
de albendazol behandeling groep (Hoofdstuk 3). Het is echter niet duidelijk welk mechanisme 
hierachter zit. We hebben ook aangetoond dat er geen effect was van wormbehandeling op 
de ziekteverschijnselen van malaria. Door het voortdurend afnemen van malaria infecties in 
onze studiepopulatie tijdens de onderzoeksperiode, was er een veel lager aantal co-infecties 
van malaria en wormen dan wij verwachtten op basis van onze bevindingen in de testfase van 
het onderzoek. Er zijn studies nodig in regio’s met veel malaria om vast te kunnen stellen of 
worminfecties een effect hebben op malaria infecties of op klinische symptomen van malaria. 
Zoals beschreven in Hoofdstuk 4, hebben we gevonden dat afweerreacties zijn verbeterd 
na de behandeling met albendazol. Er was een aanzienlijke toename van afweer tegen malaria, 
en er werden grotere hoeveelheden van de ontstekingseiwitten tumor necrosis factor en 
interferon-γ aangemaakt. Samen met de resultaten in Hoofdstuk 3 moeten we echter vaststellen 
dat deze toename van reacties tegen malariaparasieten tijdens de onderzoeksperiode geen 
veranderingen in de klinische symptomen veroorzaakt. Dit zou veroorzaakt kunnen worden 
door persisterende ‘anti-inflammatoire’ reacties omdat er nog steeds wormen aanwezig zijn, 
waardoor de ontwikkeling van klinische symptomen onderdrukt worden. 
Hoofdstuk 5
Tegenwoordig is er duidelijk bewijs dat ontsteking een rol speelt bij het ontstaan van 
chronische ziekten, zoals HVZ en T2D. Daarom is het interessant dat sommige chronische 
infecties, in het bijzonder worminfecties, die veel voorkomen op het platteland van lage- tot 
middeninkomenslanden, ontstekings- en afweerreacties kunnen remmen, zoals besproken 
in Hoofdstuk 1. In Hoofdstuk 5 hebben we aangetoond dat mensen met worminfecties een 
lagere body mass index (BMI), een kleinere heupomvang, en lagere waarden van cholesterol 
en andere vetten hebben vergeleken met mensen zonder infecties. Daardoor lopen zij een 
kleiner risico op HVZ. We hebben ook een negatief verband gezien tussen totaal IgE (TIgE), 
een afweerstof die een verband heeft met blootstelling aan wormen, met HVZ risicofactoren 
zoals cholesterol en een aantal lipoproteinen (HDL en LDL). Echter, een direct verband tussen 
worminfectie en aderverkalking, gemeten aan de hand van de dikte van de vaatwand in de 
halsslagader (intima media thickness (IMT)) werd niet gezien. Dit komt misschien doordat 
in de bevolking van Nangapanda het IMT niveau over het algemeen erg laag was vergeleken 
met mensen van dezelfde leeftijd in hoge inkomenslanden. Verdere studies zijn nodig om het 
oorzakelijk verband tussen worminfecties en HVZ aan te tonen. 
Hoofdstuk 6
Met betrekking tot T2D, wordt er verondersteld dat chronische worminfecties algemene 
systemische ontstekingen onderdrukken, waardoor metabole ziekten zoals T2D voorkomen 
zouden kunnen worden. We hebben hier beschreven dat worminfecties inderdaad geassocieerd 
zijn met verhoogde gevoeligheid voor insuline, ofschoon er geen aanzienlijk effect op de 





te behouden in mensen met worminfecties. Dit zou kunnen betekenen dat mensen die 
worminfecties hebben of hebben gehad minder snel diabetes krijgen.
Hoofdstuk 7
In dit hoofdstuk bediscussieer ik een aantal kwesties die uit onze bevindingen naar voren 
zijn gekomen. Ten eerste: waarom zijn worminfecties gebleven ondanks onze intensieve 
wormbehandeling? Ten tweede: waarom hebben we een verhoogd risico op malaria infectie 
(vooral in de groep 15 jaar en ouder) in de groep met albendazol behandeling gevonden? 
Daarnaast heb ik me afgevraagd of het verband tussen wormen en HVZ of T2D vergelijkbaar is 
met het verband dat tussen wormen en allergie is gezien. 
Met betrekking tot de eerste vraag, denk ik dat het slechte resultaat van onze intensieve 
ontworming gerelateerd zou kunnen zijn aan de hoge besmettingsgraad van de omgeving en 
het veel vóórkomen van hernieuwde infecties. Ook zou dit verklaard kunnen worden door de 
beperkte effectiviteit van de albendazol of de mogelijkheid dat er resistentie is ontstaan tegen 
de geneesmiddelen. Aangezien er uitgebreide campagnes aan de gang zijn om worminfecties 
te controleren en te elimineren, geeft onze bevinding aan dat het noodzakelijk is om nieuwe 
benaderingen te vinden voor worm-eliminatie programma’s. Bovendien zijn er goed opgezette 
bevolkingsstudies nodig waarin procedures voor wormbehandeling worden getest om onze 
voorlopige conclusies te bevestigen. Ook zijn er diagnostische methoden nodig om de lichte 
Trichuris infecties of andere intestinale infecties aan te kunnen tonen.
Betreffende de tweede vraag denk ik dat de verhoging van het risico op malaria infectie in 
onze studie-deelnemers veroorzaakt zou kunnen zijn door het verlaagde niveau van Ascaris 
infectie. Het is mogelijk dat Ascaris infecties in de oudere mensen voor de behandeling minder 
zwaar zijn geweest dan in de jongere groep, en dat de infecties in de oudere groep daadwerkelijk 
zijn verdwenen. De Ascaris infectie in de jongere leeftijdsgroep kan echter voldoende zijn 
geweest om malaria infectie onderdrukt te houden. Of dit verband tussen worm- en malaria 
infecties te maken heeft met het afweersysteem of met concurrentie om voedingsmiddelen is 
op dit moment onbekend.
In gebieden waar geen worminfecties voorkomen is allergie geassocieerd met hoge TIgE 
niveaus, terwijl in gebieden met hoge TIgE niveaus vanwege worminfecties, die worminfecties 
juist omgekeerd zijn gecorreleerd met allergie. Het is boeiend dat er in hoge inkomenslanden 
is aangetoond dat verhoogd TIgE een hoger risico op HVZ geeft. In tegenstelling hebben 
wij gevonden dat TIgE niveaus hoger zijn bij blootstelling aan wormen, maar dat dit ook een 
lager risico geeft op HVZ, bijvoorbeeld met een lagere bloedsuikerspiegel. Men zou zich voor 
kunnen stellen dat het afweersysteem tijdens worminfecties op één of andere manier wordt 
veranderd waardoor dit niet meer tot HVZ kan leiden. Bovendien kan chronische blootstelling 
aan worminfecties vermindering van de energie-inname veroorzaken en door de slechte 
voedingstoestand die dan ontstaat een belangrijke rol spelen bij het opzetten van een effectief 
regulatoir netwerk, gunstig om HVZ en T2D te voorkomen. Een mogelijke benadering om dit 
verder te onderzoeken is een lange-termijn, robuust, placebo-gecontroleerd onderzoek met 
wormbehandeling, om na te gaan of wormen een verband hebben met minder ontsteking, 
lagere hoeveelheden vetten en suikers en gevoeligheid voor insuline. In dat geval zou 











AAM  Alternatively activated macrophages
ACT  Artemisinin-combination therapy
Ag  Antigen
BMI  Body mass index
Breg  Regulatory B cells
CAM  Classically activated macrophages
CBC  Complete blood count
cIMT  Carotid Intima Media Thickness
CT  Cycle-treshold
CTLA-4  Cytotoxic T-lymphocyte-associated protein 4
CRP  C-reactive protein
CVD  Cardiovascular diseases
Dreg  Regulatory D cells
DM2  Type-2 diabetes
FBG  Fasting blood glucose
HC  Hip circumference
HDL  High density lipoprotein
HIC  High income countries
HIV  Human immunodeficiency virus
HOMA-IR Homeostasis model assessment for insulin resistance
IBD  Inflammatory bowel diseases
IFN-γ  Interferon γ
IgE  Immunoglobulin E
IL   Interleukin
iRBC(PfRBC) Infected red blood cells (Plasmodium falciparum infected red blood cells)
ITN  Insecticide-treated nets
LDL  Low density lipoprotein
LLIN  long-lasting insecticide-treated nets
LMIC  Low-to-middle income countries
LPS  Lipopolysaccharide 
miRNA  MicroRNA
metS  Metabolic syndrome
MS  Multiple sclerosis
PRDX  Peroxiredoxin
PHA  Phytohaemagglutinin
RCT  Randomized control trial
SPT  Skin prick test
STH  Soil-transmitted helminths
T2D  Type-2 diabetes
TB  Tuberculosis




TGF-β  Transforming growth factor β
TIgE  Total IgE
TNF/TNF-α Tumor necrosis factor/ Tumor necrosis factor- α
Treg  Regulatory T cells
TST  Tuberculin skin test
uRBC  Uninfected red blood cells
WC  Waist circumference
WHR  Waist-to-hip ratio
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